molecule_chembl_id,target_chembl_id,target_pref_name,standard_type,standard_relation,standard_value,standard_units,assay_chembl_id,assay_type,assay_description,document_chembl_id,readout,smiles
CHEMBL376897,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.1,nM,CHEMBL745651,B,Compound was evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS radioligand using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12
CHEMBL59347,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,32589.6,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,COc1cc2c(cc1OC)C1Oc3ccc4[nH]c(C)cc4c3CN1CC2
CHEMBL303758,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2720.9,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(C)ccc2C1O3
CHEMBL61494,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,10315.1,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,CCOC(=O)c1c[nH]c2ccc3c(c12)CN1CCc2cc(OC)c(OC)cc2C1O3
CHEMBL60142,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3704.2,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,CCOC(=O)c1c[nH]c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL277642,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,333.6,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,C[C@@H]1OC(=O)[C@H]2C[C@H]3CCCC[C@@H]3[C@@H](/C=C/[C@H]3CCC[C@H](C)N3C)[C@@H]12
CHEMBL1092,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,26.3,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,Cl.OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1
CHEMBL62247,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2629.0,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(OCC)ccc2C1O3
CHEMBL294726,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,15293.8,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,COc1ccc2c(c1)CCN1Cc3c(ccc4[nH]c(C)cc34)OC21
CHEMBL62251,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2817.0,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,COc1ccc2c(c1)CCN1Cc3c(ccc4[nH]c(C)c(C(=O)OC(C)C)c34)OC21
CHEMBL61700,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3067.8,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(Oc4ccccc4)ccc2C1O3
CHEMBL61412,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1482.3,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,CCCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,880.0,nM,CHEMBL745651,B,Compound was evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS radioligand using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL300987,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,10804.1,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2ccc(OC)cc2C1O3
CHEMBL58228,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1616.4,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(OC)c(OC)cc2C1O3
CHEMBL301041,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5493.9,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2ccccc2C1O3
CHEMBL59898,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,950.0,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL304036,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2827.7,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cccc(C)c2C1O3
CHEMBL61774,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,12612.2,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,COC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2ccccc2C1O3
CHEMBL59939,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3394.0,nM,CHEMBL745650,B,Evaluated for its binding affinity at human muscarinic receptor m3 by the displacement of [3H]NMS binding using membranes from transfected chinese hamster ovarian cell,CHEMBL1131391,IC50,COC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL137384,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,380.0,nM,CHEMBL746514,B,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",CHEMBL1130270,IC50,CO/N=C(\C#N)[C@H]1CN2CC[C@H]1C2
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,9100.0,nM,CHEMBL746514,B,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",CHEMBL1130270,IC50,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL134641,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,60.0,nM,CHEMBL746514,B,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",CHEMBL1130270,IC50,CO/N=C(\C#N)[C@H]1CN2CCC1CC2
CHEMBL341447,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5400.0,nM,CHEMBL746514,B,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",CHEMBL1130270,IC50,C[N+](C)(C)CC#CCOC(=O)c1cccc(Cl)c1
CHEMBL344892,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,300.0,nM,CHEMBL746514,B,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",CHEMBL1130270,IC50,CO/N=C(\C#N)C12CCN(CC1)C2
CHEMBL7303,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,11000.0,nM,CHEMBL746514,B,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",CHEMBL1130270,IC50,COC(=O)C1=CCCN(C)C1
CHEMBL132698,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2200.0,nM,CHEMBL746514,B,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",CHEMBL1130270,IC50,CO/N=C/[C@H]1CN2CC[C@H]1C2
CHEMBL135328,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1200.0,nM,CHEMBL746514,B,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB) as radioligand in human cloned Muscarinic acetylcholine receptor M3",CHEMBL1130270,IC50,CO/N=C(\C#N)[C@@H]1CN2CC[C@H]1C2
CHEMBL135645,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,28.0,nM,CHEMBL746515,B,"In vitro affinity is evaluated, using quinuclidynyl benzylate (QNB)radioligand in human cloned Muscarinic acetylcholine receptor M3",CHEMBL1130270,IC50,CO/N=C(\C#N)C12CCCN(CC1)C2
CHEMBL15675,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,9700.0,nM,CHEMBL747474,B,Compound was evaluated for its ability to displace [3H]N-methylscopolamine ([3H]NMS) binding to cloned CHO cell lines expressing Muscarinic acetylcholine receptor M3,CHEMBL1131636,IC50,CN1CCC2=C(C1)c1nsnc1SC2
CHEMBL15936,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,100000.0,nM,CHEMBL747474,B,Compound was evaluated for its ability to displace [3H]N-methylscopolamine ([3H]NMS) binding to cloned CHO cell lines expressing Muscarinic acetylcholine receptor M3,CHEMBL1131636,IC50,c1cc2nsnc2c2c1CCNC2
CHEMBL15944,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1600.0,nM,CHEMBL747474,B,Compound was evaluated for its ability to displace [3H]N-methylscopolamine ([3H]NMS) binding to cloned CHO cell lines expressing Muscarinic acetylcholine receptor M3,CHEMBL1131636,IC50,CSc1nsnc1C1=CCCN(C)C1
CHEMBL7634,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,17000.0,nM,CHEMBL747474,B,Compound was evaluated for its ability to displace [3H]N-methylscopolamine ([3H]NMS) binding to cloned CHO cell lines expressing Muscarinic acetylcholine receptor M3,CHEMBL1131636,IC50,O=C1CCCN1CC#CCN1CCCC1
CHEMBL7303,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,58000.0,nM,CHEMBL747474,B,Compound was evaluated for its ability to displace [3H]N-methylscopolamine ([3H]NMS) binding to cloned CHO cell lines expressing Muscarinic acetylcholine receptor M3,CHEMBL1131636,IC50,COC(=O)C1=CCCN(C)C1
CHEMBL120472,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,114.7,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OCCC2CCCCC2)C1.O=C(O)C(=O)O
CHEMBL118241,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,675.6,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCCCCOC(=O)C1CN(CC)CC=C1c1ccccc1.O=C(O)C(=O)O
CHEMBL124173,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1491.0,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC=C(c2ccccc2)C(C(=O)OCCc2ccc(C)cc2)C1.O=C(O)C(=O)O
CHEMBL334093,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2046.8,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC=C(c2ccccc2)C(C(=O)OCCCCCc2ccccc2)C1.O=C(O)C(=O)O
CHEMBL332980,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,40.8,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OC2CCCCC2)C1.O=C(O)C(=O)O
CHEMBL1160977,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,521.6,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCCOC(=O)C1CN(CC)CC=C1c1ccccc1.O=C(O)C(O)C(O)C(=O)O
CHEMBL543890,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,749.3,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OCCCc2ccccc2)C1.Cl
CHEMBL120109,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5523.7,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OC)C1.O=C(O)C(=O)O
CHEMBL332181,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,290.0,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCOC(=O)C1CN(CC)CC=C1c1ccccc1.O=C(O)C(=O)O
CHEMBL120581,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,257.5,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OCC(C)C)C1.O=C(O)C(=O)O
CHEMBL431688,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1927.8,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCc1noc(C2=C(c3ccccc3)CCN(CC)C2)n1.O=C(O)C(=O)O
CHEMBL340561,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,356.9,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCOC(=O)C1=C(c2ccccc2)CCN(CC)C1.O=C(O)C(=O)O
CHEMBL9967,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,955.6,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1
CHEMBL120539,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,6874.7,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCOC(=O)C1CN(CC)CC=C1c1ccccc1.O=C(O)C(=O)O
CHEMBL543177,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,211.3,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OCc2ccccc2)C1.Cl
CHEMBL330892,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1653.8,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC=C(c2ccccc2)C(C(=O)OCCc2ccccc2)C1.O=C(O)C(=O)O
CHEMBL120135,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2551.1,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC[C@@H](c2ccccc2)[C@@H](C(=O)OC2CCCCC2)C1
CHEMBL121552,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,844.6,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC=C(c2ccccc2)C(C(=O)OCC(C)C)C1.O=C(O)C(=O)O
CHEMBL262198,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,100.7,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OCCc2ccccc2)C1.O=C(O)C(=O)O
CHEMBL1160977,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,630.5,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCCOC(=O)C1CN(CC)CC=C1c1ccccc1.O=C(O)C(O)C(O)C(=O)O
CHEMBL121385,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2801.3,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OCCCC2CCCCC2)C1.O=C(O)C(=O)O
CHEMBL121059,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,201.6,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCCCCCOC(=O)C1=C(c2ccccc2)CCN(CC)C1
CHEMBL333125,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1842.0,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OCCCCc2ccccc2)C1.O=C(O)C(=O)O
CHEMBL332645,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,16753.5,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC=C(c2ccccc2)C(C(=O)Oc2ccccc2)C1.O=C(O)C(=O)O
CHEMBL262303,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,4514.2,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC[C@@H](c2ccccc2)[C@H](C(=O)OC2CCCCC2)C1.O=C(O)C(=O)O
CHEMBL338280,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,4069.7,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CCC(c2ccccc2)=C(C(=O)Oc2ccccc2)C1.O=C(O)C(=O)O
CHEMBL121476,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1095.5,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCCCOC(=O)C1CN(CC)CC=C1c1ccccc1.O=C(O)C(=O)O
CHEMBL120080,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,86.5,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCCCCOC(=O)C1=C(c2ccccc2)CCN(CC)C1.O=C(O)C(=O)O
CHEMBL118553,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,24861.7,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC=C(c2ccccc2)C(C(=O)OCCCC2CCCCC2)C1.O=C(O)C(=O)O
CHEMBL333940,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,983.0,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCCCCCCOC(=O)C1CN(CC)CC=C1c1ccccc1
CHEMBL121298,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,14309.6,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC=C(c2ccccc2)C(C(=O)OCCCCc2ccccc2)C1.O=C(O)C(=O)O
CHEMBL121520,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,155.8,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OCC2CCCCC2)C1.O=C(O)C(=O)O
CHEMBL120963,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5051.5,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OCC(c2ccccc2)c2ccccc2)C1.O=C(O)C(=O)O
CHEMBL122353,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2312.2,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCOC(=O)C1CN(CC)CC=C1c1ccccc1.O=C(O)C(=O)O
CHEMBL116601,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,918.0,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCOC(=O)C1CN(CC)CC=C1c1ccccc1.O=C(O)C(=O)O
CHEMBL340780,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,220.3,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCCOC(=O)[C@H]1CN(CC)CC[C@H]1c1ccccc1.O=C(O)C(=O)O
CHEMBL120972,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1600.8,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCCCCCOC(=O)C1CN(CC)CC=C1c1ccccc1
CHEMBL334194,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3175.4,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC[C@@H](c2ccccc2)[C@@H](C(=O)OCCc2ccccc2)C1.O=C(O)C(=O)O
CHEMBL123099,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,52495.5,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OCCc2ccc(OC)cc2)C1.O=C(O)C(=O)O
CHEMBL333065,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1308.0,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCCOC(=O)C1CN(CC)CC=C1c1ccccc1.O=C(O)C(=O)O
CHEMBL330999,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,109.6,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC=C(c2ccccc2)C(C(=O)OCC2CCCCC2)C1.O=C(O)C(=O)O
CHEMBL122354,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,349.0,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCCOC(=O)C1=C(c2ccccc2)CCN(CC)C1.O=C(O)C(=O)O
CHEMBL324712,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,535.5,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCOC(=O)C1=C(c2ccccc2)CCN(CC)C1.O=C(O)C(=O)O
CHEMBL332320,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,399.5,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCCCCCCOC(=O)C1=C(c2ccccc2)CCN(CC)C1
CHEMBL541584,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,403.6,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC=C(c2ccccc2)C(C(=O)OCc2ccccc2)C1.Cl
CHEMBL120119,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,88.3,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OCCc2ccc(C)cc2)C1.O=C(O)C(=O)O
CHEMBL540316,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1244.3,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC=C(c2ccccc2)C(C(=O)OCCCc2ccccc2)C1.Cl
CHEMBL331516,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,447.9,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OCCCCCc2ccccc2)C1.O=C(O)C(=O)O
CHEMBL1160977,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,457.8,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCCOC(=O)C1CN(CC)CC=C1c1ccccc1.O=C(O)C(O)C(O)C(=O)O
CHEMBL121299,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1218.7,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC=C(c2ccccc2)C(C(=O)OCCc2ccc(OC)cc2)C1.O=C(O)C(=O)O
CHEMBL334245,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,162.5,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCCCOC(=O)C1=C(c2ccccc2)CCN(CC)C1.O=C(O)C(=O)O
CHEMBL123198,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,871.1,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC=C(c2ccccc2)C(C(=O)OCC(c2ccccc2)c2ccccc2)C1.O=C(O)C(=O)O
CHEMBL120329,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,684.0,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCOC(=O)C1=C(c2ccccc2)CCN(CC)C1.O=C(O)C(=O)O
CHEMBL2112589,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,315.4,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC[C@@H](c2ccccc2)[C@H](C(=O)OCCc2ccccc2)C1.O=C(O)C(=O)O
CHEMBL324936,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,299.3,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC=C(c2ccccc2)C(C(=O)OC2CCCCC2)C1.O=C(O)C(=O)O
CHEMBL330885,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,88401.3,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC=C(c2ccccc2)C(C(=O)OC)C1.O=C(O)C(=O)O
CHEMBL332335,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1689.3,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCOC(=O)C1=C(c2ccccc2)CCN(CC)C1.O=C(O)C(=O)O
CHEMBL120599,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,529.6,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCN1CC=C(c2ccccc2)C(C(=O)OCCC2CCCCC2)C1.O=C(O)C(=O)O
CHEMBL332405,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,6712.1,nM,CHEMBL746513,B,Displacement of [3H]-NMS binding to human Muscarinic acetylcholine receptor M3 using membranes from transfected CHO cells,CHEMBL1132561,IC50,CCCCCc1noc(C2CN(CC)CC=C2c2ccccc2)n1.O=C(O)C(=O)O
CHEMBL556798,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2070.0,nM,CHEMBL869756,B,Binding affinity to muscarinic M3 receptor,CHEMBL1138901,IC50,CCCCN1C(=O)C(CC2CCCCC2)NC(=O)C12CCN(Cc1ccc3c(c1)OCCO3)CC2.Cl
CHEMBL496376,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,11000.0,nM,CHEMBL1003790,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1139391,IC50,NC(=O)CN1CCCC(c2ccccc2)(C2CCN(Cc3ccc(Br)cc3)CC2)C1
CHEMBL498556,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3000.0,nM,CHEMBL1003790,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1139391,IC50,CC(=O)N1CCCC(c2ccccc2)(C2CCN(Cc3ccc(Br)cc3)CC2)C1
CHEMBL493079,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,31.62,nM,CHEMBL1024867,B,Inhibition of human cloned muscarinic M3 receptor expressed in CHO cells by FLIPR assay,CHEMBL1140120,IC50,O=C(NCc1cccc(-c2cccc(CN3CCNCC3)c2)c1)c1ccc2c(c1)OCO2
CHEMBL461571,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1560.0,nM,CHEMBL980773,B,Displacement of radioligand from muscarinic M3 receptor,CHEMBL1139415,IC50,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1
CHEMBL76897,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.59,nM,CHEMBL947359,B,Displacement of radiolabeled 4DAMP from human muscarinic M3 receptor,CHEMBL1140203,IC50,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL505197,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5890.0,nM,CHEMBL1006036,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,CHEMBL1141748,IC50,CCCCCCCCCC(OC(=O)C(CCCCN(O)C(C)=O)NC(=O)c1coc(-c2ccccc2O)n1)C(C)C(=O)NC1CCCCN(O)C1=O
CHEMBL499519,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,630.0,nM,CHEMBL1006036,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,CHEMBL1141748,IC50,CCCCCCCCCCCC(OC(=O)C(CCCCN(O)C(C)=O)NC(=O)c1coc(-c2ccccc2O)n1)C(C)C(=O)NC1CCCCN(O)C1=O
CHEMBL507760,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,4700.0,nM,CHEMBL1006036,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,CHEMBL1141748,IC50,CCCCCCCCCCCC(OC(=O)C(CCCCN(O)C(C)=O)NC(=O)c1coc(-c2ccccc2O)n1)C(C)C(=O)NC1CCCCNC1=O
CHEMBL450986,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1100.0,nM,CHEMBL1006036,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,CHEMBL1141748,IC50,CCCCCCCCCCCCCC(OC(=O)C(CCCCN(O)C(C)=O)NC(=O)c1coc(-c2ccccc2O)n1)C(C)C(=O)NC1CCCCN(O)C1=O
CHEMBL510340,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,4560.0,nM,CHEMBL1006036,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,CHEMBL1141748,IC50,CCCCCCCCCCCCCC(OC(=O)C(CCCCN(O)C(C)=O)NC(=O)c1coc(-c2ccccc2O)n1)C(C)C(=O)NC1CCCCNC1=O
CHEMBL508807,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,6290.0,nM,CHEMBL1006036,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,CHEMBL1141748,IC50,CCCCCCCCCCCCCCCC(OC(=O)C(CCCCN(O)C(C)=O)NC(=O)c1coc(-c2ccccc2O)n1)C(C)C(=O)NC1CCCCN(O)C1=O
CHEMBL480464,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,126.0,nM,CHEMBL972959,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in insect Sf9 cells,CHEMBL1158736,IC50,CC[C@@H](C)[C@@H](O)C(=O)OC[C@H]1CCN2CCC[C@@H]12
CHEMBL76897,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.6,nM,CHEMBL982837,B,Inhibition of human muscarinic M3 receptor,CHEMBL1155111,IC50,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL549577,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.76,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1CN2CCC1CC2)C1c2ccccc2Oc2ccccc21
CHEMBL551525,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,94.0,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1CN2CCC1CC2)C1c2ccccc2CCc2ccccc21
CHEMBL563887,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.92,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1CN2CCC1CC2)C1(O)c2ccccc2-c2ccccc21
CHEMBL551729,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.23,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1CN2CCC1CC2)C(O)(c1cccs1)c1cccs1
CHEMBL558910,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.9,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1CN2CCC1CC2)C(O)(c1ccccc1)c1ccccc1
CHEMBL564747,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.31,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1CN2CCC1CC2)[C@@](O)(c1ccccc1)c1cccs1
CHEMBL556426,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.42,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1CN2CCC1CC2)[C@](O)(c1ccccc1)c1cccs1
CHEMBL562642,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.39,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1CN2CCC1CC2)[C@](O)(c1cccs1)C1CCCC1
CHEMBL554699,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.7,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1CN2CCC1CC2)[C@@](O)(c1cccs1)C1CCCC1
CHEMBL563996,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.68,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,CCCCCCC[N+]12CCC(CC1)[C@@H](OC(=O)C1(O)c3ccccc3-c3ccccc31)C2.[Br-]
CHEMBL562655,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.04,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(CCc3ccccc3)CCC1CC2)C1(O)c2ccccc2-c2ccccc21.[Br-]
CHEMBL561870,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.71,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C1(O)c2ccccc2-c2ccccc21.[Br-]
CHEMBL560327,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.6,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,C[N+]12CCC(CC1)[C@@H](OC(=O)C(O)(c1cccs1)c1cccs1)C2.[Br-]
CHEMBL549784,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.39,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,CCCCCCC[N+]12CCC(CC1)[C@@H](OC(=O)C(O)(c1cccs1)c1cccs1)C2.[Br-]
CHEMBL556634,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,200.0,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(Cc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]
CHEMBL564057,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.2,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(CCc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]
CHEMBL554725,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.45,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(CCCCc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]
CHEMBL551466,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.17,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]
CHEMBL559106,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.31,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(CCc3ccccc3)CCC1CC2)C1c2ccccc2Oc2ccccc21.[Br-]
CHEMBL564515,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.28,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(CCc3ccccc3)CCC1CC2)C1(O)c2ccccc2Oc2ccccc21.[Br-]
CHEMBL562890,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.04,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C1(O)c2ccccc2Oc2ccccc21.[Br-]
CHEMBL551731,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.61,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL556635,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.18,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)[C@](O)(c1cccs1)C1CCCC1.[Br-]
CHEMBL549986,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.62,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)[C@@](O)(c1cccs1)C1CCCC1.[Br-]
CHEMBL556221,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.24,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,CC1(C(=O)O[C@H]2C[N+]3(CCCOc4ccccc4)CCC2CC3)c2ccccc2Oc2ccccc21.[Br-]
CHEMBL559931,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.96,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,CC1(C(=O)O[C@H]2C[N+]3(CCCOc4ccccc4)CCC2CC3)c2ccccc2-c2ccccc21.[Br-]
CHEMBL551063,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.37,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(c1cccs1)c1cccs1.[Br-]
CHEMBL551327,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.24,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1ccsc1)c1ccsc1.[Br-]
CHEMBL561187,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.59,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,CC(C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c1cccs1)c1cccs1.[Br-]
CHEMBL556222,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.25,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)[C@@](O)(c1ccccc1)c1cccs1.[Br-]
CHEMBL564765,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.48,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)[C@](O)(c1ccccc1)c1cccs1.[Br-]
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.35,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL1908368,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.07,nM,CHEMBL1058942,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHOK1 cells by microplate scintillation counting,CHEMBL1152978,IC50,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2.O.[Br-]
CHEMBL1084850,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.995,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,OC(CCC1CCNCC1)c1ccccc1-c1cccc(Cl)c1
CHEMBL1084851,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,12.59,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,Clc1cccc(-c2ccccc2/C=C/CC2CCNCC2)c1
CHEMBL1085556,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1995.26,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,O=C(NCc1ccccc1-c1cccc(Cl)c1)C1CCNCC1
CHEMBL1084804,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,125.89,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,O=C(Cc1ccccc1-c1cccc(Cl)c1)NC1CCNCC1
CHEMBL1084805,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,70.0,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,CN(C(=O)Cc1ccccc1-c1cccc(Cl)c1)C1CCNCC1
CHEMBL1083402,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,19.95,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,O=S(=O)(CCC1CCNCC1)c1ccccc1-c1cccc(Cl)c1
CHEMBL1083403,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3981.07,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,Fc1cccc(-c2cc(Cl)ccc2Cl)c1-c1nc(C2CCNCC2)no1
CHEMBL1083404,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1258.93,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,O=C(NCC1CCNCC1)c1c(F)cccc1-c1cc(Cl)ccc1Cl
CHEMBL1083925,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,39.81,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,C[C@H]1CNCC[C@@H]1CNC(=O)c1c(F)cccc1-c1cccc(Cl)c1
CHEMBL1083926,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2511.89,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,C[C@H]1CNCC[C@H]1CNC(=O)c1c(F)cccc1-c1cccc(Cl)c1
CHEMBL1083618,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3162.28,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,O=C(NCC1=CCNCC1)c1c(F)cccc1-c1cccc(Cl)c1
CHEMBL1083002,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,10000.0,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,CC[C@H]1CNCC[C@@H]1CNC(=O)c1c(F)cccc1-c1cccc(Cl)c1
CHEMBL1083003,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,10000.0,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,O=C(NC[C@H]1CCNC[C@H]1F)c1c(F)cccc1-c1cccc(Cl)c1
CHEMBL1083317,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,10000.0,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,O=C(NCC1=C(F)CNCC1)c1c(-c2cccc(Cl)c2)ccc(Cl)c1F
CHEMBL1085985,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1258.93,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,O=C(NCC1(F)CCNCC1)c1c(F)cccc1-c1cccc(Cl)c1
CHEMBL1082365,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5011.87,nM,CHEMBL1117839,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158595,IC50,C[C@H]1CNCC[C@]1(F)CNC(=O)c1c(F)cccc1-c1cccc(Cl)c1
CHEMBL1085507,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3981.07,nM,CHEMBL1118805,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158607,IC50,O=C(NCC1CCNCC1)c1ccccc1-c1cccc(Cl)c1
CHEMBL1083723,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,251.19,nM,CHEMBL1118805,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158607,IC50,Cc1ccc(-c2ccccc2C(=O)NCC2CCNCC2)cc1Cl
CHEMBL1083108,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1000.0,nM,CHEMBL1118805,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158607,IC50,O=C(NCC1CCNCC1)c1ccccc1-c1cc(Cl)ccc1F
CHEMBL1084993,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1258.93,nM,CHEMBL1118805,B,Inhibition of human muscarinic M3 receptor expressed in CHO cells,CHEMBL1158607,IC50,CC1CNCCC1CNC(=O)c1ccccc1-c1cccc(Cl)c1
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.05012,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL1201027,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.2512,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.[Br-]
CHEMBL551466,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1259,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]
CHEMBL1290183,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,100.0,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,O=C(c1ccccc1)N1CCC2(CCN(Cc3cccc(Cl)c3)CC2)CC1
CHEMBL1290184,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,100.0,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,Cc1cccc(CN2CCC3(CC2)CCN(C(=O)c2ccccc2)CC3)c1
CHEMBL1290294,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,125.89,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,O=C(c1ccccc1)N1CCC2(CCN(Cc3ccccc3)CC2)CC1
CHEMBL1290410,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,316.23,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,O=C(c1ccsc1)N1CCC2(CCN(Cc3ccccc3)CC2)CC1
CHEMBL1290634,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,794.33,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,CCOc1ccccc1C(=O)N1CCC2(CCN(Cc3ccccc3)CC2)CC1
CHEMBL1290635,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,251.19,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,O=C(c1ccccc1)N1CCOC2(CCN(Cc3ccc(Cl)cc3)CC2)C1
CHEMBL1290752,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,31.62,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,O=C(c1ccc2occc2c1)N1CCOC2(CCN(Cc3ccc(Cl)cc3)CC2)C1
CHEMBL1290753,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,50.12,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,Cc1ccc(C(=O)N2CCOC3(CCN(Cc4ccc(Cl)cc4)CC3)C2)o1
CHEMBL1289081,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,63.1,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,O=C(c1ccco1)N1CCOC2(CCN(Cc3ccc(Cl)cc3)CC2)C1
CHEMBL1289082,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,63.1,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,O=C(c1cccs1)N1CCOC2(CCN(Cc3ccc(Cl)cc3)CC2)C1
CHEMBL1289201,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,100.0,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,O=C(c1ccc(CO)o1)N1CCOC2(CCN(Cc3ccc(Cl)cc3)CC2)C1
CHEMBL1289202,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,125.89,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,O=C(c1ccoc1)N1CCOC2(CCN(Cc3ccc(Cl)cc3)CC2)C1
CHEMBL1289314,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,199.53,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,O=C(c1cnsn1)N1CCOC2(CCN(Cc3ccc(Cl)cc3)CC2)C1
CHEMBL1289315,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,398.11,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,O=C(c1ncccn1)N1CCOC2(CCN(Cc3ccc(Cl)cc3)CC2)C1
CHEMBL1289432,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,398.11,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,O=C(c1ccon1)N1CCOC2(CCN(Cc3ccc(Cl)cc3)CC2)C1
CHEMBL1289544,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,158.49,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,O=C(c1cscn1)N1CCOC2(CCN(Cc3ccc(Cl)cc3)CC2)C1
CHEMBL1289545,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,10.0,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,Cc1nc(C(=O)N2CCOC3(CCN(Cc4ccc(Cl)cc4)CC3)C2)cs1
CHEMBL1289653,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.259,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,Cc1nc(C(=O)N2CCOC3(CCN(Cc4cccc(Cl)c4)CC3)C2)cs1
CHEMBL1289654,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,7.943,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,Cc1nc(C(=O)N2CCOC3(CCN(Cc4ccccc4Cl)CC3)C2)cs1
CHEMBL1289758,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,15.85,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,CCc1nc(C(=O)N2CCOC3(CCN(Cc4ccc(Cl)cc4)CC3)C2)cs1
CHEMBL1289865,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,15.85,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,CC(C)c1nc(C(=O)N2CCOC3(CCN(Cc4ccc(Cl)cc4)CC3)C2)cs1
CHEMBL1289866,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.981,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,CC(C)c1nc(C(=O)N2CCOC3(CCN(Cc4ccccc4)CC3)C2)cs1
CHEMBL1289982,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,19.95,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,CC(C)c1nc(C(=O)N2CCOC3(CCN(Cc4ccccc4Cl)CC3)C2)cs1
CHEMBL1289983,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5.012,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,CC(C)c1nc(C(=O)N2CCOC3(CCN(Cc4cccc(Cl)c4)CC3)C2)cs1
CHEMBL1290077,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,398.11,nM,CHEMBL1291429,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 16 hrs by scintillation proximity assay,CHEMBL1287723,IC50,Cc1ccccc1CN1CCC2(CC1)CN(C(=O)c1csc(C(C)C)n1)CCO2
CHEMBL76897,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.9,nM,CHEMBL1663601,B,Inhibition of human muscarinic M3 receptor,CHEMBL1649335,IC50,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL1770373,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,300.0,nM,CHEMBL1772902,B,Binding affinity to muscarinic M3 receptor,CHEMBL1770110,IC50,c1ccc(Cc2ncc3c(n2)CCNCC3)cc1
CHEMBL1779031,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,796.8,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1CN2CCC1CC2)N(c1ccccc1)c1ccccc1
CHEMBL1777826,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.2,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1CN2CCC1CC2)N(Cc1ccccc1)c1ccccc1
CHEMBL1779032,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.6,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1CN2CCC1CC2)N(CCc1ccccc1)c1ccccc1
CHEMBL1779033,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.6,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1CN2CCC1CC2)N(Cc1cccs1)c1ccccc1
CHEMBL1779034,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.0,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1CN2CCC1CC2)N(Cc1ccsc1)c1ccccc1
CHEMBL1779035,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,71.1,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,CCCN(C(=O)O[C@H]1CN2CCC1CC2)c1ccccc1
CHEMBL1779036,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,4.3,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,CCCCN(C(=O)O[C@H]1CN2CCC1CC2)c1ccccc1
CHEMBL1779037,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.7,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,CCCCCN(C(=O)O[C@H]1CN2CCC1CC2)c1ccccc1
CHEMBL1779038,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,659.3,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,CC(C)N(C(=O)O[C@H]1CN2CCC1CC2)c1ccccc1
CHEMBL1779039,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,22.5,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1CN2CCC1CC2)N(Cc1ccccc1)Cc1cccs1
CHEMBL1779040,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5.9,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1CN2CCC1CC2)N(Cc1cccs1)Cc1cccs1
CHEMBL1779041,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,17.7,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,CCCCN(Cc1cccs1)C(=O)O[C@H]1CN2CCC1CC2
CHEMBL1779042,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,74.7,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,Cc1ccc(N(Cc2ccccc2)C(=O)O[C@H]2CN3CCC2CC3)cc1
CHEMBL1779043,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,15.0,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1CN2CCC1CC2)N(Cc1ccccc1)c1ccc(F)cc1
CHEMBL1779044,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.4,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1CN2CCC1CC2)N(Cc1cccc(F)c1)c1cccc(F)c1
CHEMBL1779045,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.4,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,Cc1cccc(N(Cc2cc(F)c(F)cc2F)C(=O)O[C@H]2CN3CCC2CC3)c1
CHEMBL1779046,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.5,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1CN2CCC1CC2)N(Cc1cc(F)c(F)c(F)c1)c1cccc(F)c1
CHEMBL1200803,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,130.8,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O)CCC(=O)O.O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1
CHEMBL1779047,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,6.0,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,Cl.O=C(Nc1ccccc1-c1ccccc1)OC12CCN(CC1)CC2
CHEMBL1779048,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,17.7,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1C[N+]2(CCc3ccccc3)CCC1CC2)N(Cc1ccccc1)c1ccccc1.[Br-]
CHEMBL1779049,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.3,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1C[N+]2(CCCc3ccccc3)CCC1CC2)N(Cc1ccccc1)c1ccccc1.[Br-]
CHEMBL1779128,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.6,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1C[N+]2(CCCc3cccs3)CCC1CC2)N(Cc1ccccc1)c1ccccc1.[Br-]
CHEMBL1779129,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.0,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1C[N+]2(CCOc3ccccc3)CCC1CC2)N(Cc1ccccc1)c1ccccc1.[Br-]
CHEMBL1779130,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,18.6,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,C[N+]12CCC(CC1)[C@@H](OC(=O)N(Cc1cccs1)c1ccccc1)C2.[Br-]
CHEMBL1777827,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.5,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1C[N+]2(CCCc3cccs3)CCC1CC2)N(Cc1cccs1)c1ccccc1.[Br-]
CHEMBL1779131,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.3,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1C[N+]2(CCOc3ccccc3)CCC1CC2)N(Cc1cccs1)c1ccccc1.[Br-]
CHEMBL1779132,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.6,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1C[N+]2(CCCc3cccs3)CCC1CC2)N(Cc1ccsc1)c1ccccc1.[Br-]
CHEMBL1779133,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.2,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1C[N+]2(CCOc3ccccc3)CCC1CC2)N(Cc1ccsc1)c1ccccc1.[Br-]
CHEMBL1779134,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,19.0,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,CCCCN(C(=O)O[C@H]1C[N+]2(CCc3ccccc3)CCC1CC2)c1ccccc1.[Br-]
CHEMBL1779135,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.8,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,CCCCN(C(=O)O[C@H]1C[N+]2(CCCc3ccccc3)CCC1CC2)c1ccccc1.[Br-]
CHEMBL1779136,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.6,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,CCCCN(C(=O)O[C@H]1C[N+]2(CCCc3cccs3)CCC1CC2)c1ccccc1.[Br-]
CHEMBL1779137,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.8,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,CCCCN(C(=O)O[C@H]1C[N+]2(CCOc3ccccc3)CCC1CC2)c1ccccc1.[Br-]
CHEMBL1779138,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.9,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,Cc1cccc(N(Cc2cc(F)c(F)cc2F)C(=O)O[C@H]2C[N+]3(CCCc4ccccc4)CCC2CC3)c1.[Br-]
CHEMBL1779139,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.2,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,Cc1cccc(N(Cc2cc(F)c(F)cc2F)C(=O)O[C@H]2C[N+]3(CCOc4ccccc4)CCC2CC3)c1.[Br-]
CHEMBL1779140,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.6,nM,CHEMBL1781310,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 1 hr by scintillation counting,CHEMBL1777779,IC50,O=C(O[C@H]1C[N+]2(CCOc3ccccc3)CCC1CC2)N(Cc1cc(F)c(F)c(F)c1)c1cccc(F)c1.[Br-]
CHEMBL221753,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,383.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]
CHEMBL517712,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.071,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2
CHEMBL1201203,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.285,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2
CHEMBL296419,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,840.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1
CHEMBL1201207,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,6429.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O
CHEMBL1113,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1781.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
CHEMBL195437,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,19004.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CCCCCCCCc1ccc(O)cc1
CHEMBL633,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3201.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1
CHEMBL629,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,26.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN(C)CCC=C1c2ccccc2CCc2ccccc21
CHEMBL305660,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,647.5,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1
CHEMBL64894,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,4330.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]
CHEMBL808,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1789.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
CHEMBL1319362,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,76.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,Br.CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)c1ccccc1)C2
CHEMBL30008,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1479.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1
CHEMBL41,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3595.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
CHEMBL726,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,4728.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
CHEMBL1201353,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2579.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1
CHEMBL334255,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,34.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]
CHEMBL1626,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,39.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1
CHEMBL657,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,647.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN(C)CCOC(c1ccccc1)c1ccccc1
CHEMBL936,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,245.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1
CHEMBL7002,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,14947.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1
CHEMBL1628227,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,69.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN(C)CCC=C1c2ccccc2COc2ccccc21
CHEMBL1123,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,4.375,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1
CHEMBL648,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,748.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN1CCN(C(c2ccccc2)c2ccccc2)CC1
CHEMBL104,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,9928.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1
CHEMBL1172,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,446.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1
CHEMBL411,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,18432.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1
CHEMBL954,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2071.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1
CHEMBL42,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,78.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL1200406,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,447.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O
CHEMBL71,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,206.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL43064,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,762.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1
CHEMBL1479,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,17747.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C
CHEMBL415,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,170.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21
CHEMBL516,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,46.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1
CHEMBL900,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,175.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,Cc1ccccc1C(OCCN(C)C)c1ccccc1
CHEMBL490,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,179.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1
CHEMBL564,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,416.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN(C)CCCN1c2ccccc2Sc2ccccc21
CHEMBL643,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,20.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CC(CN1c2ccccc2Sc2ccccc21)N(C)C
CHEMBL75880,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3118.6,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1
CHEMBL715,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,392.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL445,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,171.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CNCCC=C1c2ccccc2CCc2ccccc21
CHEMBL1262,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,4531.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
CHEMBL1231,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.71,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1
CHEMBL1909073,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,157.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-]
CHEMBL728,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1514.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL7568,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1255.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12
CHEMBL534,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2209.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1
CHEMBL21731,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,473.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CNCCCC12CCC(c3ccccc31)c1ccccc12
CHEMBL1354199,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.129,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12.[Br-]
CHEMBL6437,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1405.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN1CCN2c3ccccc3Cc3ccccc3C2C1
CHEMBL91,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3154.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
CHEMBL1200633,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,6062.6,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O
CHEMBL787,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,6626.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1
CHEMBL395110,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,191.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1
CHEMBL1490,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,15.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1
CHEMBL2107687,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,26.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-]
CHEMBL1200604,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,142.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1
CHEMBL479,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,90.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
CHEMBL1221,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3404.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
CHEMBL83,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2974.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
CHEMBL404849,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,4623.8,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1
CHEMBL1306,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,14537.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,IC50,CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
CHEMBL1922058,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.2512,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(Cc3noc(-c4ccccc4)n3)CCC1CC2)(c1cccs1)N1CCCCC1
CHEMBL1922057,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.3981,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(Cc3cc(-c4ccccc4)no3)CCC1CC2)(c1cccs1)N1CCCCC1
CHEMBL1922056,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.3162,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(Cc3nc(-c4ccccc4)no3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1922055,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1995,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(Cc3cc(-c4ccccc4)on3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1922054,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1585,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,Cc1ccc2nc(C[N+]34CCC(CC3)[C@@H](OC(=O)[C@](C)(c3ccccc3)N3CCCCC3)C4)oc2c1
CHEMBL1922053,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CC(=O)Nc3cncc(Cl)n3)CCC1CC2)(c1cccs1)N1CCCCC1
CHEMBL1922052,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1995,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CC(=O)Nc3ccon3)CCC1CC2)(c1cccs1)N1CCCCC1
CHEMBL1922051,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1585,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CC(=O)Nc3ccon3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1922050,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1995,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CC(=O)Nc3cnccn3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1922049,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.0,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CC(=O)Nc3cccnn3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1922048,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.259,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CC(=O)Nc3ccncn3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921946,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1259,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CC(=O)Nc3ccccn3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921945,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CC(=O)Nc3cccc(F)c3)CCC1CC2)(c1cccs1)N1CCCCC1
CHEMBL1921944,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1995,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CC(=O)Nc3cccc(F)c3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921943,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1995,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CC(=O)Nc3ccccc3)CCC1CC2)(c1cccs1)N1CCCCC1
CHEMBL1921942,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1995,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CC(=O)Nc3ccccc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921941,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1259,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CC(N)=O)CCC1CC2)(c1cccs1)N1CCCCC1
CHEMBL1921940,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1995,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CC(N)=O)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921939,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.5012,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCOCCc3ccccc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921938,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.7943,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCOCc3ccccc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921937,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.07943,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCCOc3ccc(F)cc3)CCC1CC2)(c1cccs1)N1CCCCC1
CHEMBL1921936,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.631,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCCOc3ccc(F)cc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921935,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.0631,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c1cccs1)N1CCCCC1
CHEMBL1921934,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5.012,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCOc3ccncc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921933,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.0,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,Cc1cccc(OCC[N+]23CCC(CC2)[C@@H](OC(=O)[C@](C)(c2ccccc2)N2CCCCC2)C3)c1
CHEMBL1921932,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.3162,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,Cc1ccc(OCC[N+]23CCC(CC2)[C@@H](OC(=O)[C@](C)(c2ccccc2)N2CCCCC2)C3)cc1
CHEMBL1921931,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.259,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCOc3ccc(Cl)cc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921930,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.162,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCOc3ccc(F)cc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921929,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.631,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCOc3ccccc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921928,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.2512,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCCCc3ccccc3)CCC1CC2)(c1cccs1)N1CCCCC1
CHEMBL1921927,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1995,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCCCc3ccccc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921926,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.3981,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCCc3ccc4ncsc4c3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921925,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.0631,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCCc3cc4ccccc4s3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921924,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.3162,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCCc3nc4ccccc4o3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921923,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.162,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCCc3cncnc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921922,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.259,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,Cc1ccc(CCC[N+]23CCC(CC2)[C@@H](OC(=O)[C@](C)(c2ccccc2)N2CCCCC2)C3)cn1
CHEMBL1921921,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.3162,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCCc3cccnc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921920,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.512,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,Cc1cc(CCC[N+]23CCC(CC2)[C@@H](OC(=O)[C@](C)(c2ccccc2)N2CCCCC2)C3)cc(C)n1
CHEMBL1921919,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1259,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,Cc1cc(CCC[N+]23CCC(CC2)[C@@H](OC(=O)[C@](C)(c2ccccc2)N2CCCCC2)C3)ccn1
CHEMBL1921918,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1585,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCCc3ccncc3)CCC1CC2)(c1cccs1)N1CCCCC1
CHEMBL1921917,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.07943,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCCc3ccncc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921914,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1995,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCC3CCCCC3)CCC1CC2)(c1cccs1)N1CCCCC1
CHEMBL1921913,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.585,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCc3c[nH]c4ccccc34)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921912,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,6.31,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCc3cc4ccccc4o3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921911,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1585,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCC3=CC4CCOC4C=C3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921802,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.162,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCc3cccnc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921910,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1995,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCc3ccc4ccccc4c3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921908,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.05012,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCc3ccc(Cl)s3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921907,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.0631,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCc3cccc(Br)c3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1921904,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1585,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCc3ccc(F)cc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1924025,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1585,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCc3ccccc3F)CCC1CC2)(c1cccs1)N1CCCCC1
CHEMBL1924049,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1259,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCc3ccccc3F)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1924046,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.631,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CC(C)=CCC[N+]12CCC(CC1)[C@@H](OC(=O)[C@](C)(c1ccccc1)N1CCCCC1)C2
CHEMBL1924045,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,7.943,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCCC#N)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1924044,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5.012,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CCCC[N+]12CCC(CC1)[C@@H](OC(=O)[C@](C)(c1ccccc1)N1CCCCC1)C2
CHEMBL1924043,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,251.19,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CCC(CC)[N+]12CCC(CC1)[C@@H](OC(=O)[C@](C)(c1ccccc1)N1CCCCC1)C2
CHEMBL1924042,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.0,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CC(C)[N+]12CCC(CC1)[C@@H](OC(=O)[C@](C)(c1ccccc1)N1CCCCC1)C2
CHEMBL1924041,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.162,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@](C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1924040,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.05012,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c1ccccc1)N1CCCCC1
CHEMBL1924039,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5.012,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CC(C(=O)O[C@H]1CN2CCC1CC2)(c1ccccc1)N1CCCC1
CHEMBL1924037,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.512,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CC(C(=O)OC1CC[N+](C)(C)CC1)(c1ccc(Cl)cc1)N1CCCCC1
CHEMBL1924038,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5.012,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CN1CCC(OC(=O)C(C)(c2ccccc2)N2CCCC2)CC1
CHEMBL1924035,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,158.49,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CCCN(CCC)C(C)(C(=O)OC1CC[N+](C)(C)CC1)c1ccccc1
CHEMBL1924036,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CC(C(=O)OC1CC[N+](C)(C)CC1)(c1cccs1)N1CCCCC1
CHEMBL1924034,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,10.0,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CN(C)C(C)(C(=O)OC1CC[N+](C)(C)CC1)c1ccccc1
CHEMBL1924033,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.0,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CC1CCN(C(C)(C(=O)OC2CC[N+](C)(C)CC2)c2ccccc2)CC1
CHEMBL1924032,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.259,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CC(C(=O)OC1CC[N+](C)(C)CC1)(c1ccccc1)N1CCC(F)(F)CC1
CHEMBL1924031,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.7943,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CC(C(=O)OC1CC[N+](C)(C)CC1)(c1ccccc1)N1CCSCC1
CHEMBL1924030,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.7943,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CC(C(=O)OC1CC[N+](C)(C)CC1)(c1ccccc1)N1C=CC=CC=C1
CHEMBL1924029,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.2512,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CC(C(=O)OC1CC[N+](C)(C)CC1)(c1ccccc1)N1CCCCC1
CHEMBL1924028,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.162,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CC(C(=O)OC1CC[N+](C)(C)CC1)(c1ccccc1)N1CCCC1
CHEMBL1924027,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.03162,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[C@@](C(=O)OC1CC[N+](C)(C)CC1)(c1ccccc1)C1CCCC1.[Br-]
CHEMBL1924026,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.585,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,CC(C(=O)O[C@@H]1CC[N+](C)(C)C1)(c1ccccc1)C1CCCC1.[Br-]
CHEMBL1201335,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.2512,nM,CHEMBL1924273,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs,CHEMBL1921723,IC50,C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1
CHEMBL2203713,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,4500.0,nM,CHEMBL2210242,B,Inhibition of muscarinic M3 receptor,CHEMBL2203205,IC50,N=C(Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1
CHEMBL1180285,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,88.0,nM,CHEMBL2317631,B,Binding affinity to human M3 muscarinic receptor expressed in cell membranes by radioligand binding assay,CHEMBL2311283,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OCCc2ccc(C)cc2)C1
CHEMBL1180284,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5524.0,nM,CHEMBL2317631,B,Binding affinity to human M3 muscarinic receptor expressed in cell membranes by radioligand binding assay,CHEMBL2311283,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OC)C1
CHEMBL1180343,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,52496.0,nM,CHEMBL2317631,B,Binding affinity to human M3 muscarinic receptor expressed in cell membranes by radioligand binding assay,CHEMBL2311283,IC50,CCN1CCC(c2ccccc2)=C(C(=O)OCCc2ccc(OC)cc2)C1
CHEMBL2391353,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,57000.0,nM,CHEMBL2395044,B,Binding affinity to M3 receptor (unknown origin) by radioligand displacement assay,CHEMBL2390872,IC50,O=C(CN1CCN2CCC[C@H]2C1)NC1CCCCC1
CHEMBL2391356,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,83000.0,nM,CHEMBL2395044,B,Binding affinity to M3 receptor (unknown origin) by radioligand displacement assay,CHEMBL2390872,IC50,CC(C)NC(=O)CN1CCNCC1
CHEMBL1983100,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,87000.0,nM,CHEMBL2395044,B,Binding affinity to M3 receptor (unknown origin) by radioligand displacement assay,CHEMBL2390872,IC50,O=C(CN1CCNCC1)NC1CCCCC1
CHEMBL76897,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.43,nM,CHEMBL2395005,B,Binding affinity to human muscarinic M3 receptor by radioligand displacement assay,CHEMBL2390917,IC50,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL76897,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5.1,nM,CHEMBL2395093,B,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHOK1 cells after 2 hrs,CHEMBL2390918,IC50,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL76897,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.56,nM,CHEMBL2395684,B,Binding affinity to human muscarinic M3 receptor by radioligand displacement assay,CHEMBL2390830,IC50,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL3087958,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.3162,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1C[N+]2(Cc3nnc(-c4ccccc4)o3)CCC1CC2)C1(C2=CC=CC2)CCCCCC1
CHEMBL3087957,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.07943,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1C[N+]2(Cc3cc(-c4ccccc4)on3)CCC1CC2)C1(C2=CC=CC2)CCCCCC1
CHEMBL3087956,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,25.12,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1C[N+]2(Cc3csc(-c4ccccc4)n3)CCC1CC2)C1(C2=CC=CC2)CCCCCC1
CHEMBL3087955,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.3981,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1C[N+]2(Cc3ccn(-c4ccccc4)n3)CCC1CC2)C1(C2=CC=CC2)CCCCCC1
CHEMBL3087954,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.2512,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1C[N+]2(Cc3cc(-c4ccccc4)no3)CCC1CC2)C1(C2=CC=CC2)CCCCCC1
CHEMBL3087953,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1585,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1C[N+]2(Cc3nc(-c4ccccc4)no3)CCC1CC2)C1(C2=CC=CC2)CCCCCC1
CHEMBL3087952,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1C[N+]2(Cc3nc4ccccc4o3)CCC1CC2)C1(C2=CC=CC2)CCCCCC1
CHEMBL3087951,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,6.31,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)NCCCNC(=O)c1ccccn1
CHEMBL3087950,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.162,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)NCCNC(=O)c1cnccn1
CHEMBL3087949,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1cncc(Cl)n1
CHEMBL3087948,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.631,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,Cc1cncc(NC(=O)C[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)n1
CHEMBL3087947,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.7943,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,Cc1cnc(NC(=O)C[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)cn1
CHEMBL3087946,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1995,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1ccc(Cl)nn1
CHEMBL3087945,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.512,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1ccc(C(F)(F)F)nn1
CHEMBL3087379,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.7943,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,Cc1ccc(NC(=O)C[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)nn1
CHEMBL3087378,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.0,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,Cc1cc(NC(=O)C[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)ncn1
CHEMBL3087377,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.3981,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,Cc1nccc(NC(=O)C[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)n1
CHEMBL3087376,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.7943,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,Cc1ccc(NC(=O)C[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)cn1
CHEMBL3087375,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.2512,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1ccc(C(F)(F)F)nc1
CHEMBL3087374,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.512,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1cccc(C(F)(F)F)n1
CHEMBL3087373,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.7943,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,Cc1ccnc(NC(=O)C[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)c1
CHEMBL3087372,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.631,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1ccc(F)cn1
CHEMBL3087371,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.5012,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,Cc1ccc(NC(=O)C[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)nc1
CHEMBL3087370,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.2512,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1ncccc1F
CHEMBL3087368,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1585,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1cccnn1
CHEMBL3087367,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1585,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1ccncn1
CHEMBL3087366,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.631,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1cncnc1
CHEMBL3087365,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.512,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1ccncc1
CHEMBL3087364,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1995,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1cccnc1
CHEMBL3087363,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,31.62,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1ccccn1
CHEMBL3087362,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1585,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1ccccn1
CHEMBL3087361,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,10.0,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,CC(C)(C)c1cc(NC(=O)C[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)no1
CHEMBL3087245,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,12.59,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1ncco1
CHEMBL3087244,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.3981,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1ncns1
CHEMBL3087243,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,7.943,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1nncs1
CHEMBL3087242,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1cc[nH]n1
CHEMBL3087241,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1585,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,Cc1cc(NC(=O)C[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)no1
CHEMBL3087239,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,100.0,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)N1CCOCC1
CHEMBL3087238,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1259,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1cccc(F)c1
CHEMBL3087237,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.2512,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2)Nc1ccccc1
CHEMBL3087236,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1995,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,NC(=O)C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2
CHEMBL3087235,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.05012,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1C[N+]2(CCCc3nc4ccccc4o3)CCC1CC2)C1(C2=CC=CC2)CCCCCC1
CHEMBL3087234,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.5012,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,Cn1ccc(CCC[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)n1
CHEMBL3087233,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.0,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,Cc1ccc(CCC[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)c(C)n1
CHEMBL3087232,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1585,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,Cc1ccc(CCC[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)cn1
CHEMBL3087230,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.05012,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1C[N+]2(CCCc3ccncc3)CCC1CC2)C1(c2cccs2)CCCCCC1
CHEMBL3088086,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.0631,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C1(C2=CC=CC2)CCCCCC1
CHEMBL3088085,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1259,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1C[N+]2(CCOCc3ccccc3)CCC1CC2)C1(C2=CC=CC2)CCCCCC1
CHEMBL3088084,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1585,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1C[N+]2(CCOc3ccccc3)CCC1CC2)C1(C2=CC=CC2)CCCCCC1
CHEMBL3088083,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.162,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,N#Cc1ccc(CC[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)cc1
CHEMBL3088081,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.0631,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,Cc1ccc(CC[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)s1
CHEMBL3088080,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.07943,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1C[N+]2(CCc3ccccc3)CCC1CC2)C1(C2=CC=CC2)CCCCCC1
CHEMBL3088079,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.162,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,COc1cccc(C[N+]23CCC(CC2)[C@@H](OC(=O)C2(C4=CC=CC4)CCCCCC2)C3)c1
CHEMBL3088078,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,39.81,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1C[N+]2(Cc3ccc(F)c(F)c3)CCC1CC2)C1(C2=CC=CC2)CCCCCC1
CHEMBL3088077,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,39.81,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1C[N+]2(Cc3ccccc3)CCC1CC2)C1(C2=CC=CC2)CCCCCC1
CHEMBL3088076,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.512,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,C[N+]12CCC(CC1)[C@@H](OC(=O)C1(C3=CC=CC3)CCCCCC1)C2
CHEMBL3088075,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.07943,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1CN2CCC1CC2)C1(c2cccs2)CCCCCC1
CHEMBL3087961,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.0631,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,O=C(O[C@H]1CN2CCC1CC2)C1(c2ccccc2)CCCCCC1
CHEMBL3087960,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.2512,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,C[N+]1(C)CCC(OC(=O)C2(c3ccccc3)CCCCCC2)CC1
CHEMBL3087959,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.03162,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,CC(C(=O)OC1CC[N+](C)(C)CC1)(c1ccccc1)C1CCCC1
CHEMBL1201335,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.1259,nM,CHEMBL3091164,B,Displacement of [3H]NMS from recombinant human M3 receptor expressed in CHO-K1 cells after 16 hrs by SPA method,CHEMBL3085673,IC50,C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1
CHEMBL3401640,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,15.0,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,O=C(N[C@H]1CN2CCC1CC2)C(O)(c1ccccc1)c1ccccc1
CHEMBL3401641,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.2,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,O=C(N[C@H]1CN2CCC1CC2)C(O)(c1cccs1)c1cccs1
CHEMBL3401642,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,110.0,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,O=C(N[C@H]1CN2CCC1CC2)C(c1cccs1)c1cccs1
CHEMBL3401643,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.1,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,O=C(N[C@H]1CN2CCC1CC2)[C@](O)(c1cccs1)C1CCCC1
CHEMBL3401644,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,889.4,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,CCC(O)(C(=O)N[C@H]1CN2CCC1CC2)c1cccs1
CHEMBL3401644,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,738.6,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,CCC(O)(C(=O)N[C@H]1CN2CCC1CC2)c1cccs1
CHEMBL3401645,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,18.7,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,O=C(N[C@H]1CN2CCC1CC2)C1(O)c2ccccc2-c2ccccc21
CHEMBL3401646,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,37.3,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,O=C(N[C@H]1CN2CCC1CC2)C1c2ccccc2Oc2ccccc21
CHEMBL3401647,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,172.5,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,CN(C(=O)C1c2ccccc2Oc2ccccc21)[C@H]1CN2CCC1CC2
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.4,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL1908368,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.7,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2.O.[Br-]
CHEMBL3401648,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.7,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,O=C(N[C@H]1C[N+]2(CCCc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]
CHEMBL3401649,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.7,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,O=C(N[C@H]1C[N+]2(CCCc3cccs3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]
CHEMBL3401650,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.7,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,O=C(N[C@H]1C[N+]2(CCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]
CHEMBL3401651,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.0,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,O=C(N[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]
CHEMBL3401652,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,33.4,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,O=C(N[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(c1cccs1)c1cccs1.[Br-]
CHEMBL3401653,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,130.5,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,CN(CCC[N+]12CCC(CC1)[C@@H](NC(=O)C1(O)c3ccccc3-c3ccccc31)C2)c1ccccc1.[Cl-]
CHEMBL3401654,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.8,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,O=C(N[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C1c2ccccc2Oc2ccccc21.[Br-]
CHEMBL3401655,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,64.4,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,CN(C(=O)C1c2ccccc2Oc2ccccc21)[C@H]1C[N+]2(CCCn3cccc3)CCC1CC2.[Br-]
CHEMBL3401656,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,60.2,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,CN(C(=O)C1c2ccccc2Oc2ccccc21)[C@H]1C[N+]2(CCCOc3ccc(-c4ccccc4)cc3)CCC1CC2.[Cl-]
CHEMBL3401657,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1069.4,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,O=C(N[C@@H]1CN2CCC1CC2)C(O)(c1cccs1)c1cccs1
CHEMBL3401658,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,599.3,nM,CHEMBL3406980,B,Displacement of [3H]NMS from human M3 receptor expressed in CHOK1 cell membranes after 4 hrs by scintillation counting method,CHEMBL3400012,IC50,O=C(N[C@@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]
CHEMBL76897,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.41,nM,CHEMBL3779726,B,Displacement of [3H]4-DAMP from human recombinant muscarinic M3 receptor expressed in CHO cells,CHEMBL3774372,IC50,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL76897,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.41,nM,CHEMBL3876369,B,Displacement of [3H]4-DAMP from human recombinant M3 receptor expressed in CHO cells measured after 60 mins by scintillation counting method,CHEMBL3875185,IC50,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL3917058,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.23,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,IC50,C[C@@](C(=O)O[C@@H]1CC2CCC1[N+]2(C)C)(c1ccccc1)C1CCCC1
CHEMBL3670826,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.25,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,IC50,C[N+]1(C)C2CCC1[C@H](OC(=O)[C@@](O)(c1ccccc1)C1CCCC1)C2
CHEMBL3670827,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.25,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,IC50,C[N+]1(C)C2CCC1[C@@H](OC(=O)[C@@](O)(c1ccccc1)C1CCCC1)C2
CHEMBL3670828,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.3,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,IC50,C[N+]1(C)C2CCC1[C@@H](OC(=O)[C@](O)(c1ccccc1)C1CCCC1)C2
CHEMBL3670828,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.1,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,IC50,C[N+]1(C)C2CCC1[C@@H](OC(=O)[C@](O)(c1ccccc1)C1CCCC1)C2
CHEMBL3670828,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.9,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,IC50,C[N+]1(C)C2CCC1[C@@H](OC(=O)[C@](O)(c1ccccc1)C1CCCC1)C2
CHEMBL3670826,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,19.0,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,IC50,C[N+]1(C)C2CCC1[C@H](OC(=O)[C@@](O)(c1ccccc1)C1CCCC1)C2
CHEMBL3670827,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,36.0,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,IC50,C[N+]1(C)C2CCC1[C@@H](OC(=O)[C@@](O)(c1ccccc1)C1CCCC1)C2
CHEMBL3900995,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.3,nM,CHEMBL3887837,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 ul. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 uM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 ug/well, respectively. After an incubation period of two hours with gentle shaking, 150 ul of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer.",CHEMBL3886468,IC50,CN(CCCn1c(=O)oc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1
CHEMBL3961014,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.4,nM,CHEMBL3887837,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 ul. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 uM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 ug/well, respectively. After an incubation period of two hours with gentle shaking, 150 ul of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer.",CHEMBL3886468,IC50,CN(CCCn1c(=O)[nH]c2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1
CHEMBL3892021,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.6,nM,CHEMBL3887837,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 ul. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 uM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 ug/well, respectively. After an incubation period of two hours with gentle shaking, 150 ul of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer.",CHEMBL3886468,IC50,CN(CCCn1ccc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1
CHEMBL3890898,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.4,nM,CHEMBL3887837,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 ul. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 uM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 ug/well, respectively. After an incubation period of two hours with gentle shaking, 150 ul of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer.",CHEMBL3886468,IC50,CN(CCCc1nc(-c2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)no1)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1
CHEMBL3915401,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.4,nM,CHEMBL3887837,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 ul. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 uM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 ug/well, respectively. After an incubation period of two hours with gentle shaking, 150 ul of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer.",CHEMBL3886468,IC50,CN(CCN(C)[C@H]1CC[C@H](OC(C(=O)O)(c2cccs2)c2cccs2)CC1)C(=O)COc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1
CHEMBL3971284,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.2,nM,CHEMBL3887837,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 ul. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 uM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 ug/well, respectively. After an incubation period of two hours with gentle shaking, 150 ul of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer.",CHEMBL3886468,IC50,CN(CCNC(=O)COc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1
CHEMBL3906438,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.2,nM,CHEMBL3887837,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 ul. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 uM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 ug/well, respectively. After an incubation period of two hours with gentle shaking, 150 ul of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer.",CHEMBL3886468,IC50,COc1cc(-c2noc(CCCN(C)[C@H]3CC[C@H](OC(=O)C(O)(c4cccs4)c4cccs4)CC3)n2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3905320,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.4,nM,CHEMBL3887837,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 ul. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 uM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 ug/well, respectively. After an incubation period of two hours with gentle shaking, 150 ul of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer.",CHEMBL3886468,IC50,COc1cc(OCC(=O)N(C)CCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3908788,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.5,nM,CHEMBL3887837,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 ul. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 uM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 ug/well, respectively. After an incubation period of two hours with gentle shaking, 150 ul of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer.",CHEMBL3886468,IC50,CN(CCCn1c(=O)sc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1
CHEMBL3923686,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.0,nM,CHEMBL3887837,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 ul. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 uM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 ug/well, respectively. After an incubation period of two hours with gentle shaking, 150 ul of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer.",CHEMBL3886468,IC50,CN(CCCn1c(=O)oc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C2(C)c3ccccc3Oc3ccccc32)CC1
CHEMBL3926721,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5.9,nM,CHEMBL3887837,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 ul. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 uM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 ug/well, respectively. After an incubation period of two hours with gentle shaking, 150 ul of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer.",CHEMBL3886468,IC50,CN(CCCn1c(=O)oc2cc(CNC[C@H](O)c3ccc(O)c(NC=O)c3)ccc21)[C@H]1CC[C@H](c2cccc3c2C(C)(C(=O)O)c2ccccc2O3)CC1
CHEMBL3960091,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.6,nM,CHEMBL3887837,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 ul. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 uM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 ug/well, respectively. After an incubation period of two hours with gentle shaking, 150 ul of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer.",CHEMBL3886468,IC50,CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)[C@](O)(c2cccs2)C2CCCC2)CC1
CHEMBL3963770,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.4,nM,CHEMBL3887837,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 ul. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 uM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 ug/well, respectively. After an incubation period of two hours with gentle shaking, 150 ul of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer.",CHEMBL3886468,IC50,CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4c3OCC(=O)N4)ccc21)[C@H]1CC[C@H](OC(=O)[C@](O)(c2cccs2)C2CCCC2)CC1
CHEMBL3911114,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.8,nM,CHEMBL3887837,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 ul. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 uM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 ug/well, respectively. After an incubation period of two hours with gentle shaking, 150 ul of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer.",CHEMBL3886468,IC50,CN(CCCn1c(=O)oc2cc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1
CHEMBL3910208,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.6,nM,CHEMBL3887837,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 ul. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 uM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 ug/well, respectively. After an incubation period of two hours with gentle shaking, 150 ul of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer.",CHEMBL3886468,IC50,CC(Cc1ccc(OCC(=O)NCCN[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3934254,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.2,nM,CHEMBL3888304,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 μl. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 μM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 μg/well, respectively. After an incubation period of two hours with gentle shaking, 150 μl of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer (Tris 50 mM; NaCl 100 mM; pH: 7.4), containing 0.05% PEI (Sigma) during one hour. Bound and free [3H]-NMS were separated by rapid vacuum filtration in a manifold from Millipore and washed four times with ice cold wash buffer. After drying 30 min, 30 μl of OPTIPHASE Supermix were added to each well and radioactivity quantified using a Microbeta microplate scintillation counter.",CHEMBL3886646,IC50,CN(CCCCCCCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12)C1CCC(OC(=O)C(O)(c2cccs2)c2cccs2)CC1
CHEMBL3902803,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.3,nM,CHEMBL3888304,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 μl. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 μM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 μg/well, respectively. After an incubation period of two hours with gentle shaking, 150 μl of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer (Tris 50 mM; NaCl 100 mM; pH: 7.4), containing 0.05% PEI (Sigma) during one hour. Bound and free [3H]-NMS were separated by rapid vacuum filtration in a manifold from Millipore and washed four times with ice cold wash buffer. After drying 30 min, 30 μl of OPTIPHASE Supermix were added to each well and radioactivity quantified using a Microbeta microplate scintillation counter.",CHEMBL3886646,IC50,CN(CCOc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C1CCC(OC(=O)C(O)(c2cccs2)c2cccs2)CC1
CHEMBL3978112,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.1,nM,CHEMBL3888304,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 μl. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 μM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 μg/well, respectively. After an incubation period of two hours with gentle shaking, 150 μl of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer (Tris 50 mM; NaCl 100 mM; pH: 7.4), containing 0.05% PEI (Sigma) during one hour. Bound and free [3H]-NMS were separated by rapid vacuum filtration in a manifold from Millipore and washed four times with ice cold wash buffer. After drying 30 min, 30 μl of OPTIPHASE Supermix were added to each well and radioactivity quantified using a Microbeta microplate scintillation counter.",CHEMBL3886646,IC50,COc1cc(NC(=O)CCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3948979,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.2,nM,CHEMBL3888304,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 μl. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 μM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 μg/well, respectively. After an incubation period of two hours with gentle shaking, 150 μl of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer (Tris 50 mM; NaCl 100 mM; pH: 7.4), containing 0.05% PEI (Sigma) during one hour. Bound and free [3H]-NMS were separated by rapid vacuum filtration in a manifold from Millipore and washed four times with ice cold wash buffer. After drying 30 min, 30 μl of OPTIPHASE Supermix were added to each well and radioactivity quantified using a Microbeta microplate scintillation counter.",CHEMBL3886646,IC50,CN(CCC(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1Cl)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1
CHEMBL3916700,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.6,nM,CHEMBL3888304,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 μl. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 μM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 μg/well, respectively. After an incubation period of two hours with gentle shaking, 150 μl of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer (Tris 50 mM; NaCl 100 mM; pH: 7.4), containing 0.05% PEI (Sigma) during one hour. Bound and free [3H]-NMS were separated by rapid vacuum filtration in a manifold from Millipore and washed four times with ice cold wash buffer. After drying 30 min, 30 μl of OPTIPHASE Supermix were added to each well and radioactivity quantified using a Microbeta microplate scintillation counter.",CHEMBL3886646,IC50,COc1cc(NC(=O)OCCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3892218,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.1,nM,CHEMBL3888304,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 μl. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 μM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 μg/well, respectively. After an incubation period of two hours with gentle shaking, 150 μl of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer (Tris 50 mM; NaCl 100 mM; pH: 7.4), containing 0.05% PEI (Sigma) during one hour. Bound and free [3H]-NMS were separated by rapid vacuum filtration in a manifold from Millipore and washed four times with ice cold wash buffer. After drying 30 min, 30 μl of OPTIPHASE Supermix were added to each well and radioactivity quantified using a Microbeta microplate scintillation counter.",CHEMBL3886646,IC50,COc1cc(NC(=O)CCN(C)[C@H]2CC[C@](C)(OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3962171,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.0,nM,CHEMBL3888304,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 μl. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 μM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 μg/well, respectively. After an incubation period of two hours with gentle shaking, 150 μl of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer (Tris 50 mM; NaCl 100 mM; pH: 7.4), containing 0.05% PEI (Sigma) during one hour. Bound and free [3H]-NMS were separated by rapid vacuum filtration in a manifold from Millipore and washed four times with ice cold wash buffer. After drying 30 min, 30 μl of OPTIPHASE Supermix were added to each well and radioactivity quantified using a Microbeta microplate scintillation counter.",CHEMBL3886646,IC50,COc1cc(NC(=O)CCCN[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3934681,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.0,nM,CHEMBL3888304,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 μl. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 μM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 μg/well, respectively. After an incubation period of two hours with gentle shaking, 150 μl of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer (Tris 50 mM; NaCl 100 mM; pH: 7.4), containing 0.05% PEI (Sigma) during one hour. Bound and free [3H]-NMS were separated by rapid vacuum filtration in a manifold from Millipore and washed four times with ice cold wash buffer. After drying 30 min, 30 μl of OPTIPHASE Supermix were added to each well and radioactivity quantified using a Microbeta microplate scintillation counter.",CHEMBL3886646,IC50,COc1cc(NC(=O)CCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(F)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3963417,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.6,nM,CHEMBL3888304,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 μl. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 μM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 μg/well, respectively. After an incubation period of two hours with gentle shaking, 150 μl of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer (Tris 50 mM; NaCl 100 mM; pH: 7.4), containing 0.05% PEI (Sigma) during one hour. Bound and free [3H]-NMS were separated by rapid vacuum filtration in a manifold from Millipore and washed four times with ice cold wash buffer. After drying 30 min, 30 μl of OPTIPHASE Supermix were added to each well and radioactivity quantified using a Microbeta microplate scintillation counter.",CHEMBL3886646,IC50,CN(CCC(=O)Nc1cc(F)c(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1F)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1
CHEMBL3940214,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.7,nM,CHEMBL3888304,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 μl. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 μM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 μg/well, respectively. After an incubation period of two hours with gentle shaking, 150 μl of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer (Tris 50 mM; NaCl 100 mM; pH: 7.4), containing 0.05% PEI (Sigma) during one hour. Bound and free [3H]-NMS were separated by rapid vacuum filtration in a manifold from Millipore and washed four times with ice cold wash buffer. After drying 30 min, 30 μl of OPTIPHASE Supermix were added to each well and radioactivity quantified using a Microbeta microplate scintillation counter.",CHEMBL3886646,IC50,COc1cc(NC(=O)CCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3943564,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.4,nM,CHEMBL3888304,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 μl. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 μM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 μg/well, respectively. After an incubation period of two hours with gentle shaking, 150 μl of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer (Tris 50 mM; NaCl 100 mM; pH: 7.4), containing 0.05% PEI (Sigma) during one hour. Bound and free [3H]-NMS were separated by rapid vacuum filtration in a manifold from Millipore and washed four times with ice cold wash buffer. After drying 30 min, 30 μl of OPTIPHASE Supermix were added to each well and radioactivity quantified using a Microbeta microplate scintillation counter.",CHEMBL3886646,IC50,COc1cc(NC(=O)OCCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(C#N)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3915601,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.3,nM,CHEMBL3888304,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 μl. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 μM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 μg/well, respectively. After an incubation period of two hours with gentle shaking, 150 μl of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer (Tris 50 mM; NaCl 100 mM; pH: 7.4), containing 0.05% PEI (Sigma) during one hour. Bound and free [3H]-NMS were separated by rapid vacuum filtration in a manifold from Millipore and washed four times with ice cold wash buffer. After drying 30 min, 30 μl of OPTIPHASE Supermix were added to each well and radioactivity quantified using a Microbeta microplate scintillation counter.",CHEMBL3886646,IC50,COc1cc(OCCCCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3947244,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.7,nM,CHEMBL3888304,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 μl. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 μM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 μg/well, respectively. After an incubation period of two hours with gentle shaking, 150 μl of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer (Tris 50 mM; NaCl 100 mM; pH: 7.4), containing 0.05% PEI (Sigma) during one hour. Bound and free [3H]-NMS were separated by rapid vacuum filtration in a manifold from Millipore and washed four times with ice cold wash buffer. After drying 30 min, 30 μl of OPTIPHASE Supermix were added to each well and radioactivity quantified using a Microbeta microplate scintillation counter.",CHEMBL3886646,IC50,COc1cc(NC(=O)OCCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2c1OCC(=O)N2
CHEMBL3973386,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,8.5,nM,CHEMBL3888304,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 μl. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 μM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 μg/well, respectively. After an incubation period of two hours with gentle shaking, 150 μl of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer (Tris 50 mM; NaCl 100 mM; pH: 7.4), containing 0.05% PEI (Sigma) during one hour. Bound and free [3H]-NMS were separated by rapid vacuum filtration in a manifold from Millipore and washed four times with ice cold wash buffer. After drying 30 min, 30 μl of OPTIPHASE Supermix were added to each well and radioactivity quantified using a Microbeta microplate scintillation counter.",CHEMBL3886646,IC50,COc1cc(NC(=O)OCCN(C)[C@H]2CC[C@H](OC(=O)[C@](O)(c3ccccc3)C3CCCC3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3906808,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.8,nM,CHEMBL3888304,B,"Muscarinic Receptor Binding Assay: The study of binding to human muscarinic M1, M2, M3, M4 and M5 receptors was performed using commercial membranes (Perkin Elmer) prepared from CHO-K1 cells. Radioligand binding experiments were conducted in 96 polypropylene well plates in a total volume of 200 μl. All reagents were dissolved in assay binding buffer (PBS with calcium and magnesium, SIGMA), except compounds that were dissolved in DMSO 100%. Non-specific binding (NSB) was measured in the presence of 1 μM atropine. [3H]-NMS was used as the radioligand at a concentration of 1 nM for M2, M3 and M5 and 0.3 nM for M1 and M4. [3H]-NMS and antagonists were incubated with membranes that express human muscarinic receptors M1, M2, M3, M4 and M5 at concentrations of 8.1, 10, 4.9, 4.5 and 4.9 μg/well, respectively. After an incubation period of two hours with gentle shaking, 150 μl of the reaction mix were transferred to 96 GF/C filter plates (Millipore), previously treated with wash buffer (Tris 50 mM; NaCl 100 mM; pH: 7.4), containing 0.05% PEI (Sigma) during one hour. Bound and free [3H]-NMS were separated by rapid vacuum filtration in a manifold from Millipore and washed four times with ice cold wash buffer. After drying 30 min, 30 μl of OPTIPHASE Supermix were added to each well and radioactivity quantified using a Microbeta microplate scintillation counter.",CHEMBL3886646,IC50,COc1cc(NC(=O)OCCN(C)[C@H]2CC[C@H](OC(=O)[C@](O)(c3cccs3)C3CCCC3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL517712,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.2,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2
CHEMBL1740585,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,CC(C)[N+]1(C)[C@@H]2CC[C@H]1CC(OC(=O)C(CO)c1ccccc1)C2
CHEMBL3985491,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,31.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@@H]1CC2CC[N+]1(CCCOc1ccccc1)CC2)C(c1ccccc1)c1ccccc1
CHEMBL1194336,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,15.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1
CHEMBL3956822,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,22.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,CC(C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c1ccccc1)c1ccccc1
CHEMBL3974189,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,4.8,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1cccs1
CHEMBL3948162,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,14.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(C/C=C/c3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccco1
CHEMBL3949833,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,6.6,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCOc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccco1
CHEMBL3978891,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,6.8,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccco1
CHEMBL1194314,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,13.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(c1cccs1)c1cccs1
CHEMBL1197251,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,2.7,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1
CHEMBL1195513,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.8,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCCc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1
CHEMBL1194325,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,4.4,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1
CHEMBL3955111,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5.6,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccc(F)cc3)CCC1CC2)C(O)(c1cccs1)c1cccs1
CHEMBL3960065,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,8.2,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3O)CCC1CC2)C(O)(c1cccs1)c1cccs1
CHEMBL3963421,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,16.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCn3cccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1
CHEMBL3904721,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3.1,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCc3cccs3)CCC1CC2)C(O)(c1cccs1)c1cccs1
CHEMBL3965159,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCc3cccs3)CCC1CC2)C(O)(c1cccs1)c1cccs1
CHEMBL3931995,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,9.9,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCOCc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1
CHEMBL1194321,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,5.4,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1ccsc1)c1ccsc1
CHEMBL3914137,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,31.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(C/C=C/c3ccccc3)CCC1CC2)C1(O)c2ccccc2-c2ccccc21
CHEMBL1197183,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,14.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C1(O)c2ccccc2-c2ccccc21
CHEMBL1197209,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,7.6,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCc3ccccc3)CCC1CC2)C1(O)c2ccccc2-c2ccccc21
CHEMBL4109862,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,31.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,CCC1([N+]23CCC(CC2)[C@@H](OC(=O)C2(O)c4ccccc4-c4ccccc42)C3)c2ccsc21
CHEMBL3948099,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,14.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,CC1(C(=O)O[C@H]2C[N+]3(C/C=C/c4ccccc4)CCC2CC3)c2ccccc2-c2ccccc21
CHEMBL1197117,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,23.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,CC1(C(=O)O[C@H]2C[N+]3(CCCOc4ccccc4)CCC2CC3)c2ccccc2-c2ccccc21
CHEMBL3920279,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,13.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCCc3ccccc3)CCC1CC2)C1c2ccccc2Oc2ccccc21
CHEMBL3956752,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,16.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCOc3ccccc3)CCC1CC2)C1c2ccccc2Oc2ccccc21
CHEMBL3932738,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,8.8,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C1c2ccccc2Oc2ccccc21
CHEMBL1197028,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,6.3,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCc3ccccc3)CCC1CC2)C1c2ccccc2Oc2ccccc21
CHEMBL1197216,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,11.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C1(O)c2ccccc2Oc2ccccc21
CHEMBL1197261,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,6.9,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCc3ccccc3)CCC1CC2)C1(O)c2ccccc2Oc2ccccc21
CHEMBL3933797,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,19.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,O=C(O[C@H]1C[N+]2(CCCc3cccs3)CCC1CC2)C1(O)c2ccccc2Oc2ccccc21
CHEMBL1196246,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,13.0,nM,CHEMBL3888427,B,[3H]-NMS Binding Assay: The binding of [3H]-NMS to human muscarinic receptors was performed according to Waelbroek et al (1990) (1). Assays were carried out at 25° C. Membrane preparations from stably transfected chinese hamster ovary-K1 cells (CHO) expressing the genes for the human muscarinic receptors Hm3 were used.,CHEMBL3886704,IC50,CC1(C(=O)O[C@H]2C[N+]3(CCCOc4ccccc4)CCC2CC3)c2ccccc2Oc2ccccc21
CHEMBL76897,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.31,nM,CHEMBL4001175,B,Displacement of [3H]4-DAMP from human recombinant Muscarinic acetylcholine receptor M3 expressed in CHO cells after 60 mins by scintillation counting,CHEMBL4000185,IC50,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL4128926,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,0.73,nM,CHEMBL4121488,B,Displacement of [3H]4-DAMP from human recombinant M3 receptor after 60 mins by scintillation counting analysis,CHEMBL4118122,IC50,CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12
CHEMBL3039518,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.585,nM,CHEMBL4406927,B,Antagonist activity at human M3 receptor,CHEMBL4406790,IC50,COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL4297483,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.585,nM,CHEMBL4406927,B,Antagonist activity at human M3 receptor,CHEMBL4406790,IC50,CN(CCCn1nnc2cc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)ccc21)[C@H]1CC[C@H](OC(=O)C(O)(c2cccs2)c2cccs2)CC1
CHEMBL3916700,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.585,nM,CHEMBL4406927,B,Antagonist activity at human M3 receptor,CHEMBL4406790,IC50,COc1cc(NC(=O)OCCN(C)[C@H]2CC[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL4465556,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,1.585,nM,CHEMBL4406927,B,Antagonist activity at human M3 receptor,CHEMBL4406790,IC50,CC(C)c1ncc(C(=O)N2CCOC3(CCN(Cc4ccc(F)c(CCNC[C@H](O)c5ccc(O)c6[nH]c(=O)sc56)c4)CC3)C2)s1
CHEMBL237067,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,150.0,nM,CHEMBL4432080,B,Inhibition of M3 receptor (unknown origin),CHEMBL4431324,IC50,CC(C)=CCn1c(N2CCC[C@H](N)C2)nc2c1c(=O)n(CC(=O)c1ccccc1)c(=O)n2C
CHEMBL4297224,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3300.0,nM,CHEMBL4723557,B,Binding affinity to muscarinic acetylcholine receptor M3 (unknown origin),CHEMBL4715859,IC50,CN(C)CC1CCOC1(c1ccccc1)c1ccccc1
CHEMBL4778407,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,100.0,nM,CHEMBL4725737,B,Displacement of [3H]N -methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells incubated for 90 mins by scintillation counting method,CHEMBL4725222,IC50,O=C(O[C@@H](Cc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1)C1CN(C(=O)c2ccc(COc3cccc(CN(C(=O)O[C@H]4CN5CCC4CC5)c4ccccc4)c3)cc2)C1
CHEMBL4297224,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,3300.0,nM,CHEMBL5225129,B,Binding affinity to muscarinic 3 receptor (unknown origin),CHEMBL5223132,IC50,CN(C)CC1CCOC1(c1ccccc1)c1ccccc1
CHEMBL5271406,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,300.0,nM,CHEMBL5239847,B,Binding affinity to human muscarinic M3 receptor expressed in human HEK293T cells assessed as inhibition of carbachol-induced G-protein signaling by measuring inositol accumulation preincubated for 30 mins followed by carbachol stimulation and measured after 90 mins by HTRF assay,CHEMBL5236624,IC50,CC1(C)C(/C=C/C=C/C=C2/N(CCCCS(=O)(=O)O)c3ccccc3C2(C)C)=[N+](CCCCCC(=O)NCCCCCCCCN2CCC(OC(=O)Nc3ccc(F)cc3-c3ccc(F)c(Cl)c3)CC2)c2ccc(S(=O)(=O)[O-])cc21
CHEMBL5285607,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,130.0,nM,CHEMBL5239847,B,Binding affinity to human muscarinic M3 receptor expressed in human HEK293T cells assessed as inhibition of carbachol-induced G-protein signaling by measuring inositol accumulation preincubated for 30 mins followed by carbachol stimulation and measured after 90 mins by HTRF assay,CHEMBL5236624,IC50,CN(C)c1ccc2c(-c3ccc(-c4cn(CCCCCn5cc(CCCCCCN6CCC(COC(=O)Nc7ccc(F)cc7-c7ccc(F)c(Cl)c7)CC6)nn5)nn4)cc3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1
CHEMBL5271406,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,450.0,nM,CHEMBL5239848,B,Binding affinity to human muscarinic M3 receptor expressed in human HEK293T cells cells co-expressing beta-arrestin2 assessed as inhibition of carbachol-induced beta-arrestin recruitment preincubated for 30 mins followed by carbachol stimulation and measured after 90 mins by PathHunter assay,CHEMBL5236624,IC50,CC1(C)C(/C=C/C=C/C=C2/N(CCCCS(=O)(=O)O)c3ccccc3C2(C)C)=[N+](CCCCCC(=O)NCCCCCCCCN2CCC(OC(=O)Nc3ccc(F)cc3-c3ccc(F)c(Cl)c3)CC2)c2ccc(S(=O)(=O)[O-])cc21
CHEMBL5285607,CHEMBL245,Muscarinic acetylcholine receptor M3,IC50,=,430.0,nM,CHEMBL5239848,B,Binding affinity to human muscarinic M3 receptor expressed in human HEK293T cells cells co-expressing beta-arrestin2 assessed as inhibition of carbachol-induced beta-arrestin recruitment preincubated for 30 mins followed by carbachol stimulation and measured after 90 mins by PathHunter assay,CHEMBL5236624,IC50,CN(C)c1ccc2c(-c3ccc(-c4cn(CCCCCn5cc(CCCCCCN6CCC(COC(=O)Nc7ccc(F)cc7-c7ccc(F)c(Cl)c7)CC6)nn5)nn4)cc3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1
CHEMBL59836,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.2,nM,CHEMBL745493,B,Binding affinity for human cloned Muscarinic M3 receptors,CHEMBL1132129,KI,CC(C)=CCCN1CCC(NC(=O)[C@](O)(c2ccccc2)C2CCCC2)CC1
CHEMBL64000,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,680.0,nM,CHEMBL747824,B,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,CHEMBL1133759,KI,CC(=O)OC1CC2CCCC1N2
CHEMBL313738,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3000.0,nM,CHEMBL747824,B,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,CHEMBL1133759,KI,CN1C2CCCC1C(OC(=O)C1CCCCC1)C2
CHEMBL84113,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1300.0,nM,CHEMBL747824,B,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,CHEMBL1133759,KI,O=C(OC1CC2CCCC1N2)c1ccccc1
CHEMBL440138,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7400.0,nM,CHEMBL747824,B,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,CHEMBL1133759,KI,CCC(=O)OC1CC2CCCC1N2C
CHEMBL310558,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,11400.0,nM,CHEMBL747824,B,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,CHEMBL1133759,KI,CCC(=O)OC1CC2CCCC1N2
CHEMBL315428,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,450.0,nM,CHEMBL747825,B,The binding affinity was measured as inhibition of binding of [3H]- quinuclidinyl benzilate to m3 Muscarinic acetylcholine receptor M3 in membranes of CHO cells,CHEMBL1133759,KI,O=C(OC1CC2CCCC1N2)c1ccc([N+](=O)[O-])cc1
CHEMBL294273,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,15000.0,nM,CHEMBL747824,B,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,CHEMBL1133759,KI,CC(=O)OC1CC2CCCC1N2C
CHEMBL85190,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3200.0,nM,CHEMBL747824,B,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,CHEMBL1133759,KI,CN1C2CCCC1C(OC(=O)c1ccccc1)C2
CHEMBL314493,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6700.0,nM,CHEMBL747824,B,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,CHEMBL1133759,KI,CN1C2CCCC1C(OC(=O)OCC(Cl)(Cl)Cl)C2
CHEMBL82754,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7500.0,nM,CHEMBL747824,B,Inhibition of [3H]- quinuclidinyl benzilate binding to human Muscarinic acetylcholine receptor M3 expressed in CHO cell membranes,CHEMBL1133759,KI,O=C(OC1CC2CCCC1N2)C1CCCCC1
CHEMBL443780,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,9.9,nM,CHEMBL747817,B,Antimuscarinic potency and subset specificity was characterised by its inhibition of the [3H]NMS Muscarinic acetylcholine receptor M3 subtype,CHEMBL1125426,KI,CCN(CC)CCOC(=O)C(C)(c1ccccc1)C1CCCCC1
CHEMBL26505,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.7,nM,CHEMBL747667,B,Antimuscarinic potency and subset specificity was characterised by inhibition of the [3H]NMS Binding to Muscarinic acetylcholine receptor M3 subtype,CHEMBL1125426,KI,CCN(CC)CCOC(=O)C(C)(c1ccccc1)c1ccccc1
CHEMBL24369,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,178.0,nM,CHEMBL747816,B,Antimuscarinic potency and subset specificity was characterised by its inhibition of the [3H]NMS Binding to Muscarinic acetylcholine receptor M3 subtype,CHEMBL1125426,KI,CCN(CC)CCCCCOC(=O)C(C)(c1ccccc1)C1CCCCC1
CHEMBL285440,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,31.2,nM,CHEMBL747816,B,Antimuscarinic potency and subset specificity was characterised by its inhibition of the [3H]NMS Binding to Muscarinic acetylcholine receptor M3 subtype,CHEMBL1125426,KI,CN(C)CCCCOC(=O)C(C)(c1ccccc1)C1CCCCC1
CHEMBL284137,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.0,nM,CHEMBL747816,B,Antimuscarinic potency and subset specificity was characterised by its inhibition of the [3H]NMS Binding to Muscarinic acetylcholine receptor M3 subtype,CHEMBL1125426,KI,CCN(CC)CCCOC(=O)C(C)(c1ccccc1)C1CCCCC1
CHEMBL285898,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,160.0,nM,CHEMBL747816,B,Antimuscarinic potency and subset specificity was characterised by its inhibition of the [3H]NMS Binding to Muscarinic acetylcholine receptor M3 subtype,CHEMBL1125426,KI,CCN(CC)CCCCOC(=O)C(C)(c1ccccc1)C1CCCCC1
CHEMBL286008,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.7,nM,CHEMBL747816,B,Antimuscarinic potency and subset specificity was characterised by its inhibition of the [3H]NMS Binding to Muscarinic acetylcholine receptor M3 subtype,CHEMBL1125426,KI,CN(C)CCCOC(=O)C(C)(c1ccccc1)C1CCCCC1
CHEMBL542622,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.9,nM,CHEMBL745494,B,Binding affinity towards human muscarinic M3 receptor,CHEMBL1131780,KI,CCCCCCSc1nccnc1O[C@H]1CN2CCC1C2.Cl
CHEMBL69733,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1995.26,nM,CHEMBL743975,B,Compound was evaluated for binding affinity against Muscarinic M3 receptor using radioligand binding assay,CHEMBL1153669,KI,COc1ccc(CCCN2CCC(CCC(=O)c3cc(Cl)c(N)c4c3OCCO4)CC2)cc1OC
CHEMBL308566,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.7,nM,CHEMBL747821,B,Binding affinity against Muscarinic acetylcholine receptor M3 expressed in CHO-K1 cells,CHEMBL1132767,KI,C=C(c1ccc(S(=O)(=O)c2ccc(OC)cc2)cc1)C1CCN(C2CCN(C(=O)OCC)CC2)CC1
CHEMBL71147,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.48,nM,CHEMBL747821,B,Binding affinity against Muscarinic acetylcholine receptor M3 expressed in CHO-K1 cells,CHEMBL1132767,KI,C=C(c1ccc(S(=O)(=O)c2ccc(OC)cc2)cc1)C1CCN(C2CCCCC2)CC1
CHEMBL72551,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,121.6,nM,CHEMBL747821,B,Binding affinity against Muscarinic acetylcholine receptor M3 expressed in CHO-K1 cells,CHEMBL1132767,KI,C=C(c1ccc(S(=O)(=O)c2ccc(OC)cc2)cc1)C1CCN(C2CCN(C(=O)CCC)CC2)CC1
CHEMBL420008,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.4,nM,CHEMBL747821,B,Binding affinity against Muscarinic acetylcholine receptor M3 expressed in CHO-K1 cells,CHEMBL1132767,KI,C=C(c1ccc(S(=O)(=O)c2ccc(OC)cc2)cc1)C1CCN(C2CCNCC2)CC1
CHEMBL421113,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.1,nM,CHEMBL747821,B,Binding affinity against Muscarinic acetylcholine receptor M3 expressed in CHO-K1 cells,CHEMBL1132767,KI,C=C(c1ccc(S(=O)(=O)c2ccc(OC)cc2)cc1)C1CCN(C2CCN(S(=O)(=O)CCC)CC2)CC1
CHEMBL94772,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6900.0,nM,CHEMBL743971,B,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),CHEMBL1151999,KI,OC1(C2=CN3CCC2CC3)c2ccccc2CCc2ccccc21
CHEMBL335542,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.012,nM,CHEMBL752413,B,Compound was tested for binding inhibition of [3H](R)-QNB to Muscarinic acetylcholine receptor M3 expressed in A9 L cells,CHEMBL1145111,KI,CN1CCC=C(c2nsnc2OCCOCCOCCOCCOc2nsnc2C2=CCCN(C)C2)C1
CHEMBL538793,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,125.89,nM,CHEMBL752413,B,Compound was tested for binding inhibition of [3H](R)-QNB to Muscarinic acetylcholine receptor M3 expressed in A9 L cells,CHEMBL1145111,KI,CC(=O)OCCCCCCCCCCCCOc1nsnc1C1=CCCN(C)C1.Cl
CHEMBL327664,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,17000.0,nM,CHEMBL743971,B,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),CHEMBL1151999,KI,OC1(C2=CN3CCC2CC3)c2ccccc2Oc2ccccc21
CHEMBL94921,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2600.0,nM,CHEMBL743971,B,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),CHEMBL1151999,KI,CC(=O)c1ccc(C2=CN3CCC2CC3)s1
CHEMBL21536,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,79.43,nM,CHEMBL752413,B,Compound was tested for binding inhibition of [3H](R)-QNB to Muscarinic acetylcholine receptor M3 expressed in A9 L cells,CHEMBL1145111,KI,CCCCCCOc1nsnc1C1=CCCN(C)C1
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6309.57,nM,CHEMBL752413,B,Compound was tested for binding inhibition of [3H](R)-QNB to Muscarinic acetylcholine receptor M3 expressed in A9 L cells,CHEMBL1145111,KI,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL96042,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1500.0,nM,CHEMBL743971,B,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),CHEMBL1151999,KI,COc1ccccc1C(O)C1=CN2CCC1CC2
CHEMBL136027,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,79.43,nM,CHEMBL752413,B,Compound was tested for binding inhibition of [3H](R)-QNB to Muscarinic acetylcholine receptor M3 expressed in A9 L cells,CHEMBL1145111,KI,COc1nsnc1OCCCCCCCCCCCCOc1nsnc1C1=CCCN(C)C1
CHEMBL545077,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,79.43,nM,CHEMBL752413,B,Compound was tested for binding inhibition of [3H](R)-QNB to Muscarinic acetylcholine receptor M3 expressed in A9 L cells,CHEMBL1145111,KI,CN1CCC=C(c2nsnc2OCCCCCCCCCCCCO)C1.Cl
CHEMBL553058,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25.12,nM,CHEMBL752413,B,Compound was tested for binding inhibition of [3H](R)-QNB to Muscarinic acetylcholine receptor M3 expressed in A9 L cells,CHEMBL1145111,KI,COc1nsnc1OCCOCCOCCOCCOc1nsnc1C1=CCCN(C)C1.Cl
CHEMBL273586,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,100.0,nM,CHEMBL743971,B,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),CHEMBL1151999,KI,c1ccc2c(c1)C(=C1CN3CCC1CC3)c1ccccc1-2
CHEMBL264747,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4800.0,nM,CHEMBL743971,B,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),CHEMBL1151999,KI,O=Cc1ccc(C2=CN3CCC2CC3)s1
CHEMBL93709,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2000.0,nM,CHEMBL743971,B,In vitro binding affinity towards muscarinic receptor in parotid gland (M3),CHEMBL1151999,KI,COc1ccccc1C(=O)C1=CN2CCC1CC2
CHEMBL294649,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,50118.72,nM,CHEMBL743974,B,Binding affinity against Muscarinic M3 receptor,CHEMBL1128795,KI,Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c2ccccc21
CHEMBL298612,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,31622.78,nM,CHEMBL743974,B,Binding affinity against Muscarinic M3 receptor,CHEMBL1128795,KI,Cn1cc(C(=O)C(=O)N[C@@H]2CN3CCC2CC3)c2ccccc21
CHEMBL27979,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1659.59,nM,CHEMBL752411,B,Binding affinity towards human muscarinic M3 receptor,CHEMBL1136688,KI,C[C@H]1CC[C@H](C)N1CCCOc1ccc(-c2ccc(C(=O)N3CCOCC3)cc2)cc1
CHEMBL369575,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2754.23,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CC(C1=C(CCN2CCOCC2)Cc2ccccc21)c1ccccn1
CHEMBL564226,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3388.44,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,C[C@H](C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1
CHEMBL423831,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25.7,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CN(C)CCC1=C(C(C)(C)c2ccccn2)c2ccccc2C1
CHEMBL167223,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,95.5,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CC(C1=C(CCN(C)C)Cc2cc(Cl)ccc21)c1ccccn1
CHEMBL354523,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,281.84,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CCC(C1=C(CCN(C)C)Cc2cc(Cl)ccc21)c1ccccn1
CHEMBL352966,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2511.89,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,Cc1ccc2c(c1)C(C(C)c1ccccn1)=C(CCN(C)C)C2
CHEMBL354678,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,309.03,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CCC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1
CHEMBL169594,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8128.31,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CN(C)CCOC(=O)C1=C(Cc2cccnc2)c2ccccc2C1
CHEMBL355392,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1778.28,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CC(C1=C(CCN2CCCCC2)Cc2ccccc21)c1ccccn1
CHEMBL169680,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,11748.98,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CN(C)CCC1=C(Cc2ccncc2)c2ccccc2C1
CHEMBL172234,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8912.51,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CN(C)CCOC(=O)C1=C(Cc2ccccn2)c2ccccc2C1
CHEMBL168223,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,134896.29,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CN(C)CCNC(=O)C1=C(Cc2ccncc2)c2ccccc2C1
CHEMBL355560,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8128.31,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CN(C)CCC1=C(Cc2cccnc2)c2ccccc2C1
CHEMBL354841,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,501.19,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,Cc1ccc2c(c1)CC(CCN(C)C)=C2C(C)c1ccccn1
CHEMBL352404,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3162.28,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,COc1ccc2c(c1)C(C(C)c1ccccn1)=C(CCN(C)C)C2
CHEMBL355455,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1905.46,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CC(C1=C(CCN2CCCC2)Cc2ccccc21)c1ccccn1
CHEMBL170221,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,288.4,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccc1
CHEMBL355851,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,48977.88,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CN(C)CCNC(=O)C1=C(Cc2cccnc2)c2ccccc2C1
CHEMBL168707,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,501.19,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CC(C1=C(CCN(C)C)Cc2ccc(Cl)cc21)c1ccccn1
CHEMBL171216,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,741.31,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CC(C1=C(CN(C)C(C)C)Cc2ccccc21)c1ccccn1
CHEMBL170088,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,630.96,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CCCC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1
CHEMBL352375,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2238.72,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CC(C1=C(CCN(C(C)C)C(C)C)Cc2ccccc21)c1ccccn1
CHEMBL352779,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,23988.33,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CN(C)CCNC(=O)C1=C(Cc2ccccn2)c2ccccc2C1
CHEMBL172233,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,707.95,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CC(C1=C(CCN(C)CCF)Cc2ccccc21)c1ccccn1
CHEMBL167027,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1174.9,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,COc1ccc2c(c1)CC(CCN(C)C)=C2C(C)c1ccccn1
CHEMBL352375,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,20892.96,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CC(C1=C(CCN(C(C)C)C(C)C)Cc2ccccc21)c1ccccn1
CHEMBL168704,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,954.99,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CCN(CC)CCC1=C(C(C)c2ccccn2)c2ccccc2C1
CHEMBL1493369,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,138.04,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,C[C@@H](C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1
CHEMBL353290,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,263.03,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CC(C1=C(CCN(C)C)Cc2ccc(F)cc21)c1ccccn1
CHEMBL355769,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1819.7,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CC(C1=C(CCN(C)C(C)C)Cc2ccccc21)c1ccccn1
CHEMBL169494,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1548.82,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CN(C)CCC1=C(Cc2ccccn2)c2ccccc2C1
CHEMBL352723,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1047.13,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CSc1ccc2c(c1)C(C(C)c1ccccn1)=C(CCN(C)C)C2
CHEMBL171102,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,67.61,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CN(C)CCC1=C(C(c2ccccc2)c2ccccn2)c2ccccc2C1
CHEMBL352375,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4073.8,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CC(C1=C(CCN(C(C)C)C(C)C)Cc2ccccc21)c1ccccn1
CHEMBL434684,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,31.62,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CC(C1=C(CN(C)C)Cc2ccccc21)c1ccccn1
CHEMBL169401,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,575.44,nM,CHEMBL752412,B,Binding affinity towards cloned human muscarinic acetylcholine receptor M3 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,CHEMBL1136812,KI,CC(C1=C(CCCN(C)C)Cc2ccccc21)c1ccccn1
CHEMBL69452,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,840.0,nM,CHEMBL747819,B,Binding affinity of compound was determined towards human Muscarinic acetylcholine receptor M3 using [3H]QNB radioligand,CHEMBL1144998,KI,CCO/C(O)=C1\CN2CC(CCC2COCc2ccccc2)C1=O
CHEMBL308924,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,37000.0,nM,CHEMBL747819,B,Binding affinity of compound was determined towards human Muscarinic acetylcholine receptor M3 using [3H]QNB radioligand,CHEMBL1144998,KI,CCO/C(O)=C1\CN2CC(CCC2CN(C)C)C1=O
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,20000.0,nM,CHEMBL747819,B,Binding affinity of compound was determined towards human Muscarinic acetylcholine receptor M3 using [3H]QNB radioligand,CHEMBL1144998,KI,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL7303,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,43000.0,nM,CHEMBL747819,B,Binding affinity of compound was determined towards human Muscarinic acetylcholine receptor M3 using [3H]QNB radioligand,CHEMBL1144998,KI,COC(=O)C1=CCCN(C)C1
CHEMBL69452,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7500.0,nM,CHEMBL747819,B,Binding affinity of compound was determined towards human Muscarinic acetylcholine receptor M3 using [3H]QNB radioligand,CHEMBL1144998,KI,CCO/C(O)=C1\CN2CC(CCC2COCc2ccccc2)C1=O
CHEMBL306462,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1500.0,nM,CHEMBL747819,B,Binding affinity of compound was determined towards human Muscarinic acetylcholine receptor M3 using [3H]QNB radioligand,CHEMBL1144998,KI,CCO/C(O)=C1\CN2CCCC(C2)C1=O
CHEMBL20732,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,14125.38,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,CN(C)CCOC(=O)C1=C/C(=C\c2ccccn2)c2ccccc21
CHEMBL278074,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2089.3,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,O=C(OC1CN2CCC1CC2)C1=C/C(=C\c2ccncc2)c2ccccc21
CHEMBL21321,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1698.24,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,O=C(OC1CN2CCC1CC2)C1=C/C(=C\c2cccnc2)c2ccccc21
CHEMBL279453,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,66.07,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,CCCN(CCC)CC1CCCCN1CCNC(=O)N1c2ccccc2C(=O)Nc2cccnc21
CHEMBL21716,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1737.8,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,O=C(OC1CN2CCC1CC2)C1=C/C(=C\c2ccccn2)c2ccccc21
CHEMBL21509,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,21379.62,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,CN(C)CCC1=C/C(=C\c2ccccn2)c2ccccc21
CHEMBL21328,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,72443.6,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,CN(C)CCN(C)C(=O)C1=C/C(=C\c2cccnc2)c2ccccc21
CHEMBL22108,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,190.55,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,CC(C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1
CHEMBL279520,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,40738.03,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,CN(C)CCNC(=O)C1=C/C(=C\c2cccnc2)c2ccccc21
CHEMBL424214,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,97723.72,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,CN1CCN(C(=O)C2=C/C(=C\c3ccncc3)c3ccccc32)CC1
CHEMBL21937,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,61659.5,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,CN(C)CCNC(=O)C1=C/C(=C\c2ccccn2)c2ccccc21
CHEMBL283320,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,45708.82,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,CN(C)CCNC(=O)C1=C/C(=C\c2ccncc2)c2ccccc21
CHEMBL279225,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,63095.73,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,CN(C)CCN(C)C(=O)C1=C/C(=C\c2ccccn2)c2ccccc21
CHEMBL280684,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10000.0,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,CN(C)CCOC(=O)C1=C/C(=C\c2cccnc2)c2ccccc21
CHEMBL265256,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,38.02,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,CN(CCCCCCCCN(C)CCCCCCN(CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CCCCCCNCC(=O)N1c2ccccc2C(=O)Nc2cccnc21
CHEMBL21508,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,27542.29,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,CN(C)CCC1=C/C(=C\c2cccnc2)c2ccccc21
CHEMBL278129,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,15135.61,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,CN(C)CCOC(=O)C1=C/C(=C\c2ccncc2)c2ccccc21
CHEMBL277642,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,93.33,nM,CHEMBL752409,B,Affinity for Muscarinic acetylcholine receptor M3 expressed in CHO cells by [3H]-NMS displacement.,CHEMBL1134266,KI,C[C@@H]1OC(=O)[C@H]2C[C@H]3CCCC[C@@H]3[C@@H](/C=C/[C@H]3CCC[C@H](C)N3C)[C@@H]12
CHEMBL56275,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,676.08,nM,CHEMBL746304,B,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,CHEMBL1135177,KI,C[C@@H]1OC(=O)[C@@H]2C[C@@H]3CCCC[C@@H]3[C@@H](/C=C\[C@H]3CCC[C@H](C)N3C)[C@H]12
CHEMBL148404,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,15.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,Nc1ccc(CN2CCC(NC(=O)[C@](O)(c3ccccc3)[C@@H]3CCC(F)(F)C3)CC2)nc1
CHEMBL343659,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,11.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,Cc1cccc(CN2CCC(NC(=O)C(O)(c3ccccc3)C3CCCC3)CC2)n1
CHEMBL146464,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.5,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(Cc2ccccc2)CC1)C(O)(c1ccccc1)C1CCCC1
CHEMBL149486,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.4,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,Cc1ccc(CN2CCC(NC(=O)C(O)(c3ccccc3)C3CCCC3)CC2)cc1
CHEMBL148328,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,100.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(Cc2cccnc2)CC1)C(O)(c1ccccc1)C1CCCC1
CHEMBL147653,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.8,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(Cc2ccccc2)CC1)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL146249,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,11.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,CC(C)=CCCN1CCC(NC(=O)[C@](O)(c2ccccc2)[C@H]2CC[C@@H](F)C2)CC1
CHEMBL147778,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8.9,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,Cc1cccc(CN2CCC(NC(=O)[C@](O)(c3ccccc3)[C@@H]3CCC(F)(F)C3)CC2)n1
CHEMBL146351,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,16.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,CC(C)=CCCN1CCC(NC(=O)[C@](O)(c2ccccc2)[C@H]2CCC(F)(F)C2)CC1
CHEMBL343644,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,19.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,CC(C)=CCCN1CCC(NC(=O)[C@](O)(c2ccccc2)[C@H]2CC[C@H](F)C2)CC1
CHEMBL358193,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.6,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(Cc2ccsc2)CC1)C(O)(c1ccccc1)C1CCCC1
CHEMBL145913,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.4,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(Cc2cccc(O)c2)CC1)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL147554,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,17.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(Cc2cccc(CO)c2)CC1)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL277642,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,93.33,nM,CHEMBL746304,B,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,CHEMBL1135177,KI,C[C@@H]1OC(=O)[C@H]2C[C@H]3CCCC[C@@H]3[C@@H](/C=C/[C@H]3CCC[C@H](C)N3C)[C@@H]12
CHEMBL359197,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,190.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(Cc2ccncc2)CC1)C(O)(c1ccccc1)C1CCCC1
CHEMBL356181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.1,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,Nc1ccc(CN2CCC(NC(=O)[C@](O)(c3ccccc3)[C@@H]3CCC(F)(F)C3)CC2)cc1F
CHEMBL146359,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,18.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(CC2CCCCC2)CC1)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL343449,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.8,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,Nc1ccc(CN2CCC(NC(=O)[C@](O)(c3ccccc3)[C@@H]3CCC(F)(F)C3)CC2)cc1
CHEMBL356305,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.5,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,Cc1cc(CN2CCC(NC(=O)C(O)(c3ccccc3)C3CCCC3)CC2)cs1
CHEMBL58824,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,794.33,nM,CHEMBL746304,B,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,CHEMBL1135177,KI,C[C@@H]1OC(=O)[C@H]2C[C@H]3CCCC[C@H]3[C@H](/C=C\[C@H]3CCC[C@H](C)N3C)[C@@H]12
CHEMBL150219,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.2,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,CC(C)=CCCN1CCC(NC(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL147105,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,13.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(Cc2ccccn2)CC1)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL346194,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,14.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(Cc2ccccn2)CC1)C(O)(c1ccccc1)C1CCCC1
CHEMBL69678,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.8,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,Nc1cccc(CN2CCC(NC(=O)[C@](O)(c3ccccc3)[C@@H]3CCC(F)(F)C3)CC2)n1
CHEMBL345985,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,270.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(CC2CCCC2)CC1)C(O)(c1ccccc1)C1CCCC1
CHEMBL57485,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2089.3,nM,CHEMBL746304,B,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,CHEMBL1135177,KI,C[C@@H]1OC(=O)[C@H]2C[C@H]3CCCC[C@H]3[C@H](/C=C/[C@H]3CCC[C@H](C)N3C)[C@@H]12
CHEMBL358726,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.3,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,Cc1cccc(CN2CCC(NC(=O)C(O)(c3ccccc3)C3CCCC3)CC2)c1
CHEMBL422665,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.9,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,Nc1cccc(CN2CCC(NC(=O)[C@](O)(c3ccccc3)[C@@H]3CCC(F)(F)C3)CC2)c1
CHEMBL149484,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.5,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,COc1cccc(CN2CCC(NC(=O)[C@](O)(c3ccccc3)[C@@H]3CCC(F)(F)C3)CC2)c1
CHEMBL291562,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5011.87,nM,CHEMBL746304,B,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,CHEMBL1135177,KI,C[C@@H]1OC(=O)[C@H]2C[C@H]3CCCC[C@H]3[C@H](C#C[C@H]3CCC[C@H](C)N3C)[C@@H]12
CHEMBL148129,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,12.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(CC2CCCCCC2)CC1)C(O)(c1ccccc1)C1CCCC1
CHEMBL146291,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,93.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(CC2CCCCCCC2)CC1)C(O)(c1ccccc1)C1CCCC1
CHEMBL148450,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.9,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,COc1cccc(CN2CCC(NC(=O)C(O)(c3ccccc3)C3CCCC3)CC2)c1
CHEMBL358289,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,28.0,nM,CHEMBL697866,B,Ability to inhibit binding of [3H]NMS was determined by receptor binding assay using membranes from chinese hamster ovary (CHO) cells expressing cloned Muscarinic acetylcholine receptor M3,CHEMBL1133569,KI,O=C(NC1CCN(CC2CCCCCC2)CC1)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL148310,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,220.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,Cc1ccccc1CN1CCC(NC(=O)C(O)(c2ccccc2)C2CCCC2)CC1
CHEMBL149769,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,17.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(CC2CCCCC2)CC1)C(O)(c1ccccc1)C1CCCC1
CHEMBL146307,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,21.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,NCc1cccc(CN2CCC(NC(=O)[C@](O)(c3ccccc3)[C@@H]3CCC(F)(F)C3)CC2)c1
CHEMBL59836,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.2,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,CC(C)=CCCN1CCC(NC(=O)[C@](O)(c2ccccc2)C2CCCC2)CC1
CHEMBL147611,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.1,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(Cc2cccc(F)c2)CC1)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL277642,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,104.71,nM,CHEMBL746304,B,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,CHEMBL1135177,KI,C[C@@H]1OC(=O)[C@H]2C[C@H]3CCCC[C@@H]3[C@@H](/C=C/[C@H]3CCC[C@H](C)N3C)[C@@H]12
CHEMBL55698,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1949.84,nM,CHEMBL746304,B,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,CHEMBL1135177,KI,C[C@@H]1OC(=O)[C@H]2C[C@H]3CCCC[C@@H]3[C@@H](/C=C\[C@H]3CCC[C@H](C)N3C)[C@@H]12
CHEMBL294663,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3311.31,nM,CHEMBL746304,B,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,CHEMBL1135177,KI,C[C@@H]1OC(=O)[C@H]2C[C@H]3CCCC[C@@H]3[C@@H](C#C[C@H]3CCC[C@H](C)N3C)[C@@H]12
CHEMBL146567,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.0,nM,CHEMBL697866,B,Ability to inhibit binding of [3H]NMS was determined by receptor binding assay using membranes from chinese hamster ovary (CHO) cells expressing cloned Muscarinic acetylcholine receptor M3,CHEMBL1133569,KI,Cc1cccc(CN2CCC(NC(=O)[C@](O)(c3ccccc3)[C@@H]3CCC(F)(F)C3)CC2)c1
CHEMBL147695,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,30.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(Cc2ccoc2)CC1)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL430587,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10964.78,nM,CHEMBL746304,B,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,CHEMBL1135177,KI,C[C@@H]1OC(=O)[C@@H]2C[C@@H]3CCCC[C@@H]3[C@@H](C#C[C@H]3CCC[C@H](C)N3C)[C@H]12
CHEMBL359220,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,18.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,CC(C)=CCCN1CCC(NC(=O)[C@](O)(c2ccccc2)[C@H]2CC[C@H](O)C2)CC1
CHEMBL147672,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,50.0,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(Cc2ccoc2)CC1)C(O)(c1ccccc1)C1CCCC1
CHEMBL301670,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1621.81,nM,CHEMBL746304,B,Binding affinity against human muscarine receptor (hM3) cloned in CHO cells,CHEMBL1135177,KI,C[C@@H]1OC(=O)[C@@H]2C[C@@H]3CCCC[C@@H]3[C@@H](/C=C/[C@H]3CCC[C@H](C)N3C)[C@H]12
CHEMBL356505,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.2,nM,CHEMBL747663,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 expressed in CHO cells,CHEMBL1133569,KI,O=C(NC1CCN(Cc2ccsc2)CC1)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL314831,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.585,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(C1CCC1)N(c1ccc(Br)cc1)C1CCN(Cc2ccccc2)CC1
CHEMBL85892,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.0,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1ccccc1)N(c1ccc(Br)cc1)C1CCN(Cc2ccccc2)CC1
CHEMBL82850,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,158.49,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,CC(=O)N(c1ccc(Br)cc1)C1CCN(Cc2ccccc2)CC1
CHEMBL86012,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25.12,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1ccc(Cl)cc1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1
CHEMBL85568,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,158.49,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1ccccc1)N(Cc1ccccc1)C1CCN(Cc2ccccc2)CC1
CHEMBL353140,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,46.4,nM,CHEMBL743972,B,Tested in vitro for the binding affinity against muscarinic receptor subtype 3 (M3),CHEMBL1129888,KI,CCN(CCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1)C(=O)c1ccc(F)cc1
CHEMBL82859,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.981,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,COc1ccc(N(C(=O)c2ccccc2)C2CCN(Cc3ccccc3)CC2)cc1
CHEMBL83982,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.512,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1ccccc1)N(c1ccc(O)cc1)C1CCN(Cc2ccccc2)CC1
CHEMBL310132,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.995,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1ccccc1)N(c1ccc(Cl)c(Cl)c1)C1CCN(Cc2ccccc2)CC1
CHEMBL166385,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,39.2,nM,CHEMBL743972,B,Tested in vitro for the binding affinity against muscarinic receptor subtype 3 (M3),CHEMBL1129888,KI,CCOC(=O)N(CC)CCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1
CHEMBL85511,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1000.0,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1ccc(Br)cc1)N(c1cccnc1)C1CCN(Cc2ccccc2)CC1
CHEMBL83363,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,15.85,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(C1CCC1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1
CHEMBL85996,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.7943,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1ccc(Cl)cc1)N(c1ccc(Br)cc1)C1CCN(Cc2ccccc2)CC1
CHEMBL87302,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25.12,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1ccccc1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1
CHEMBL86309,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25.12,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(Cc1ccccc1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1
CHEMBL168145,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,33.5,nM,CHEMBL743972,B,Tested in vitro for the binding affinity against muscarinic receptor subtype 3 (M3),CHEMBL1129888,KI,CCN(CCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1)C(=O)c1cccc(I)c1
CHEMBL83459,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.943,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1ccc([N+](=O)[O-])s1)N(c1ccc(Br)cc1)C1CCN(Cc2ccccc2)CC1
CHEMBL82512,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.995,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1cccs1)N(c1ccc(Br)cc1)C1CCN(Cc2ccccc2)CC1
CHEMBL2112313,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,630.96,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1cccs1)N(c1c(Cl)cccc1Cl)C1CCN(Cc2ccccc2)CC1
CHEMBL87132,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,31.62,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1ccc(Br)cc1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1
CHEMBL168149,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,79.1,nM,CHEMBL743972,B,Tested in vitro for the binding affinity against muscarinic receptor subtype 3 (M3),CHEMBL1129888,KI,CCN(CCCCC1CCN(CC(=O)N2c3ccccc3C(=O)N(C(=O)c3ccc(F)cc3)c3ccccc32)CC1)C(=O)c1ccc(F)cc1
CHEMBL84993,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.259,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1ccccc1)N(c1ccc(Cl)cc1)C1CCN(Cc2ccccc2)CC1
CHEMBL315127,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,794.33,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1ccc([N+](=O)[O-])cc1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1
CHEMBL85950,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,79.43,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(CCc1ccccc1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1
CHEMBL85391,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.981,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1cccs1)N(c1ccc(Cl)cc1)C1CCN(Cc2ccccc2)CC1
CHEMBL88078,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25.12,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1cccs1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1
CHEMBL310016,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,100.0,nM,CHEMBL752410,B,In vitro affinity for muscarinic M3 receptor.,CHEMBL1135318,KI,O=C(c1ccco1)N(c1ccccc1)C1CCN(Cc2ccccc2)CC1
CHEMBL306903,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,17.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,O=C(NCC1CCNCC1)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL71799,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,100.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,NCC1CCC(NC(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL69402,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,16.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,NCC(=O)N1CCN(C(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL302720,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,650.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,NCc1ccc(NC(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)cc1
CHEMBL71933,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,120.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,CNCCC1CCN(C(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL69678,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.8,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,Nc1cccc(CN2CCC(NC(=O)[C@](O)(c3ccccc3)[C@@H]3CCC(F)(F)C3)CC2)n1
CHEMBL68584,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.1,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,NC1CCN(C(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL69648,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.1,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,NCCC1CCN(C(=O)[C@](O)(c2ccccc2)C2CCCC2)CC1
CHEMBL263040,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,76.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,NCCCCC1CCN(C(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL71431,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.4,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,NC1CCN(C(=O)[C@](O)(c2ccccc2)C2CCCC2)CC1
CHEMBL302145,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,93.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,NCc1cccc(NC(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)c1
CHEMBL69582,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,9.6,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,NCCN1CCN(C(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL410890,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.7,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,NCCC1CCN(C(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL66820,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,47.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,NCCCC1CCN(C(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL69765,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,930.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,CN(C)CCC1CCN(C(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL69383,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,320.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,O=C(NC1CCNCC1)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL305531,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.9,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,NCC1CCN(C(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)C1
CHEMBL66322,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,11.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,NCC1CCN(C(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL67873,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,89.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,O=C(NCCC1CCNCC1)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL71483,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,26.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,CC(C)(N)CC1CCN(C(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL443267,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,CCC1(CCN)CCN(C(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL302809,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.3,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,CC1(CCN)CCN(C(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL68384,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.2,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,NCC=C1CCN(C(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL69904,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2400.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,O=C(N1CCC(CCN2CCCCC2)CC1)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL307554,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,290.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,O=C(Nc1ccc2c(c1)CNC2)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL67814,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,50.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,O=C(N1CCNCC1)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL424416,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,17.0,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,O=C(N1CCCNCC1)[C@](O)(c1ccccc1)[C@@H]1CCC(F)(F)C1
CHEMBL68609,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8.3,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,CC1(N)CCN(C(=O)[C@](O)(c2ccccc2)[C@@H]2CCC(F)(F)C2)CC1
CHEMBL66400,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.7,nM,CHEMBL747820,B,Binding affinity against human muscarinic acetylcholine receptor M3 in transfected CHO cells,CHEMBL1136082,KI,NCC1CCN(C(=O)[C@](O)(c2ccccc2)C2CCCC2)CC1
CHEMBL130835,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,97.2,nM,CHEMBL747664,B,Affinity for human M3 cloned muscarinic receptor subtype expressed in CHO-K1 cells,CHEMBL1134278,KI,COc1ccccc1CN1CCC(C2CCN(C(=O)CCCCCCC(=O)N3CCC(C4CCN(Cc5ccccc5OC)CC4)CC3)CC2)CC1
CHEMBL127273,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,422.0,nM,CHEMBL747664,B,Affinity for human M3 cloned muscarinic receptor subtype expressed in CHO-K1 cells,CHEMBL1134278,KI,COc1ccccc1CN1CCC(C2CCN(CCCCCCCCN3CCC(C4CCN(Cc5ccccc5OC)CC4)CC3)CC2)CC1
CHEMBL27673,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,277.0,nM,CHEMBL747664,B,Affinity for human M3 cloned muscarinic receptor subtype expressed in CHO-K1 cells,CHEMBL1134278,KI,COc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1OC
CHEMBL106219,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,50.12,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCOC(=O)c1c(CC)n(Cc2ccccc2)c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL7303,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5700.0,nM,CHEMBL747822,B,Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M3,CHEMBL1131242,KI,COC(=O)C1=CCCN(C)C1
CHEMBL420662,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,407.38,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,C=CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL320465,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,70.79,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCCc1[nH]c2ccc3c(c2c1C(=O)OCC)CN1CCc2cc(OC)ccc2C1O3
CHEMBL318995,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,338.84,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCCCc1[nH]c2ccc3c(c2c1C(=O)OCC)CN1CCc2cc(SC)ccc2C1O3
CHEMBL107680,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25703.96,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(O)ccc2C1O3
CHEMBL104210,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,457.09,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCCCCc1[nH]c2ccc3c(c2c1C(=O)OCC)CN1CCc2cc(OC)ccc2C1O3
CHEMBL2112955,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.31,nM,CHEMBL747818,B,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,CHEMBL1135983,KI,O=C(CCNC(=O)CNC(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1)NC[C@H]1CCCN(CC2CCCCC2)C1
CHEMBL2112957,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.25,nM,CHEMBL747818,B,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,CHEMBL1135983,KI,O=C(NC[C@H]1CCCN(CC2CCCCC2)C1)[C@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1
CHEMBL104332,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,676.08,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,C=CCOC(=O)c1c(C)n(Cc2ccc(OC)cc2)c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL104574,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1380.38,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,COc1ccc2c(c1)CCN1Cc3c(ccc4[nH]c(C)c(C(=O)OCc5ccccc5)c34)OC21
CHEMBL369062,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.1,nM,CHEMBL747818,B,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,CHEMBL1135983,KI,O=C(CCCNC(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1)NCCC(=O)NCC1CCCN(CC2CCCCC2)C1
CHEMBL105148,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,91.2,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCOC(=O)c1c(CC)[nH]c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL2112961,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.2,nM,CHEMBL747818,B,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,CHEMBL1135983,KI,O=C(CNC(=O)[C@@H]1CCCN1C(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1)NC[C@H]1CCCN(CC2CCCCC2)C1
CHEMBL517712,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.5,nM,CHEMBL747818,B,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,CHEMBL1135983,KI,CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2
CHEMBL106218,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,218.78,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCOC(=O)c1c(CC)n(C)c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL1346,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.84,nM,CHEMBL747818,B,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,CHEMBL1135983,KI,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1
CHEMBL106224,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,70.79,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCCc1c(C(=O)OCC)c2c3c(ccc2n1C)OC1c2ccc(OC)cc2CCN1C3
CHEMBL2112956,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.0,nM,CHEMBL747818,B,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,CHEMBL1135983,KI,O=C(CCCCCNC(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1)NC[C@H]1CCCN(CC2CCCCC2)C1
CHEMBL59898,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,257.04,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL294273,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,15000.0,nM,CHEMBL747822,B,Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M3,CHEMBL1131242,KI,CC(=O)OC1CC2CCCC1N2C
CHEMBL177040,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.3,nM,CHEMBL747818,B,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,CHEMBL1135983,KI,O=C(CCCNC(=O)CNC(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1)NCC1CCCN(CC2CCCCC2)C1
CHEMBL64788,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,18000.0,nM,CHEMBL747822,B,Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M3,CHEMBL1131242,KI,COC(=O)C1CC2CCCC1N2
CHEMBL105593,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5128.61,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cccc(Cl)c2C1O3
CHEMBL104804,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2041.74,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,COc1ccc2c(c1)CCN1Cc3c(ccc4[nH]c(C)c(Cc5ccccc5)c34)OC21
CHEMBL105945,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,398.11,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,COC(=O)c1c(C)n(C)c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL105160,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,281.84,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCCCCCc1[nH]c2ccc3c(c2c1C(=O)OCC)CN1CCc2cc(OC)ccc2C1O3
CHEMBL326450,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,151.36,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCCCc1[nH]c2ccc3c(c2c1C(=O)OCC)CN1CCc2cc(OC)ccc2C1O3
CHEMBL107679,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,263.03,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCOC(=O)c1c(C)n(CC)c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL106259,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,15488.17,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCN(C)C(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL2112959,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.76,nM,CHEMBL747818,B,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,CHEMBL1135983,KI,O=C(CCNC(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1)NCCC(=O)NC[C@H]1CCCN(CC2CCCCC2)C1
CHEMBL280220,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,229.09,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCCc1c(C(=O)OCC)c2c3c(ccc2n1C)OC1c2ccc(SC)cc2CCN1C3
CHEMBL105674,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2754.23,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(Cl)ccc2C1O3
CHEMBL107444,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,912.01,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCOC(=O)c1c(C)n(C)c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL104803,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3090.3,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,COc1ccc2c(c1)CCN1Cc3c(ccc4[nH]c(C)c(-c5nc(C)no5)c34)OC21
CHEMBL105122,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,229.09,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(SC)ccc2C1O3
CHEMBL2112958,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.47,nM,CHEMBL747818,B,Binding affinity (Ki) against binding of [3H]NMS using membranes from CHO cells expressing cloned human Muscarinic acetylcholine receptor M3,CHEMBL1135983,KI,O=C(CCNC(=O)[C@@H]1CCCN1C(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1)NC[C@H]1CCCN(CC2CCCCC2)C1
CHEMBL106505,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1023.29,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCCCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL104693,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,100.0,nM,CHEMBL752414,B,Inhibition of [3H]NMS binding to human muscarinic acetylcholine receptor M3 in transfected CHO cells.,CHEMBL1135505,KI,CCCc1[nH]c2ccc3c(c2c1C(=O)OCC)CN1CCc2cc(SC)ccc2C1O3
CHEMBL64000,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,680.0,nM,CHEMBL747822,B,Inhibition of binding of [3H]quinuclidinyl benzilate to muscarinic receptors in membranes of CHO cells transfected with Muscarinic acetylcholine receptor M3,CHEMBL1131242,KI,CC(=O)OC1CC2CCCC1N2
CHEMBL2114068,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.13,nM,CHEMBL747826,B,Binding affinity against Muscarinic acetylcholine receptor M3,CHEMBL1132745,KI,C=C(c1ccc([S@@+]([O-])c2ccc(OC)cc2)cc1)C1CCN(C2CCCCC2)CC1
CHEMBL2115126,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,58.8,nM,CHEMBL747826,B,Binding affinity against Muscarinic acetylcholine receptor M3,CHEMBL1132745,KI,COc1ccc([S@+]([O-])c2ccc(C(C#N)C3CCN(C4CCCCC4)CC3)cc2)cc1
CHEMBL2114064,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,37.04,nM,CHEMBL747826,B,Binding affinity against Muscarinic acetylcholine receptor M3,CHEMBL1132745,KI,COc1ccc([S@@+]([O-])c2ccc(C(C#N)C3CCN(C4CCCCC4)CC3)cc2)cc1
CHEMBL2115128,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.38,nM,CHEMBL747826,B,Binding affinity against Muscarinic acetylcholine receptor M3,CHEMBL1132745,KI,C=C(c1ccc([S@+]([O-])c2ccc(OC)cc2)cc1)C1CCN(C2CCCCC2)CC1
CHEMBL71124,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.16,nM,CHEMBL747826,B,Binding affinity against Muscarinic acetylcholine receptor M3,CHEMBL1132745,KI,COc1ccc([S+]([O-])c2ccc(C(C)C3CCN(C4CCCCC4)CC3)cc2)cc1
CHEMBL307810,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.97,nM,CHEMBL747826,B,Binding affinity against Muscarinic acetylcholine receptor M3,CHEMBL1132745,KI,COc1ccc([S+]([O-])c2ccc(C(C)N3CCN(C4CCCCC4)CC3)cc2)cc1
CHEMBL2115127,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,20.1,nM,CHEMBL747826,B,Binding affinity against Muscarinic acetylcholine receptor M3,CHEMBL1132745,KI,COc1ccc([S@+]([O-])c2ccc(C(=O)C3CCN(C4CCCCC4)CC3)cc2)cc1
CHEMBL71147,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.48,nM,CHEMBL747826,B,Binding affinity against Muscarinic acetylcholine receptor M3,CHEMBL1132745,KI,C=C(c1ccc(S(=O)(=O)c2ccc(OC)cc2)cc1)C1CCN(C2CCCCC2)CC1
CHEMBL2114067,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,27.8,nM,CHEMBL747826,B,Binding affinity against Muscarinic acetylcholine receptor M3,CHEMBL1132745,KI,COc1ccc([S@@+]([O-])c2ccc(C(=O)C3CCN(C4CCCCC4)CC3)cc2)cc1
CHEMBL2111540,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,29.4,nM,CHEMBL747826,B,Binding affinity against Muscarinic acetylcholine receptor M3,CHEMBL1132745,KI,COc1ccc([S@@+]([O-])c2ccc(C(C#N)N3CCN(C4CCCCC4)CC3)cc2)cc1
CHEMBL71971,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.8,nM,CHEMBL747826,B,Binding affinity against Muscarinic acetylcholine receptor M3,CHEMBL1132745,KI,COc1ccc(S(=O)(=O)c2ccc(C(C#N)N3CCN(C4CCCCC4)CC3)cc2)cc1
CHEMBL71531,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,13.76,nM,CHEMBL747826,B,Binding affinity against Muscarinic acetylcholine receptor M3,CHEMBL1132745,KI,COc1ccc(S(=O)(=O)c2ccc(C(=O)C3CCN(C4CCCCC4)CC3)cc2)cc1
CHEMBL381623,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.13,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@]1(C#CC(O)(c2ccccc2)c2ccccc2)CN2CCC1CC2
CHEMBL1346,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.3,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1
CHEMBL1231,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.3,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1
CHEMBL1382,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.2,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1
CHEMBL203249,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.0,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,COC1(C#CC(O)(c2ccccc2)c2cncnc2)CN2CCC1CC2
CHEMBL383248,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.9,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,COC1(C#CC(O)(c2ccccc2)c2cccnn2)CN2CCC1CC2
CHEMBL382213,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.79,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,COC1(C#CC(O)(c2ccccc2)c2cccnc2F)CN2CCC1CC2
CHEMBL427013,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.32,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,COC1(C#CC(O)(c2ccccc2)c2ccc(F)nc2)CN2CCC1CC2
CHEMBL381469,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,50.0,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@]1(C#CC(O)(c2cccnc2)c2cccnc2)CN2CCC1CC2
CHEMBL201933,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.3,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,COC1(C#CC(O)(c2ccccc2)c2ccncc2)CN2CCC1CC2
CHEMBL372566,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,13.0,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@]1(C#C[C@](O)(c2ccccc2)c2cccnc2)CN2CCC1CC2
CHEMBL200171,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.25,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@]1(C#C[C@@](O)(c2ccccc2)c2cccnc2)CN2CCC1CC2
CHEMBL200319,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.4,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,COC1(C#CC(O)(c2ccccc2)c2cccnc2)CN2CCC1CC2
CHEMBL200210,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.0,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,COC1(C#CC(O)(c2ccccc2)c2ccccn2)CN2CCC1CC2
CHEMBL381020,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,20.0,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,COC1(C#CC(O)(c2ccccn2)C2CCC2)CN2CCC1CC2
CHEMBL370862,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.0,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,COC1(C#CC(O)(c2ccccn2)C2CCCC2)CN2CCC1CC2
CHEMBL200401,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.08,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@]1(C#CC(O)(c2ccsc2)c2ccsc2)CN2CCC1CC2
CHEMBL370232,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.05,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@]1(C#CC(O)(c2cccs2)c2cccs2)CN2CCC1CC2
CHEMBL200566,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,100.0,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@]1(C#CC(O)C2c3ccccc3C=Cc3ccccc32)CN2CCC1CC2
CHEMBL199591,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1000.0,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@]1(C#CC(O)(c2cccc(C(F)(F)F)c2)c2cccc(C(F)(F)F)c2)CN2CCC1CC2
CHEMBL380583,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.9,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@]1(C#CC(O)(c2cccc(C)c2)c2cccc(C)c2)CN2CCC1CC2
CHEMBL383389,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.79,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@]1(C#CC(O)(c2cccc(F)c2)c2cccc(F)c2)CN2CCC1CC2
CHEMBL200209,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,100.0,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@]1(C#CC(O)(c2ccc(C)cc2)c2ccc(C)cc2)CN2CCC1CC2
CHEMBL199981,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.9,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@]1(C#CC(O)(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CN2CCC1CC2
CHEMBL381878,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.0,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@]1(C#CC(O)(c2ccc(F)cc2)c2ccc(F)cc2)CN2CCC1CC2
CHEMBL197973,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,631.0,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,COC1(C#CC(O)(Cc2ccccc2)Cc2ccccc2)CN2CCC1CC2
CHEMBL373256,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,40.0,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,COC1(C#CC(O)(Cc2ccccc2)c2ccccc2)CN2CCC1CC2
CHEMBL200416,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.63,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CCCCC(O)(C#CC1(OC)CN2CCC1CC2)c1ccccc1
CHEMBL199821,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.5,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CCCCCC(O)(C#CC1(OC)CN2CCC1CC2)c1ccccc1
CHEMBL200957,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.0,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,COC1(C#CC(O)(c2ccccc2)C2CCC2)CN2CCC1CC2
CHEMBL200432,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.25,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,COC1(C#CC(O)(c2ccccc2)C2CCCC2)CN2CCC1CC2
CHEMBL371734,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.2,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@]1(C#C[C@@](O)(c2ccccc2)C2CCCCC2)CN2CCC1CC2
CHEMBL200693,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@]1(C#CC(O)(c2ccccc2)C2CCCCC2)CN2CCC1CC2
CHEMBL200208,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,63.0,nM,CHEMBL863985,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1147773,KI,CO[C@@]1(C#CC(O)(c2ccccc2)c2ccccc2)CN2CCC1CC2
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,43651.58,nM,CHEMBL862221,B,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,CHEMBL1138195,KI,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL380759,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2398.83,nM,CHEMBL862221,B,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,CHEMBL1138195,KI,C[N+](C)(C)CC#CCOC(=O)Nc1ccc(Cl)cc1.[Cl-]
CHEMBL128365,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,851.14,nM,CHEMBL862221,B,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,CHEMBL1138195,KI,C#CCOC(=O)C1=CCCN(C)C1
CHEMBL2093084,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,33884.42,nM,CHEMBL862221,B,Binding affinity to cloned human muscarinic M3 receptor expressed in CHO cells,CHEMBL1138195,KI,C[C@@H]1O[C@H]([C@@H]2CCC[N+]2(C)C)C[S@@+]1[O-].[I-]
CHEMBL205853,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,79.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCSCC1
CHEMBL207816,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,C1CCCN(c2nc(C3CC3)nc3c2CCCCN3)CC1
CHEMBL207287,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,50.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,C1CCCN(c2nc(C3CC3)nc3c2CCCN3)CC1
CHEMBL380314,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.9,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(N[C@H]2C[C@@H]2C)nc(C2CC2)nc1N1CCCCCC1
CHEMBL208335,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2(C)CC2)nc(C2CC2)nc1N1CCCCCC1
CHEMBL202729,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.9,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CCC2)nc(C2CC2)nc1N1CCCCCC1
CHEMBL206826,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,100.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,CCc1c(NC2CC2)nc(C2CC2)nc1N1CCSCC1
CHEMBL207098,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,398.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,COc1c(NC2CC2)nc(C2CC2)nc1N1CCSCC1
CHEMBL205482,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,79.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Nc1c(NC2CC2)nc(C2CC2)nc1N1CCCCCC1
CHEMBL204777,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2512.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,O=[N+]([O-])c1c(NC2CC2)nc(C2CC2)nc1N1CCCCCC1
CHEMBL206127,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,316.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Brc1c(NC2CC2)nc(C2CC2)nc1N1CCCCCC1
CHEMBL206753,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,251.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Fc1c(NC2CC2)nc(C2CC2)nc1N1CCCCCC1
CHEMBL380135,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,63.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,c1c(NC2CC2)nc(C2CC2)nc1N1CCCCCC1
CHEMBL206087,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,398.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,C[C@@H]1C[C@H]1c1nc(NC2CC2)cc(N2CCCCCC2)n1
CHEMBL377729,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,32.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc([C@@H]2C[C@H]2C)nc1N1CCCCCC1
CHEMBL208300,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,501.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(Cc2ccccc2)nc1N1CCCCCC1
CHEMBL378904,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,126.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(CC2CC2)nc1N1CCCCCC1
CHEMBL206714,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C(C)C)nc1N1CCCCCC1
CHEMBL205841,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,79.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CCCC2)nc1N1CCCCCC1
CHEMBL205840,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,40.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CCC2)nc1N1CCCCCC1
CHEMBL380477,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,79.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NCCc2cccs2)nc(C2CC2)nc1NC1CC1
CHEMBL205737,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,126.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NCc2cccs2)nc(C2CC2)nc1NC1CC1
CHEMBL380954,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,63.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NCc2c(F)cccc2F)nc(C2CC2)nc1NC1CC1
CHEMBL208299,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,316.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCc2ccccc2C1
CHEMBL204471,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,251.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N(C)Cc1ccccc1
CHEMBL381259,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,200.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NCc2ccccc2)nc(C2CC2)nc1NC1CC1
CHEMBL205976,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.3,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CC2CCC(C2)C1
CHEMBL206780,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,398.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CCCCCC2)nc(C2CC2)nc1NC1CC1
CHEMBL377728,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,316.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CCCCC2)nc(C2CC2)nc1NC1CC1
CHEMBL205686,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,16.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCCCCCC1
CHEMBL205654,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.2,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCCCCC1
CHEMBL427390,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,100.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCCC1
CHEMBL206480,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,79.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,C=C1CCN(c2nc(C3CC3)nc(NC3CC3)c2C)CC1
CHEMBL381752,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,50.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCC(F)(F)CC1
CHEMBL380926,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,100.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCC(C(F)(F)F)CC1
CHEMBL203124,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,501.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCC(CO)CC1
CHEMBL205140,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,790.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCC(Cc2ccccc2)CC1
CHEMBL204353,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,158.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCC2(CCCC2)CC1
CHEMBL381333,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCC(C)(C)CC1
CHEMBL205992,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,32.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CC=CCC1
CHEMBL205944,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,50.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,CCC1CCN(c2nc(C3CC3)nc(NC3CC3)c2C)CC1
CHEMBL208280,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,16.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCC(C)CC1
CHEMBL205105,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,13.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCCCC1
CHEMBL382374,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3200.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCC(=O)CC1
CHEMBL205582,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,501.0,nM,CHEMBL861122,B,Displacement of [3H]methylscopolamine from recombinant human muscarinic M3 receptors expressed in CHO cells,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCC(O)CC1
CHEMBL205654,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.162,nM,CHEMBL861123,B,Binding affinity to muscarinic M3 receptors,CHEMBL1146129,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCCCCC1
CHEMBL377241,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,160.0,nM,CHEMBL864910,B,Binding affinity to muscarinic M3R,CHEMBL1138061,KI,CN[C@@H]1CCN(c2ccc(-n3ncc4cc(-c5ccc(C(F)(F)F)cc5)sc4c3=O)cn2)C1
CHEMBL275914,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,99.0,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NC[C@H]1CCCNC1)[C@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1
CHEMBL379055,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,150.0,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,NCC1CCN(C(=O)[C@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)CC(c2ccccc2)(c2ccccc2)c2ccccc2)CC1.O=C(O)C(F)(F)F
CHEMBL379483,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,49.0,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NCC1CCNCC1)[C@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F
CHEMBL385229,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,23.0,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NC[C@@H]1CCCNC1)[C@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F
CHEMBL214270,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,29.0,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NCCC1CCNCC1)[C@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F
CHEMBL212530,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,170.0,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,NC1CCCC(NC(=O)[C@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)CC(c2ccccc2)(c2ccccc2)c2ccccc2)C1.O=C(O)C(F)(F)F
CHEMBL405117,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,48.0,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,N[C@H]1CCCC[C@@H]1NC(=O)[C@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1.O=C(O)C(F)(F)F
CHEMBL215180,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NCC1CCNCC1)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccc(F)cc1)(c1ccc(F)cc1)c1ccc(F)cc1
CHEMBL214642,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.2,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NCC1CCNCC1)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1
CHEMBL212645,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.51,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NCC1CCN(C2CCCC2)CC1)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccc(F)cc1)(c1ccc(F)cc1)c1ccc(F)cc1
CHEMBL212141,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.4,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,CC(C)NC(=O)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccc(F)cc1)(c1ccc(F)cc1)c1ccc(F)cc1
CHEMBL214898,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.19,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NCC1CCN(CC2CCCC2)CC1)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccc(F)cc1)(c1ccc(F)cc1)c1ccc(F)cc1
CHEMBL215189,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.53,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NCC1CCN(CC2CCC2)CC1)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccc(F)cc1)(c1ccc(F)cc1)c1ccc(F)cc1
CHEMBL378772,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.17,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NCC1CCN(CC2CC2)CC1)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccc(F)cc1)(c1ccc(F)cc1)c1ccc(F)cc1
CHEMBL213709,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.92,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,CCN1CCC(CNC(=O)[C@H]2CCCN2C(=O)[C@@H]2C[C@@H](O)CN2C(=O)CC(c2ccc(F)cc2)(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL214342,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.51,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,CN1CCC(CNC(=O)[C@H]2CCCN2C(=O)[C@@H]2C[C@@H](O)CN2C(=O)CC(c2ccc(F)cc2)(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL438822,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.39,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NC[C@@H]1CCCNC1)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccc(F)cc1)(c1ccc(F)cc1)c1ccc(F)cc1
CHEMBL214029,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.48,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NCCC1CCNCC1)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccc(F)cc1)(c1ccc(F)cc1)c1ccc(F)cc1
CHEMBL215894,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.6,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NC[C@@H]1CCCNC1)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccc(Cl)cc1)(c1ccc(Cl)cc1)c1ccc(Cl)cc1
CHEMBL378859,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.2,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NCCC1CCNCC1)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccc(Cl)cc1)(c1ccc(Cl)cc1)c1ccc(Cl)cc1
CHEMBL378872,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.39,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NCC1CCNCC1)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccc(Cl)cc1)(c1ccc(Cl)cc1)c1ccc(Cl)cc1
CHEMBL378885,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.7,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NC[C@@H]1CCCNC1)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1
CHEMBL211976,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.8,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NCCC1CCNCC1)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccccc1)(c1ccccc1)c1ccccc1
CHEMBL215180,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL909206,B,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,CHEMBL1148687,KI,O=C(NCC1CCNCC1)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccc(F)cc1)(c1ccc(F)cc1)c1ccc(F)cc1
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6309.57,nM,CHEMBL853694,B,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,CHEMBL1138216,KI,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL219118,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,199.53,nM,CHEMBL853694,B,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,CHEMBL1138216,KI,COc1nsc(OCCCOCCCOCCCOc2nsnc2-c2cccnc2)n1
CHEMBL376295,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,199.53,nM,CHEMBL853694,B,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,CHEMBL1138216,KI,COc1nsnc1OCCCOCCCOCCCOc1nsnc1-c1cccnc1
CHEMBL216928,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,316.23,nM,CHEMBL853694,B,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,CHEMBL1138216,KI,COc1nsc(OCCOCCOCCOCCOc2nsnc2C2C=CCCN2C)n1
CHEMBL216983,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,316.23,nM,CHEMBL853694,B,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,CHEMBL1138216,KI,CN1CCC=C(c2nsnc2OCCOCCOCCOCCO)C1
CHEMBL386983,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1584.89,nM,CHEMBL853694,B,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,CHEMBL1138216,KI,COc1nsnc1OCCOCCOCCOCCOCCOc1nsnc1C1=CCCN(C)C1
CHEMBL216927,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25.12,nM,CHEMBL853694,B,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,CHEMBL1138216,KI,COc1nsnc1OCCOCCOCCOCCOc1nsnc1C1=CCCN(C)C1
CHEMBL218755,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,251.19,nM,CHEMBL853694,B,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,CHEMBL1138216,KI,COc1nsnc1OCCOCCOCCOc1nsnc1C1=CCCN(C)C1
CHEMBL373888,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,50.12,nM,CHEMBL853694,B,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,CHEMBL1138216,KI,COc1nsnc1OCCOCCOc1nsnc1C1=CCCN(C)C1
CHEMBL21536,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,79.43,nM,CHEMBL853694,B,Inhibition of [3H](R)-QNB binding to human M3 receptor expressed in A9 L cells,CHEMBL1138216,KI,CCCCCCOc1nsnc1C1=CCCN(C)C1
CHEMBL373515,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.248,nM,CHEMBL917979,B,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,CHEMBL1142937,KI,CN1CCC[C@H]1[C@H]1CSC(c2ccccc2)(c2ccccc2)O1
CHEMBL376897,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1349,nM,CHEMBL917979,B,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,CHEMBL1142937,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12
CHEMBL222259,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.912,nM,CHEMBL917979,B,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,CHEMBL1142937,KI,C[N+]1(C)CCC[C@@H]1[C@@H]1CS[C@@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL376057,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.5888,nM,CHEMBL917979,B,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,CHEMBL1142937,KI,C[N+]1(C)CCC[C@H]1[C@H]1CS[C@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL220393,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.898,nM,CHEMBL917979,B,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,CHEMBL1142937,KI,C[N+]1(C)CCC[C@@H]1[C@@H]1CS[C@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL219786,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3388,nM,CHEMBL917979,B,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,CHEMBL1142937,KI,C[N+]1(C)CCC[C@H]1[C@H]1CS[C@@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL375851,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.012,nM,CHEMBL917979,B,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,CHEMBL1142937,KI,C[N+]1(C)CCC[C@@H]1[C@@H]1CSC(c2ccccc2)(c2ccccc2)O1.[I-]
CHEMBL375969,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.7413,nM,CHEMBL917979,B,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,CHEMBL1142937,KI,C[N+]1(C)CCC[C@H]1[C@H]1CSC(c2ccccc2)(c2ccccc2)O1.[I-]
CHEMBL219825,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.445,nM,CHEMBL917979,B,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,CHEMBL1142937,KI,CN1CCC[C@@H]1[C@@H]1CS[C@@](c2ccccc2)(C2CCCCC2)O1
CHEMBL376255,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.698,nM,CHEMBL917979,B,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,CHEMBL1142937,KI,CN1CCC[C@H]1[C@H]1CS[C@](c2ccccc2)(C2CCCCC2)O1
CHEMBL376870,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.188,nM,CHEMBL917979,B,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,CHEMBL1142937,KI,CN1CCC[C@@H]1[C@@H]1CS[C@](c2ccccc2)(C2CCCCC2)O1
CHEMBL385328,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.8913,nM,CHEMBL917979,B,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,CHEMBL1142937,KI,CN1CCC[C@H]1[C@H]1CS[C@@](c2ccccc2)(C2CCCCC2)O1
CHEMBL375073,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.455,nM,CHEMBL917979,B,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,CHEMBL1142937,KI,CN1CCC[C@@H]1[C@@H]1CSC(c2ccccc2)(c2ccccc2)O1
CHEMBL45454,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.778,nM,CHEMBL917979,B,Binding affinity to human cloned muscarinic receptor M3 expressed in CHO cells,CHEMBL1142937,KI,C[N+](C)(C)C[C@@H]1CS[C@@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL222425,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,612.0,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(Cc2ccccc2)CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)CC1
CHEMBL222449,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.01,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(CC(=O)c2cccc(F)c2)CC[C@@H](N2CC(c3ccc(F)cc3)(c3ccc(F)cc3)NC2=O)C1
CHEMBL374513,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.84,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(CC(=O)c2ccccc2)CC[C@@H](N2CC(c3ccc(F)cc3)(c3ccc(F)cc3)NC2=O)C1
CHEMBL223668,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.75,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(CCc2ccccc2)CC[C@@H](N2CC(c3ccc(F)cc3)(c3ccc(F)cc3)NC2=O)C1
CHEMBL224783,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.6,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(CCOc2ccccc2)CC[C@H](N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1
CHEMBL387546,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.04,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(CCOc2ccccc2)CC[C@@H](N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1
CHEMBL222917,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,356.0,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,COCC[N+]1(CCOc2ccccc2)CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1
CHEMBL222916,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,541.0,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,N#CC[N+]1(CCOc2ccccc2)CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1
CHEMBL376900,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.66,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(C[C@H]2O[C@@H]2c2ccccc2)CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1
CHEMBL222636,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.89,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(CC(=O)c2ccccc2)CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1
CHEMBL223028,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.76,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(CCCOc2ccccc2)CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1
CHEMBL222976,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.7,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(CCOCc2ccccc2)CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1
CHEMBL374989,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.89,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(CCOc2ccccc2)CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1
CHEMBL374452,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.7,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(CCCc2ccccc2)CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1
CHEMBL223055,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.67,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(CCc2ccccc2)CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1.[Br-]
CHEMBL223724,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2065.0,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+](C)(C)CCCN1CC(c2ccccc2)(c2ccccc2)NC1=O
CHEMBL438243,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,619.0,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,CC(=O)NC(C)(C)C(=O)N1CCC[C@H]1C(=O)NC(C)(C)C(=O)N[C@@H](C)C(=O)NC(C)(C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)NC(C)(C)C(=O)N[C@H](C(=O)NC(C)(C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NC(C)(C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](CO)Cc1ccccc1)C(C)C)C(C)C
CHEMBL224784,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,335.0,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+](C)(C)CCN1CC(c2ccccc2)(c2ccccc2)NC1=O
CHEMBL222426,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,507.0,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+](C)(CCN1CC(c2ccccc2)(c2ccccc2)NC1=O)Cc1ccccc1
CHEMBL222975,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3158.0,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(Cc2ccccc2)CC[C@H](N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1
CHEMBL221775,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,282.0,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(Cc2ccccc2)CC[C@@H](N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1
CHEMBL222090,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,310.0,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(C)CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1
CHEMBL374987,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,727.0,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(Cc2ccccc2)CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1
CHEMBL222689,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,153.0,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(C)C2CCC1CC(N1CC(c3ccccc3)(c3ccccc3)NC1=O)C2
CHEMBL224965,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2535.0,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(Cc2ccccc2)C2CCC1CC(N1CC(c3ccccc3)(c3ccccc3)NC1=O)C2
CHEMBL390839,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,249.0,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(C)CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)CC1
CHEMBL222054,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.61,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(CC(=O)c2ccccn2)CC[C@@H](N2CC(c3ccc(F)cc3)(c3ccc(F)cc3)NC2=O)C1
CHEMBL222874,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,22.9,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(CC(=O)c2cccnc2)CC[C@@H](N2CC(c3ccc(F)cc3)(c3ccc(F)cc3)NC2=O)C1
CHEMBL222450,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.62,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(CC(=O)c2ccsc2)CC[C@@H](N2CC(c3ccc(F)cc3)(c3ccc(F)cc3)NC2=O)C1
CHEMBL222634,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,9.11,nM,CHEMBL913822,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1142993,KI,C[N+]1(CC(=O)Nc2ccccc2)CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)C1
CHEMBL223029,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2185.0,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)C(=O)N1C1CCN(Cc2ccccc2)CC1
CHEMBL223188,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,26.8,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1N(C2CCN(Cc3ccccc3)CC2)CC(c2ccccc2)N1Cc1ccccc1
CHEMBL225387,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,16.8,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1OC(c2ccccc2)(c2ccccc2)CN1C1CCN(Cc2ccccc2)CC1
CHEMBL375277,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,18.5,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,CN1C(=O)N(C2CCN(Cc3ccccc3)CC2)CC1(c1ccccc1)c1ccccc1
CHEMBL376000,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.9,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(Cc2ccccc2)CC1
CHEMBL223017,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,82.0,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1[C@H]1CCN(Cc2ccccc2)C1
CHEMBL438427,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,13.3,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1[C@@H]1CCN(Cc2ccccc2)C1
CHEMBL222387,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.96,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCCN(Cc2ccccc2)CC1
CHEMBL221400,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.1,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CC2CCC(C1)N2Cc1ccccc1
CHEMBL426890,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2445.0,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCCN(Cc2ccccc2)C1
CHEMBL376781,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.75,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2cccs2)(c2cccs2)CN1C1CCN(Cc2cccc(F)c2)CC1
CHEMBL375420,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.72,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,Cc1cccc(CN2CCC(N3CC(c4cccs4)(c4cccs4)NC3=O)CC2)c1
CHEMBL222207,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.59,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(C2CCCCC2)CN1C1CCN(Cc2cccc(Cl)c2)CC1
CHEMBL222403,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.54,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,Cc1cccc(CN2CCC(N3CC(c4ccccc4)(C4CCCCC4)NC3=O)CC2)c1
CHEMBL221401,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.83,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccc(F)cc2)(c2ccc(F)cc2)CN1C1CCN(Cc2cccc(F)c2)CC1
CHEMBL223079,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.7,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccc(F)cc2)(c2ccc(F)cc2)CN1C1CCN(Cc2cccc(Cl)c2)CC1
CHEMBL373994,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.32,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(Cc2cccc(F)c2)CC1
CHEMBL223925,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,53.5,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(Cc2cccc(C(F)(F)F)c2)CC1
CHEMBL376636,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,418.0,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,N#Cc1cccc(CN2CCC(N3CC(c4ccccc4)(c4ccccc4)NC3=O)CC2)c1
CHEMBL223030,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2057.0,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(Cc2cccc(OC(F)(F)F)c2)CC1
CHEMBL221829,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.9,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,Nc1cccc(CN2CCC(N3CC(c4ccccc4)(c4ccccc4)NC3=O)CC2)c1
CHEMBL222388,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.37,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,Cc1cccc(CN2CCC(N3CC(c4ccccc4)(c4ccccc4)NC3=O)CC2)c1
CHEMBL222804,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.6,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(Cc2cccc(O)c2)CC1
CHEMBL436492,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25.8,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,COc1ccc(CN2CCC(N3CC(c4ccccc4)(c4ccccc4)NC3=O)CC2)cc1
CHEMBL225074,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8.8,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,COc1cccc(CN2CCC(N3CC(c4ccccc4)(c4ccccc4)NC3=O)CC2)c1
CHEMBL388541,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,83.7,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,COc1ccccc1CN1CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)CC1
CHEMBL269280,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,16.5,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(Cc2ccc(Cl)cc2)CC1
CHEMBL223016,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.15,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(Cc2cccc(Cl)c2)CC1
CHEMBL384670,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,13.8,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(Cc2ccccc2Cl)CC1
CHEMBL223022,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1056.0,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(Cc2c[nH]cn2)CC1
CHEMBL441873,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,13.4,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(Cc2cccs2)CC1
CHEMBL221660,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1132.0,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(Cc2cccnc2)CC1
CHEMBL426393,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,228.0,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(CCOc2ccccc2)CC1
CHEMBL223187,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1630.0,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(CCCc2ccccc2)CC1
CHEMBL223186,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,117.0,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(CCc2ccccc2)CC1
CHEMBL222527,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,354.0,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(CC2CCCCC2)CC1
CHEMBL434929,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,101.0,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(c2ccccc2)CN1C1CCN(c2ccccc2)CC1
CHEMBL222402,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,923.0,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,CN1CCC(N2CC(c3ccccc3)(c3ccccc3)NC2=O)CC1
CHEMBL221713,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,152.0,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(Cc2ccccc2)(Cc2ccccc2)CN1C1CCN(Cc2ccccc2)CC1
CHEMBL222860,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.7,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2cccs2)(c2cccs2)CN1C1CCN(Cc2ccccc2)CC1
CHEMBL223267,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.57,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccccc2)(C2CCCCC2)CN1C1CCN(Cc2ccccc2)CC1
CHEMBL374099,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,114.0,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,COc1ccc(C2(c3ccc(OC)cc3)CN(C3CCN(Cc4ccccc4)CC3)C(=O)N2)cc1
CHEMBL222424,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.8,nM,CHEMBL914427,B,Displacement of [3H]N-methyl-scopolamine from human muscarinic M3 receptor expressed in CHO K1 cells,CHEMBL1142992,KI,O=C1NC(c2ccc(F)cc2)(c2ccc(F)cc2)CN1C1CCN(Cc2ccccc2)CC1
CHEMBL27673,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,524.81,nM,CHEMBL891179,B,Displacement of [3H] N-methyl-scopolamine chloride from human muscarinic receptor M3 expressed in CHO cells,CHEMBL1147166,KI,COc1ccccc1CNCCCCCCNCCCCCCCCNCCCCCCNCc1ccccc1OC
CHEMBL242345,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,213.8,nM,CHEMBL891179,B,Displacement of [3H] N-methyl-scopolamine chloride from human muscarinic receptor M3 expressed in CHO cells,CHEMBL1147166,KI,COc1ccccc1CNCCCCCCN1CCC(CCC2CCN(CCCCCCNCc3ccccc3OC)CC2)CC1
CHEMBL205654,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.2,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCCCCC1
CHEMBL232417,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,501.0,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,FC1CN(c2cc(N3CCCCCC3)nc(C3CC3)n2)C1
CHEMBL389992,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,13.0,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,CC1CN(c2cc(N3CCCCCC3)nc(C3CC3)n2)C1
CHEMBL232416,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,79.0,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,c1c(N2CCCCCC2)nc(C2CC2)nc1N1CCC1
CHEMBL232208,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,40.0,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,COC1CN(c2nc(C3CC3)nc(N3CCCCCC3)c2C)C1
CHEMBL436814,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,631.0,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,Cc1c(N2CCCCCC2)nc(C2CC2)nc1N1CC(=O)C1
CHEMBL396761,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,200.0,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,Cc1c(N2CCCCCC2)nc(C2CC2)nc1N1CC(F)C1
CHEMBL245137,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,794.0,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,Cc1c(N2CCCCCC2)nc(C2CC2)nc1N1CC(C#N)C1
CHEMBL242823,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,200.0,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,Cc1c(N2CCCCCC2)nc(C2CC2)nc1N1CC(Br)C1
CHEMBL242822,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,158.0,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,Cc1c(N2CCCCCC2)nc(C2CC2)nc1N1CC(O)C1
CHEMBL434388,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,32.0,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,Cc1c(N2CCCCCC2)nc(C2CC2)nc1N1CC(C)(C)C1
CHEMBL232860,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,20.0,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,Cc1c(N2CCCCCC2)nc(C2CC2)nc1N1CC(C)C1
CHEMBL395571,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,40.0,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,Cc1c(N2CCCCCC2)nc(C2CC2)nc1N1CCCCCC1
CHEMBL434765,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,79.0,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,Cc1c(N2CCCCCC2)nc(C2CC2)nc1N1CCCCC1
CHEMBL234099,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.3,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,Cc1c(N2CCCCCC2)nc(C2CC2)nc1N1CCCC1
CHEMBL232419,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,16.0,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,Cc1c(N2CCCCCC2)nc(C2CC2)nc1N1CCC1
CHEMBL205654,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.162,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,Cc1c(NC2CC2)nc(C2CC2)nc1N1CCCCCC1
CHEMBL232419,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,15.85,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,Cc1c(N2CCCCCC2)nc(C2CC2)nc1N1CCC1
CHEMBL396761,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,158.49,nM,CHEMBL893770,B,Displacement of [3H]N-methylscopolamine from human recombinant M3 muscarinic receptor expressed in CHO cell membrane,CHEMBL1147942,KI,Cc1c(N2CCCCCC2)nc(C2CC2)nc1N1CC(F)C1
CHEMBL234252,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,20.0,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCCc2ccccc2)COc2ccccc2OC1
CHEMBL234440,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.22,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCCC2CCOCC2)COc2cc(Cl)c(Cl)cc2OC1
CHEMBL392186,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.2,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCCC2CCOCC2)COc2ccc(F)cc2OC1
CHEMBL234258,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.1,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCCC2CCC(CO)CC2)COc2ccccc2OC1
CHEMBL391977,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.9,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCCC2CCC(O)CC2)COc2ccccc2OC1
CHEMBL233202,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.8,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCCC2=CCSCC2)COc2ccccc2OC1
CHEMBL233201,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.8,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCCC2CCSCC2)COc2ccccc2OC1
CHEMBL394255,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,14.0,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCC=C2CCOCC2)COc2ccccc2OC1
CHEMBL435353,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,11.0,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCCC2CCOCC2)COc2ccccc2OC1
CHEMBL394137,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.5,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCCC23CC4CC(CC(C4)C2)C3)COc2ccccc2OC1
CHEMBL234439,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.7,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCCC2CCCCCC2)COc2ccccc2OC1
CHEMBL234438,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.5,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCCC2CCCCC2)COc2ccccc2OC1
CHEMBL394254,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.3,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCCC2CCCC2)COc2ccccc2OC1
CHEMBL234257,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.9,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCC2CCCCC2)COc2ccccc2OC1
CHEMBL1231,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.78,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1
CHEMBL233200,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,19.0,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCCc2ccccc2F)COc2ccccc2OC1
CHEMBL233199,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,23.0,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCCc2c(Cl)cccc2Cl)COc2ccccc2OC1
CHEMBL233198,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,56.0,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CC(C)c1ccc(CCNCC2(N(C)C)COc3ccccc3OC2)cc1
CHEMBL234254,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,20.0,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,CN(C)C1(CNCCc2ccc(Cl)cc2)COc2ccccc2OC1
CHEMBL234253,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,18.0,nM,CHEMBL891647,B,Displacement of 1-[N-methyl- 3H]scopolamine from human muscarinic M3 receptor expressed in Sf9 cells,CHEMBL1146348,KI,Cc1ccc(CCNCC2(N(C)C)COc3ccccc3OC2)cc1
CHEMBL76897,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.68,nM,CHEMBL899144,B,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1137537,KI,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL396845,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,887.0,nM,CHEMBL899144,B,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1137537,KI,C[N+]1(CC#CCOC2=NOCC2)CCc2ccccc2C1.[I-]
CHEMBL394329,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5539.0,nM,CHEMBL899144,B,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1137537,KI,C[N+]1(CC#CCOC2=NOCC2)CCc2ccccc21.[I-]
CHEMBL239436,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4740.0,nM,CHEMBL899144,B,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1137537,KI,C[N+]1(CC#CCOC2=NOCC2)CCCCC1.[I-]
CHEMBL239866,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3919.0,nM,CHEMBL899144,B,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1137537,KI,C(#CCN1CCCCC1)COC1=NOCC1.O=C(O)C(=O)O
CHEMBL398043,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,537.0,nM,CHEMBL899144,B,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1137537,KI,O=C(O)C(=O)O.O=C1CCON1CC#CCN1CCCCC1
CHEMBL239038,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1448.0,nM,CHEMBL899144,B,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1137537,KI,C[N+]1(CC#CCOc2cc(-c3ccccc3)on2)CCCC1.[I-]
CHEMBL428916,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4013.0,nM,CHEMBL899144,B,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1137537,KI,C(#CCN1CCCC1)COc1cc(-c2ccccc2)on1.O=C(O)/C=C/C(=O)O
CHEMBL238825,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7386.0,nM,CHEMBL899144,B,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1137537,KI,Cc1cc(OCC#CC[N+]2(C)CCCC2)no1.[I-]
CHEMBL239655,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3995.0,nM,CHEMBL899144,B,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1137537,KI,Cc1cc(OCC#CC[N+](C)(C)C)no1.[I-]
CHEMBL275104,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,392.0,nM,CHEMBL899144,B,Displacement of [3H]QNB from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1137537,KI,O=C1CCON1CC#CCN1CCCC1
CHEMBL252258,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1200.0,nM,CHEMBL928757,B,Inhibition of muscarinic M3 receptor,CHEMBL1140788,KI,CC(=O)N1C2C=C(CN3C4CCC3CC(NC(=O)Nc3cc(F)cc(C(F)(F)F)c3)C4)CC1CCC2
CHEMBL228144,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7585.78,nM,CHEMBL929018,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,CHEMBL1140814,KI,CC1COCC(C[N+](C)(C)C)O1.[I-]
CHEMBL667,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7079.46,nM,CHEMBL929018,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,CHEMBL1140814,KI,CC(=O)OCC[N+](C)(C)C
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,43651.58,nM,CHEMBL929018,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,CHEMBL1140814,KI,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL404557,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,61659.5,nM,CHEMBL929018,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,CHEMBL1140814,KI,C[C@@H]1COC[C@@H](C[N+](C)(C)C)O1.[I-]
CHEMBL227429,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,23442.29,nM,CHEMBL929018,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,CHEMBL1140814,KI,C[C@H]1COC[C@H](C[N+](C)(C)C)O1.[I-]
CHEMBL228144,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,35481.34,nM,CHEMBL929018,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,CHEMBL1140814,KI,CC1COCC(C[N+](C)(C)C)O1.[I-]
CHEMBL227378,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,36307.81,nM,CHEMBL929018,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,CHEMBL1140814,KI,C[C@@H]1COC[C@H](C[N+](C)(C)C)O1.[I-]
CHEMBL390842,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3388.44,nM,CHEMBL929018,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells,CHEMBL1140814,KI,C[C@H]1COC[C@@H](C[N+](C)(C)C)O1.[I-]
CHEMBL1382,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.6,nM,CHEMBL932204,B,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cells,CHEMBL1143184,KI,Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1
CHEMBL271108,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.3,nM,CHEMBL932204,B,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cells,CHEMBL1143184,KI,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCNC(=O)CCCCCNC(=O)COc2ccc(/C=C/C3=[N+]4C(=Cc5ccc(-c6cccs6)n5[B-]4(F)F)C=C3)cc2)ccc1O)C(C)C
CHEMBL257643,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,24.0,nM,CHEMBL932204,B,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cells,CHEMBL1143184,KI,CCN(CC)c1ccc(/C=C/c2cc[n+](CCC[N+](CC)(CC)CC)cc2)cc1.[Br-].[Br-]
CHEMBL257431,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,30.0,nM,CHEMBL932204,B,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cells,CHEMBL1143184,KI,CCCCN(CCCC)c1ccc(/C=C/c2cc[n+](CCC[N+](CC)(CC)CC)cc2)cc1.[Br-].[Br-]
CHEMBL381623,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1259,nM,CHEMBL931445,B,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,CHEMBL1144745,KI,CO[C@]1(C#CC(O)(c2ccccc2)c2ccccc2)CN2CCC1CC2
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1995,nM,CHEMBL931445,B,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,CHEMBL1144745,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL1908368,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL931445,B,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,CHEMBL1144745,KI,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2.O.[Br-]
CHEMBL410061,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,15.85,nM,CHEMBL931445,B,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,CHEMBL1144745,KI,COC1(C#CC(C)(c2ccccc2)c2ccccc2)CN2CCC1CC2
CHEMBL258959,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.512,nM,CHEMBL931445,B,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,CHEMBL1144745,KI,COC1(C#CC(C#N)(c2ccccc2)c2ccccc2)CN2CCC1CC2
CHEMBL411514,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.0,nM,CHEMBL931445,B,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,CHEMBL1144745,KI,COC(C#C[C@@]1(OC)CN2CCC1CC2)(c1ccccc1)c1ccccc1
CHEMBL260228,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.512,nM,CHEMBL931445,B,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,CHEMBL1144745,KI,CO[C@]1(C#C[C@@](O)(c2ccccc2)C2CCCCCCC2)CN2CCC1CC2
CHEMBL264676,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL931445,B,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,CHEMBL1144745,KI,CO[C@]1(C#C[C@](O)(c2ccccc2)C2CCCCCCC2)CN2CCC1CC2
CHEMBL264414,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.995,nM,CHEMBL931445,B,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,CHEMBL1144745,KI,CO[C@]1(C#C[C@@](O)(c2ccccc2)C2CCCCCC2)CN2CCC1CC2
CHEMBL409151,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL931445,B,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,CHEMBL1144745,KI,CO[C@]1(C#C[C@](O)(c2ccccc2)C2CCCCCC2)CN2CCC1CC2
CHEMBL371734,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.981,nM,CHEMBL931445,B,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,CHEMBL1144745,KI,CO[C@]1(C#C[C@@](O)(c2ccccc2)C2CCCCC2)CN2CCC1CC2
CHEMBL428962,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1995,nM,CHEMBL931445,B,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHO cells,CHEMBL1144745,KI,CO[C@]1(C#C[C@](O)(c2ccccc2)C2CCCCC2)CN2CCC1CC2
CHEMBL1529,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1122.02,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,Cl.OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1
CHEMBL257804,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3630.78,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,C[N+]1(C)CCC(C2CC[N+](C)(CCCC(O)(c3ccccc3)c3ccccc3)CC2)CC1.[I-].[I-]
CHEMBL257174,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5248.07,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,CN1CCC(C2CCN(CCCC(O)(c3ccccc3)c3ccccc3)CC2)CC1.Cl.Cl
CHEMBL402207,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,371.54,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,C[N+]1(CCCC(O)(c2ccccc2)c2ccccc2)CCC(C2CC[N+](C)(CCCC(O)(c3ccccc3)c3ccccc3)CC2)CC1.[I-].[I-]
CHEMBL403773,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,724.44,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,Cl.Cl.OC(CCCN1CCC(C2CCN(CCCC(O)(c3ccccc3)c3ccccc3)CC2)CC1)(c1ccccc1)c1ccccc1
CHEMBL403592,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,12302.69,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,C[N+](C)(CCCC(O)(c1ccccc1)c1ccccc1)CCC[N+](C)(C)CCCC(O)(c1ccccc1)c1ccccc1.[I-].[I-]
CHEMBL256923,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1737.8,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,CN(CCCN(C)CCCC(O)(c1ccccc1)c1ccccc1)CCCC(O)(c1ccccc1)c1ccccc1.Cl.Cl
CHEMBL257586,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,43651.58,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,C[N+](C)(CCCC(O)(c1ccccc1)c1ccccc1)CC[N+](C)(C)CCCC(O)(c1ccccc1)c1ccccc1.[I-].[I-]
CHEMBL255692,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,380189.4,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,CN(CCCC(O)(c1ccccc1)c1ccccc1)CCN(C)CCCC(O)(c1ccccc1)c1ccccc1.Cl.Cl
CHEMBL402282,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5495.41,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,C[N+]1(CCCC(O)(c2ccccc2)c2ccccc2)CCN(CCCC(O)(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL404866,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,87096.36,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,Cl.Cl.OC(CCCN1CCN(CCCC(O)(c2ccccc2)c2ccccc2)CC1)(c1ccccc1)c1ccccc1
CHEMBL257547,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7585.78,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,C[N+]1(CCCC(O)(c2ccccc2)c2ccccc2)CCN(c2ccccc2)CC1.[I-]
CHEMBL403029,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,70794.58,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,Cl.OC(CCCN1CCN(c2ccccc2)CC1)(c1ccccc1)c1ccccc1
CHEMBL436850,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4073.8,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,C[N+]1(C)CCN(CCCC(O)(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL258161,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7413.1,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,CN1CCN(CCCC(O)(c2ccccc2)c2ccccc2)CC1.Cl.Cl
CHEMBL258385,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,660.69,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,Cl.Cl.OC(CCCN1CCNCC1)(c1ccccc1)c1ccccc1
CHEMBL254586,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,275.42,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,C[N+]1(CCCC(O)(c2ccccc2)c2ccccc2)CCCCC1.[I-]
CHEMBL59898,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,724.44,nM,CHEMBL933758,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cells,CHEMBL1144815,KI,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL540359,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,31.62,nM,CHEMBL996048,B,Displacement of [3H]N-methyl Scopolamine from human muscarinic acetylcholine M3 receptor expressed in CHO cells by scintillation proximity assay,CHEMBL1156633,KI,CC(C)OC(=O)c1ccc(NC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H]2CCC[N+](C)(Cc3cccc(O)c3)C2)cc1.[I-]
CHEMBL523518,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,512.86,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,CN1CCC[C@@H]1[C@@H]1C[S+]([O-])C(c2ccccc2)(c2ccccc2)O1
CHEMBL541671,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,77.62,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,C[N+]1(C)CCC[C@H]1[C@H]1C[S+]([O-])[C@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL539121,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,162.18,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,C[N+]1(C)CCC[C@@H]1[C@@H]1C[S+]([O-])[C@@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL541671,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,323.59,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,C[N+]1(C)CCC[C@H]1[C@H]1C[S+]([O-])[C@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL539121,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.918,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,C[N+]1(C)CCC[C@@H]1[C@@H]1C[S+]([O-])[C@@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL539120,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.169,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,C[N+]1(C)CCC[C@H]1[C@H]1C[S+]([O-])[C@@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL554916,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,323.59,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,C[N+]1(C)CCC[C@@H]1[C@@H]1C[S+]([O-])[C@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL539120,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,26.92,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,C[N+]1(C)CCC[C@H]1[C@H]1C[S+]([O-])[C@@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL554916,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,288.4,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,C[N+]1(C)CCC[C@@H]1[C@@H]1C[S+]([O-])[C@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL539373,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,51.29,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,C[N+]1(C)CCC[C@H]1[C@H]1C[S+]([O-])C(c2ccccc2)(c2ccccc2)O1.[I-]
CHEMBL556390,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,416.87,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,C[N+]1(C)CCC[C@@H]1[C@@H]1C[S+]([O-])C(c2ccccc2)(c2ccccc2)O1.[I-]
CHEMBL539373,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,208.93,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,C[N+]1(C)CCC[C@H]1[C@H]1C[S+]([O-])C(c2ccccc2)(c2ccccc2)O1.[I-]
CHEMBL556390,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,263.03,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,C[N+]1(C)CCC[C@@H]1[C@@H]1C[S+]([O-])C(c2ccccc2)(c2ccccc2)O1.[I-]
CHEMBL524061,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,346.74,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,CN1CCC[C@H]1[C@H]1C[S+]([O-])[C@](c2ccccc2)(C2CCCCC2)O1
CHEMBL496915,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,199.53,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,CN1CCC[C@@H]1[C@@H]1C[S+]([O-])[C@@](c2ccccc2)(C2CCCCC2)O1
CHEMBL524061,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,691.83,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,CN1CCC[C@H]1[C@H]1C[S+]([O-])[C@](c2ccccc2)(C2CCCCC2)O1
CHEMBL496915,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,23.99,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,CN1CCC[C@@H]1[C@@H]1C[S+]([O-])[C@@](c2ccccc2)(C2CCCCC2)O1
CHEMBL493980,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,18.2,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,CN1CCC[C@H]1[C@H]1C[S+]([O-])[C@@](c2ccccc2)(C2CCCCC2)O1
CHEMBL493979,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,42.66,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,CN1CCC[C@@H]1[C@@H]1C[S+]([O-])[C@](c2ccccc2)(C2CCCCC2)O1
CHEMBL493980,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,389.05,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,CN1CCC[C@H]1[C@H]1C[S+]([O-])[C@@](c2ccccc2)(C2CCCCC2)O1
CHEMBL493979,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,194.98,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,CN1CCC[C@@H]1[C@@H]1C[S+]([O-])[C@](c2ccccc2)(C2CCCCC2)O1
CHEMBL493795,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,302.0,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,CN1CCC[C@H]1[C@H]1C[S+]([O-])C(c2ccccc2)(c2ccccc2)O1
CHEMBL523518,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,281.84,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,CN1CCC[C@@H]1[C@@H]1C[S+]([O-])C(c2ccccc2)(c2ccccc2)O1
CHEMBL493795,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,467.74,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,CN1CCC[C@H]1[C@H]1C[S+]([O-])C(c2ccccc2)(c2ccccc2)O1
CHEMBL557808,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,34.67,nM,CHEMBL958966,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells,CHEMBL1150330,KI,C[N+](C)(C)C[C@@H]1C[S+]([O-])[C@@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL521523,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.03162,nM,CHEMBL1035697,B,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,CHEMBL1140120,KI,C[C@H]1CN(Cc2cccc(-c3cc(CNC(=O)c4cccc(CC5CCNCC5)c4)ccc3F)c2)CCN1
CHEMBL76897,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.42,nM,CHEMBL947359,B,Displacement of radiolabeled 4DAMP from human muscarinic M3 receptor,CHEMBL1140203,KI,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL524097,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.13,nM,CHEMBL1015372,B,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor expressed in CHO cells coexpressing Gqi5 by scintillation proximity assay,CHEMBL1153420,KI,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCCOc3ccccc3)(CC1)CC2.[Br-]
CHEMBL523299,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.06,nM,CHEMBL1015372,B,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor expressed in CHO cells coexpressing Gqi5 by scintillation proximity assay,CHEMBL1153420,KI,OC(c1ccccc1)(c1ccccc1)C12CC[N+](CCOCc3ccccc3)(CC1)CC2.[Br-]
CHEMBL461087,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,11481.54,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,c1coc(C2CCCN2)c1
CHEMBL92387,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6165.95,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,Cc1ccc(C[N+](C)(C)C)o1
CHEMBL40554,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2398.83,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,C[N+](C)(C)CC#CCOC(=O)Nc1cccc(Cl)c1
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,43651.58,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL551563,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2691.53,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,Cc1ccc([C@@H]2CCC[N+]2(C)C)o1.[I-]
CHEMBL553434,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7762.47,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,Cc1ccc([C@H]2CCC[N+]2(C)C)o1.[I-]
CHEMBL555475,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6918.31,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,Cc1ccc(C2CCC[N+]2(C)C)o1.[I-]
CHEMBL553155,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,21379.62,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,C[N+]1(C)CCC[C@H]1c1ccco1.[I-]
CHEMBL527880,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,17782.79,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,C[N+]1(C)CCC[C@@H]1c1ccco1.[I-]
CHEMBL554532,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2754.23,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,C[N+]1(C)CCCC1c1ccco1.[I-]
CHEMBL450463,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,33113.11,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,Cc1ccc([C@@H]2CCCN2C)o1
CHEMBL513277,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,22908.68,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,Cc1ccc(C2CCCN2C)o1
CHEMBL450729,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,52480.75,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,CN1CCC[C@H]1c1ccco1
CHEMBL461502,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,81283.05,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,CN1CCC[C@@H]1c1ccco1
CHEMBL460470,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,44668.36,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,CN1CCCC1c1ccco1
CHEMBL458416,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,147910.84,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,Cc1ccc([C@@H]2CCCN2)o1
CHEMBL461089,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,12022.64,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,Cc1ccc([C@H]2CCCN2)o1
CHEMBL505086,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,18197.01,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,Cc1ccc(C2CCCN2)o1
CHEMBL451335,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,43651.58,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,c1coc([C@@H]2CCCN2)c1
CHEMBL461088,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25118.86,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,c1coc([C@H]2CCCN2)c1
CHEMBL461709,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,28840.32,nM,CHEMBL992814,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by liquid scintillation counter,CHEMBL1157506,KI,Cc1ccc([C@H]2CCCN2C)o1
CHEMBL505197,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1250.0,nM,CHEMBL1006036,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,CHEMBL1141748,KI,CCCCCCCCCC(OC(=O)C(CCCCN(O)C(C)=O)NC(=O)c1coc(-c2ccccc2O)n1)C(C)C(=O)NC1CCCCN(O)C1=O
CHEMBL499519,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,130.0,nM,CHEMBL1006036,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,CHEMBL1141748,KI,CCCCCCCCCCCC(OC(=O)C(CCCCN(O)C(C)=O)NC(=O)c1coc(-c2ccccc2O)n1)C(C)C(=O)NC1CCCCN(O)C1=O
CHEMBL507760,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1000.0,nM,CHEMBL1006036,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,CHEMBL1141748,KI,CCCCCCCCCCCC(OC(=O)C(CCCCN(O)C(C)=O)NC(=O)c1coc(-c2ccccc2O)n1)C(C)C(=O)NC1CCCCNC1=O
CHEMBL450986,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,230.0,nM,CHEMBL1006036,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,CHEMBL1141748,KI,CCCCCCCCCCCCCC(OC(=O)C(CCCCN(O)C(C)=O)NC(=O)c1coc(-c2ccccc2O)n1)C(C)C(=O)NC1CCCCN(O)C1=O
CHEMBL510340,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,970.0,nM,CHEMBL1006036,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,CHEMBL1141748,KI,CCCCCCCCCCCCCC(OC(=O)C(CCCCN(O)C(C)=O)NC(=O)c1coc(-c2ccccc2O)n1)C(C)C(=O)NC1CCCCNC1=O
CHEMBL508807,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1330.0,nM,CHEMBL1006036,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in insect Sf9 cells,CHEMBL1141748,KI,CCCCCCCCCCCCCCCC(OC(=O)C(CCCCN(O)C(C)=O)NC(=O)c1coc(-c2ccccc2O)n1)C(C)C(=O)NC1CCCCN(O)C1=O
CHEMBL265256,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,147.91,nM,CHEMBL982068,B,Displacement of [3H]N-methylscopolamine chloride from human cloned muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1155803,KI,CN(CCCCCCCCN(C)CCCCCCN(CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CCCCCCNCC(=O)N1c2ccccc2C(=O)Nc2cccnc21
CHEMBL2021479,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,40.74,nM,CHEMBL982068,B,Displacement of [3H]N-methylscopolamine chloride from human cloned muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1155803,KI,CN(C)[C@H]1CCCC[C@H]1N(C)CC(=O)N1c2ccccc2NC(=O)c2ccccc21.O=C(O)C(=O)O.O=C(O)C(=O)O
CHEMBL2021478,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,48.98,nM,CHEMBL982068,B,Displacement of [3H]N-methylscopolamine chloride from human cloned muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1155803,KI,CN(C)[C@@H]1CCCC[C@@H]1N(C)CC(=O)N1c2ccccc2NC(=O)c2ccccc21.O=C(O)C(=O)O.O=C(O)C(=O)O
CHEMBL2021477,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,39.81,nM,CHEMBL982068,B,Displacement of [3H]N-methylscopolamine chloride from human cloned muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1155803,KI,CN(C)[C@H]1CCCC[C@@H]1N(C)CC(=O)N1c2ccccc2NC(=O)c2ccccc21.O=C(O)C(=O)O.O=C(O)C(=O)O
CHEMBL2021476,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,44.67,nM,CHEMBL982068,B,Displacement of [3H]N-methylscopolamine chloride from human cloned muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1155803,KI,CN(C)[C@@H]1CCCC[C@H]1N(C)CC(=O)N1c2ccccc2NC(=O)c2ccccc21.O=C(O)C(=O)O.O=C(O)C(=O)O
CHEMBL9967,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,47.86,nM,CHEMBL982068,B,Displacement of [3H]N-methylscopolamine chloride from human cloned muscarinic M3 receptor expressed in CHOK1 cells,CHEMBL1155803,KI,CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1
CHEMBL478834,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,635.0,nM,CHEMBL993602,B,Inhibition of muscarinic M3 receptor,CHEMBL1155858,KI,CCOC(=O)N(Cc1ccccc1-c1ccccc1)[C@H]1CCNC1
CHEMBL3084662,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.995,nM,CHEMBL1061572,B,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cell membrane,CHEMBL1153488,KI,CN1[C@@H]2CC[C@H]1C[C@@H](CC(O)(c1ccccc1)c1ccccc1)C2
CHEMBL3084658,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.162,nM,CHEMBL1061572,B,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cell membrane,CHEMBL1153488,KI,C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](CC(O)(c1ccccc1)c1ccccc1)C2.[Br-]
CHEMBL3084650,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1585,nM,CHEMBL1061572,B,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cell membrane,CHEMBL1153488,KI,CN1[C@@H]2CC[C@H]1C[C@@H](CC(C#N)(c1ccccc1)c1ccccc1)C2
CHEMBL2103803,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.0631,nM,CHEMBL1061572,B,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cell membrane,CHEMBL1153488,KI,C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](CC(C#N)(c1ccccc1)c1ccccc1)C2.[Br-]
CHEMBL3084679,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.512,nM,CHEMBL1061572,B,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cell membrane,CHEMBL1153488,KI,CN1[C@@H]2CC[C@H]1C[C@@H](CC(CO)(c1ccccc1)c1ccccc1)C2
CHEMBL3084643,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.512,nM,CHEMBL1061572,B,Displacement of [3H]N-methyl Scopolamine from human cloned muscarinic M3 receptor expressed in CHO cell membrane,CHEMBL1153488,KI,C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](CC(CO)(c1ccccc1)c1ccccc1)C2.[Br-]
CHEMBL563920,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,76.0,nM,CHEMBL1051830,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO Flp-In cells by liquid scintillation counting,CHEMBL1153519,KI,C[C@@H](c1ccccn1)c1c(CCN(C)C)oc2ccccc12
CHEMBL564057,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.08,nM,CHEMBL1058946,B,Binding affinity to muscarinic M3 receptor,CHEMBL1152978,KI,O=C(O[C@H]1C[N+]2(CCc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]
CHEMBL556635,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.07,nM,CHEMBL1058946,B,Binding affinity to muscarinic M3 receptor,CHEMBL1152978,KI,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)[C@](O)(c1cccs1)C1CCCC1.[Br-]
CHEMBL551466,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.07,nM,CHEMBL1058946,B,Binding affinity to muscarinic M3 receptor,CHEMBL1152978,KI,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]
CHEMBL1908368,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.83,nM,CHEMBL1058946,B,Binding affinity to muscarinic M3 receptor,CHEMBL1152978,KI,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2.O.[Br-]
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.14,nM,CHEMBL1058946,B,Binding affinity to muscarinic M3 receptor,CHEMBL1152978,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL576663,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,95.5,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,CN1CCCC1c1ccc(C(O)(c2ccccc2)c2ccccc2)o1
CHEMBL583051,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.762,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,CN1CCCC1c1ccc(C(O)(c2ccccc2)C2CCCCC2)o1
CHEMBL571121,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.66,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,CN1CCC[C@@H]1c1ccc([C@](O)(c2ccccc2)C2CCCCC2)o1
CHEMBL571341,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,23.44,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,CN1CCC[C@H]1c1ccc([C@](O)(c2ccccc2)C2CCCCC2)o1
CHEMBL569212,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,323.59,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,CN1CCC[C@@H]1c1ccc([C@@](O)(c2ccccc2)C2CCCCC2)o1
CHEMBL569953,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1659.59,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,CN1CCC[C@H]1c1ccc([C@@](O)(c2ccccc2)C2CCCCC2)o1
CHEMBL571123,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,85.11,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,CN1CCCC1c1ccc(C(c2ccccc2)c2ccccc2)o1
CHEMBL576707,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,33.88,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,CN1CCCC1c1ccc(C(c2ccccc2)C2CCCCC2)o1
CHEMBL569729,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,36.31,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,C[N+]1(C)CCCC1c1ccc(C(O)(c2ccccc2)c2ccccc2)o1.[I-]
CHEMBL569760,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.244,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,C[N+]1(C)CCCC1c1ccc(C(O)(c2ccccc2)C2CCCCC2)o1.[I-]
CHEMBL569307,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.514,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,C[N+]1(C)CCC[C@@H]1c1ccc([C@](O)(c2ccccc2)C2CCCCC2)o1.[I-]
CHEMBL568870,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,9.333,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,C[N+]1(C)CCC[C@H]1c1ccc([C@](O)(c2ccccc2)C2CCCCC2)o1.[I-]
CHEMBL568775,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,154.88,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,C[N+]1(C)CCC[C@@H]1c1ccc([C@@](O)(c2ccccc2)C2CCCCC2)o1.[I-]
CHEMBL569089,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,512.86,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,C[N+]1(C)CCC[C@H]1c1ccc([C@@](O)(c2ccccc2)C2CCCCC2)o1.[I-]
CHEMBL583027,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,23.44,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,C[N+]1(C)CCCC1c1ccc(C(c2ccccc2)c2ccccc2)o1.[I-]
CHEMBL569712,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8.913,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,C[N+]1(C)CCCC1c1ccc(C(c2ccccc2)C2CCCCC2)o1.[I-]
CHEMBL376897,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1349,nM,CHEMBL1048033,B,Displacement of [3H]NMS from human cloned muscarinic M3 receptor expressed in CHO cells by scintillation counting,CHEMBL1156772,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12
CHEMBL565547,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8200.0,nM,CHEMBL1041014,B,Inhibition of muscarinic receptor 3,CHEMBL1155340,KI,Cc1nc2c3c(nc(Cc4ccccc4)n2n1)CCNCC3
CHEMBL593443,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,44668.36,nM,CHEMBL1067396,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,CHEMBL1153096,KI,C[C@H]1CO[C@H](C[N+](C)(C)C)CO1.[I-]
CHEMBL595265,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10964.78,nM,CHEMBL1067396,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,CHEMBL1153096,KI,C[C@@H]1OC[C@@H](C[N+](C)(C)C)O[C@H]1C.[I-]
CHEMBL390842,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7585.78,nM,CHEMBL1067396,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,CHEMBL1153096,KI,C[C@H]1COC[C@@H](C[N+](C)(C)C)O1.[I-]
CHEMBL594802,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,77624.71,nM,CHEMBL1067396,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,CHEMBL1153096,KI,CC1(C)CO[C@H](C[N+](C)(C)C)CO1.[I-]
CHEMBL594801,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,21379.62,nM,CHEMBL1067396,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,CHEMBL1153096,KI,CC1(C)COC[C@@H](C[N+](C)(C)C)O1.[I-]
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,43651.58,nM,CHEMBL1067396,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,CHEMBL1153096,KI,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL594376,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,66069.34,nM,CHEMBL1067396,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,CHEMBL1153096,KI,C[C@@H]1CO[C@H](C[N+](C)(C)C)CO1.[I-]
CHEMBL74300,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2398.83,nM,CHEMBL1067396,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,CHEMBL1153096,KI,C[N+](C)(C)CC#CCOC(=O)Nc1cccc(Cl)c1.[Cl-]
CHEMBL593685,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,16218.1,nM,CHEMBL1067396,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,CHEMBL1153096,KI,C[C@H]1OC[C@@H](C[N+](C)(C)C)OC1(C)C.[I-]
CHEMBL594803,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,32359.37,nM,CHEMBL1067396,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,CHEMBL1153096,KI,C[C@@H]1O[C@H](C[N+](C)(C)C)COC1(C)C.[I-]
CHEMBL404557,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,35481.34,nM,CHEMBL1067396,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,CHEMBL1153096,KI,C[C@@H]1COC[C@@H](C[N+](C)(C)C)O1.[I-]
CHEMBL593620,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10471.29,nM,CHEMBL1067396,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,CHEMBL1153096,KI,C[C@@H]1OC[C@@H](C[N+](C)(C)C)OC1(C)C.[I-]
CHEMBL593861,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,40738.03,nM,CHEMBL1067396,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,CHEMBL1153096,KI,CC1(C)OC[C@@H](C[N+](C)(C)C)OC1(C)C.[I-]
CHEMBL595022,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,46773.51,nM,CHEMBL1067396,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells by microplate scintillation counting,CHEMBL1153096,KI,C[C@H]1O[C@H](C[N+](C)(C)C)COC1(C)C.[I-]
CHEMBL604798,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8300.0,nM,CHEMBL1070109,B,Inhibition of muscarinic M3 receptor,CHEMBL1159071,KI,Cc1ccc2oc(N3CCN4CCC3CC4)nc2n1
CHEMBL608151,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,63.1,nM,CHEMBL1068916,B,Inhibition of muscarinic M3 receptor,CHEMBL1157620,KI,CCOC[C@H]1[C@@H]2CNC[C@@]21c1ccc(Cl)c(Cl)c1
CHEMBL1242923,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7000.0,nM,CHEMBL1248509,B,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in BHK-21 cells,CHEMBL1240489,KI,O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1
CHEMBL21536,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,13.0,nM,CHEMBL1248509,B,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in BHK-21 cells,CHEMBL1240489,KI,CCCCCCOc1nsnc1C1=CCCN(C)C1
CHEMBL1242950,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2800.0,nM,CHEMBL1248509,B,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in BHK-21 cells,CHEMBL1240489,KI,CCCCC1CCN(CCCC(=O)c2ccccc2C)CC1
CHEMBL845,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,90.0,nM,CHEMBL1248509,B,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in BHK-21 cells,CHEMBL1240489,KI,Clc1ccc2c(c1)N=C(N1CCNCC1)c1ccccc1N2
CHEMBL522460,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,430.0,nM,CHEMBL1248509,B,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in BHK-21 cells,CHEMBL1240489,KI,Cc1ccccc1CN1CCC(N2CCC(n3c(=O)[nH]c4ccccc43)CC2)CC1
CHEMBL517712,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.9,nM,CHEMBL1248509,B,Displacement of [3H]-4-DAMP from human muscarinic M3 receptor expressed in BHK-21 cells,CHEMBL1240489,KI,CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2
CHEMBL1258223,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,823.0,nM,CHEMBL1259921,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1255169,KI,CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1
CHEMBL1258452,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1095.0,nM,CHEMBL1259921,B,Binding affinity to human muscarinic M3 receptor,CHEMBL1255169,KI,CCCCN1CCC(COC(=O)c2ccc(N)c(OC)c2)CC1
CHEMBL1643900,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1395.0,nM,CHEMBL1646452,B,Inhibition of muscarinic M3 receptor,CHEMBL1641373,KI,Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1
CHEMBL1683908,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,46.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,O=C(Nc1ccccc1-c1ccccc1)OC1CCNCC1
CHEMBL1683909,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,22.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,CN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683910,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,55.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683911,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,77.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,CCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683912,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,17.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,CCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683913,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,14.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,CCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683914,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.8,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,CCCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683915,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.1,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,CCCCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683916,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,CCCCCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683917,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,9.5,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,CCCCCCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683918,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,CCCCCCCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683919,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,48.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,CCCCCCCCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683920,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,50.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,NCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683921,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,67.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,NCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683922,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,84.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,NCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683923,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,98.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,NCCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683924,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,19.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,NCCCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683925,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.53,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,NCCCCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683926,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.8,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,NCCCCCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683927,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.75,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,NCCCCCCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683928,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.6,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,NCCCCCCCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683929,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.5,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,NCCCCCCCCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683930,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.6,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,NCCCCCCCCCCCCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL1683931,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,28.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1
CHEMBL1683932,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.74,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1
CHEMBL1683933,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.32,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1
CHEMBL1683934,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.01,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1
CHEMBL1683935,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.14,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,O=CNc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1O
CHEMBL1683936,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.14,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCCNC[C@H](O)c2ccc(O)c(CO)c2)CC1
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.034,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL1683938,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.18,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)CC1
CHEMBL1683939,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,32.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCCCCCCCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)C1
CHEMBL1683940,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.5,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,O=C(Nc1ccccc1-c1ccccc1)NC1CCN(CCCCCCCCCNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)CC1
CHEMBL1683941,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,140.0,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,O=C(Nc1ccccc1-c1ccccc1)O[C@H]1C[N+]2(CCCCCCCCCNCC(O)c3ccc(O)c4[nH]c(=O)ccc34)CCC1CC2
CHEMBL1683942,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.6,nM,CHEMBL1686736,B,Displacement of [3H]-N-methyl-scopolamine from human muscarinic M3 receptor after 6 hrs by cell based assay,CHEMBL1681687,KI,C[N+]1(CCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)[C@@H]2C[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@@H]1[C@H]1O[C@H]12
CHEMBL1773196,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.091,nM,CHEMBL1775313,B,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,CHEMBL1773026,KI,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCNC(=O)Cc2cccc(CC(C)(C)NC[C@H](O)c3ccc(O)c(CO)c3)c2)ccc1O)C(C)C
CHEMBL1773197,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.276,nM,CHEMBL1775313,B,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,CHEMBL1773026,KI,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCNC(=O)Cc2cccc(CC(C)(C)NC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)c2)ccc1O)C(C)C
CHEMBL1773198,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.397,nM,CHEMBL1775313,B,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,CHEMBL1773026,KI,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCNC(=O)Cc2cccc(C[C@@H](C)NC[C@H](O)c3cc(O)cc(O)c3)c2)ccc1O)C(C)C
CHEMBL1773262,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.1,nM,CHEMBL1775313,B,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,CHEMBL1773026,KI,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCNC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)ccc1O)C(C)C
CHEMBL1773263,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.45,nM,CHEMBL1775313,B,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,CHEMBL1773026,KI,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCNC(=O)CCCCCCCCCCNC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)ccc1O)C(C)C
CHEMBL1773264,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.634,nM,CHEMBL1775313,B,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,CHEMBL1773026,KI,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOc2ccc(CCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)cc2)ccc1O)C(C)C
CHEMBL1773074,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.765,nM,CHEMBL1775313,B,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,CHEMBL1773026,KI,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOc2ccc(CCNC[C@H](O)c3ccc(O)c(CO)c3)cc2)ccc1O)C(C)C
CHEMBL1773265,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.7,nM,CHEMBL1775313,B,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,CHEMBL1773026,KI,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOc2ccc(CCNC[C@H](O)c3ccc(O)c(O)c3)cc2)ccc1O)C(C)C
CHEMBL1773266,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.99,nM,CHEMBL1775313,B,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,CHEMBL1773026,KI,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOCCCCCCNC[C@H](O)c2ccc(O)c(NS(C)(=O)=O)c2)ccc1O)C(C)C
CHEMBL1773267,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.305,nM,CHEMBL1775313,B,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,CHEMBL1773026,KI,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)ccc1O)C(C)C
CHEMBL1382,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.6,nM,CHEMBL1775313,B,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,CHEMBL1773026,KI,Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1
CHEMBL3084413,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.45,nM,CHEMBL1786277,B,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,CHEMBL1781884,KI,C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](C=C(c1cccs1)c1cccs1)C2.[Br-]
CHEMBL2103803,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.06,nM,CHEMBL1786277,B,Displacement of [3H]N-methyl Scopolamine from human muscarinic M3 receptor expressed in CHO cells by scintillation proximity assay,CHEMBL1781884,KI,C[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](CC(C#N)(c1ccccc1)c1ccccc1)C2.[Br-]
CHEMBL1382,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.6,nM,CHEMBL1838343,B,Displacement of [3H]N-methylscopolamine from human M3 receptor,CHEMBL1833828,KI,Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1
CHEMBL1836644,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,49.0,nM,CHEMBL1838343,B,Displacement of [3H]N-methylscopolamine from human M3 receptor,CHEMBL1833828,KI,Fc1cccc(F)c1-n1nc(OC2CCNCC2)c2ccccc21
CHEMBL1836645,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.0,nM,CHEMBL1838343,B,Displacement of [3H]N-methylscopolamine from human M3 receptor,CHEMBL1833828,KI,Oc1cccc(F)c1-n1nc(OC2CCNCC2)c2ccccc21
CHEMBL1836646,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.5,nM,CHEMBL1838343,B,Displacement of [3H]N-methylscopolamine from human M3 receptor,CHEMBL1833828,KI,Oc1cccc(F)c1-n1nc(OC2CCNCC2)c2c1CCCC2
CHEMBL1836647,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.2,nM,CHEMBL1838343,B,Displacement of [3H]N-methylscopolamine from human M3 receptor,CHEMBL1833828,KI,O=c1ccc2c([C@@H](O)CNCCCCCCCCCN3CCC(Oc4nn(-c5c(O)cccc5F)c5c4CCCC5)CC3)ccc(O)c2[nH]1
CHEMBL1834350,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10000.0,nM,CHEMBL1839310,B,Inhibition of human muscarinic M3 receptor,CHEMBL1833864,KI,CCN/C(=N\S(=O)(=O)c1cccc(Cl)c1)N1CC2(C=N1)CCNCC2
CHEMBL221753,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,81.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]
CHEMBL517712,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.439,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2
CHEMBL1201203,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.272,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN1[C@@H]2CC[C@H]1C[C@@H](OC(c1ccccc1)c1ccccc1)C2
CHEMBL296419,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,178.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1
CHEMBL1201207,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1363.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O
CHEMBL1113,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,378.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
CHEMBL195437,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4028.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CCCCCCCCc1ccc(O)cc1
CHEMBL633,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,679.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1
CHEMBL629,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.436,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN(C)CCC=C1c2ccccc2CCc2ccccc21
CHEMBL305660,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,137.2,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1
CHEMBL64894,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,918.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]
CHEMBL808,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,379.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
CHEMBL1319362,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,16.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,Br.CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)c1ccccc1)C2
CHEMBL30008,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,313.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1
CHEMBL41,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,762.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
CHEMBL726,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1002.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
CHEMBL1201353,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,547.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1
CHEMBL334255,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.297,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]
CHEMBL1626,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8.253,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1
CHEMBL657,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,137.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN(C)CCOC(c1ccccc1)c1ccccc1
CHEMBL936,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,52.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1
CHEMBL7002,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3168.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1
CHEMBL1628227,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,15.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN(C)CCC=C1c2ccccc2COc2ccccc21
CHEMBL1123,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.927,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1
CHEMBL648,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,159.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN1CCN(C(c2ccccc2)c2ccccc2)CC1
CHEMBL104,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2104.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1
CHEMBL1172,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,95.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1
CHEMBL411,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3907.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1
CHEMBL954,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,439.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1
CHEMBL42,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,17.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL1200406,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,95.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O
CHEMBL71,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,44.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL43064,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,162.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1
CHEMBL1479,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3762.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C
CHEMBL415,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,36.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21
CHEMBL516,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,9.655,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1
CHEMBL900,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,37.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,Cc1ccccc1C(OCCN(C)C)c1ccccc1
CHEMBL490,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,38.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1
CHEMBL564,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,88.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN(C)CCCN1c2ccccc2Sc2ccccc21
CHEMBL643,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.149,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CC(CN1c2ccccc2Sc2ccccc21)N(C)C
CHEMBL75880,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,661.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1
CHEMBL715,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,83.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL445,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,36.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CNCCC=C1c2ccccc2CCc2ccccc21
CHEMBL1262,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,960.4,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
CHEMBL1231,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.574,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1
CHEMBL1909073,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,33.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-]
CHEMBL728,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,321.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL7568,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,266.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12
CHEMBL534,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,468.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1
CHEMBL21731,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,100.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CNCCCC12CCC(c3ccccc31)c1ccccc12
CHEMBL1354199,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.239,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12.[Br-]
CHEMBL6437,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,298.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN1CCN2c3ccccc3Cc3ccccc3C2C1
CHEMBL91,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,668.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
CHEMBL1200633,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1285.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O
CHEMBL787,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1404.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1
CHEMBL395110,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,40.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1
CHEMBL1490,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.151,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1
CHEMBL2107687,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.585,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-]
CHEMBL1200604,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,30.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1
CHEMBL479,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,19.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
CHEMBL1221,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,721.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
CHEMBL83,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,630.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
CHEMBL404849,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,980.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1
CHEMBL1306,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3081.0,nM,CHEMBL1909172,B,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),CHEMBL1909046,KI,CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
CHEMBL1908368,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.29,nM,CHEMBL1913618,B,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 2 hrs by filter binding assay,CHEMBL1909511,KI,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2.O.[Br-]
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.075,nM,CHEMBL1913618,B,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 2 hrs by filter binding assay,CHEMBL1909511,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL1910849,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.9,nM,CHEMBL1913618,B,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 2 hrs by filter binding assay,CHEMBL1909511,KI,CC(C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)N1CCC(Oc2ccccc2)CC1
CHEMBL1910848,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.11,nM,CHEMBL1913618,B,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 2 hrs by filter binding assay,CHEMBL1909511,KI,CC(C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)N1CC(Oc2ccccc2)C1
CHEMBL1910847,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.4,nM,CHEMBL1913618,B,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 2 hrs by filter binding assay,CHEMBL1909511,KI,CC(C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)N1CC[C@@H](Oc2ccccc2)C1
CHEMBL1910846,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.8,nM,CHEMBL1913618,B,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 2 hrs by filter binding assay,CHEMBL1909511,KI,CC(C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)N1CC[C@H](Oc2ccccc2)C1
CHEMBL1910845,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.9,nM,CHEMBL1913618,B,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 2 hrs by filter binding assay,CHEMBL1909511,KI,NC(=O)C(CCCN1CC[C@H](Oc2ccccc2)C1)(c1ccccc1)c1ccccc1
CHEMBL1910850,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.201,nM,CHEMBL1913621,B,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 24 hrs by filter binding assay,CHEMBL1909511,KI,CC(C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)N1CC[C@@H](Oc2cccc(O)c2)C1
CHEMBL1910851,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.18,nM,CHEMBL1913621,B,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 24 hrs by filter binding assay,CHEMBL1909511,KI,CC(C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)N1CC[C@H](Oc2cccc(O)c2)C1
CHEMBL1910856,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.128,nM,CHEMBL1913621,B,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 24 hrs by filter binding assay,CHEMBL1909511,KI,CC(C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)N1CC(Oc2cccc(O)c2)C1
CHEMBL1910865,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.163,nM,CHEMBL1913621,B,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 24 hrs by filter binding assay,CHEMBL1909511,KI,CC(C)(CCC(C(N)=O)(c1ccccc1)c1ccccc1)N1CC(Oc2cccc(O)c2F)C1
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.0098,nM,CHEMBL1913621,B,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 24 hrs by filter binding assay,CHEMBL1909511,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL1908368,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.213,nM,CHEMBL1913621,B,Displacement of [3H]-NMS from human recombinant M3 receptor expressed in CHO cells after 24 hrs by filter binding assay,CHEMBL1909511,KI,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)c1ccccc1)C2.O.[Br-]
CHEMBL2023764,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.16,nM,CHEMBL2026110,B,Displacement of [3H]-N-methyl scopolamine from muscarinic acetylcholine M3 receptor expressed in CHO cell membrane,CHEMBL2021865,KI,C=CCCCC[N@+]1(C)C2CCC1C[C@H](CC(C#N)(c1ccccc1)c1ccccc1)C2.[Br-]
CHEMBL555146,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,204.0,nM,CHEMBL2033491,B,Binding affinity to human recombinant M3 receptor,CHEMBL2029214,KI,C[C@@H]1CCCN1CCc1cc2cc(C(=O)c3ccc(F)cc3)ccc2o1
CHEMBL2031737,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,512.0,nM,CHEMBL2033491,B,Binding affinity to human recombinant M3 receptor,CHEMBL2029214,KI,C[C@@H]1CCCN1CCc1cc2cc(C(=O)c3ccc([N+](=O)[O-])cc3)ccc2o1
CHEMBL2030626,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,661.0,nM,CHEMBL2033751,B,Inhibition of M3 muscarinic receptor,CHEMBL2029272,KI,C1CC2CCC1N2CC12C3C4C5C3C1C5C42
CHEMBL1231,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.514,nM,CHEMBL2045511,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL2040723,KI,CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1
CHEMBL376897,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1349,nM,CHEMBL2045511,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL2040723,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12
CHEMBL2042554,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,72.44,nM,CHEMBL2045511,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL2040723,KI,CN(C)C[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1.O=C(O)C(=O)O
CHEMBL2042553,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.514,nM,CHEMBL2045511,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL2040723,KI,CN(C)C[C@H]1COCC(c2ccccc2)(c2ccccc2)O1.O=C(O)C(=O)O
CHEMBL2042552,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.188,nM,CHEMBL2045511,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL2040723,KI,CN(C)CC1COCC(c2ccccc2)(c2ccccc2)O1.O=C(O)C(=O)O
CHEMBL2042551,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,21379.62,nM,CHEMBL2045511,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL2040723,KI,C[N+](C)(C)C[C@@H]1COC[C@@H](C(c2ccccc2)c2ccccc2)O1.[I-]
CHEMBL2042407,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8912.51,nM,CHEMBL2045511,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL2040723,KI,C[N+](C)(C)C[C@@H]1COC[C@H](C(c2ccccc2)c2ccccc2)O1.[I-]
CHEMBL2042406,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,61.66,nM,CHEMBL2045511,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL2040723,KI,C[N+](C)(C)C[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1.[I-]
CHEMBL2042405,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.479,nM,CHEMBL2045511,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL2040723,KI,C[N+](C)(C)C[C@H]1COCC(c2ccccc2)(c2ccccc2)O1.[I-]
CHEMBL2042404,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.631,nM,CHEMBL2045511,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL2040723,KI,C[N+](C)(C)CC1COCC(c2ccccc2)(c2ccccc2)O1.[I-]
CHEMBL2042403,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,31622.78,nM,CHEMBL2045511,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL2040723,KI,C[N+](C)(C)C[C@@H]1COC[C@@H](c2ccccc2)O1.[I-]
CHEMBL2042402,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,9772.37,nM,CHEMBL2045511,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL2040723,KI,C[N+](C)(C)C[C@@H]1COC[C@H](c2ccccc2)O1.[I-]
CHEMBL2042401,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,81283.05,nM,CHEMBL2045511,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL2040723,KI,CC[C@@H]1COC[C@@H](C[N+](C)(C)C)O1.[I-]
CHEMBL2042400,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,17782.79,nM,CHEMBL2045511,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL2040723,KI,CC[C@H]1COC[C@@H](C[N+](C)(C)C)O1.[I-]
CHEMBL390842,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7585.78,nM,CHEMBL2045511,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in CHO cells after 120 mins by scintillation counting,CHEMBL2040723,KI,C[C@H]1COC[C@@H](C[N+](C)(C)C)O1.[I-]
CHEMBL2205817,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2268.0,nM,CHEMBL2215569,B,Binding affinity to M3 muscarinic receptor,CHEMBL2203059,KI,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1cccnc1
CHEMBL2205816,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,209.0,nM,CHEMBL2215569,B,Binding affinity to M3 muscarinic receptor,CHEMBL2203059,KI,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1ccccn1
CHEMBL2205812,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,407.0,nM,CHEMBL2215569,B,Binding affinity to M3 muscarinic receptor,CHEMBL2203059,KI,COc1ccc(CCN2C3C4C5CC6C7C5C3C7C2(O)C64)cc1
CHEMBL2205811,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1727.0,nM,CHEMBL2215569,B,Binding affinity to M3 muscarinic receptor,CHEMBL2203059,KI,COc1cccc(CCN2C3C4C5CC6C7C5C3C7C2(O)C64)c1
CHEMBL2205836,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,543.0,nM,CHEMBL2215569,B,Binding affinity to M3 muscarinic receptor,CHEMBL2203059,KI,COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53
CHEMBL2205829,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1609.0,nM,CHEMBL2215569,B,Binding affinity to M3 muscarinic receptor,CHEMBL2203059,KI,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1ccc2c(c1)OCO2
CHEMBL2205827,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1728.0,nM,CHEMBL2215569,B,Binding affinity to M3 muscarinic receptor,CHEMBL2203059,KI,COc1ccc(CN2C3C4C5CC6C7C5C3C7C2(O)C64)cc1OC
CHEMBL2205825,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1225.0,nM,CHEMBL2215569,B,Binding affinity to M3 muscarinic receptor,CHEMBL2203059,KI,COc1ccc(CN2C3C4C5CC6C7C5C3C7C2(O)C64)cc1
CHEMBL2205823,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,360.0,nM,CHEMBL2215569,B,Binding affinity to M3 muscarinic receptor,CHEMBL2203059,KI,COc1ccccc1CN1C2C3C4CC5C6C4C2C6C1(O)C53
CHEMBL1189234,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,336.0,nM,CHEMBL2215569,B,Binding affinity to M3 muscarinic receptor,CHEMBL2203059,KI,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1ccccc1
CHEMBL2312352,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4890.0,nM,CHEMBL2320130,B,Displacement of [3H]NMS from human M3 muscarinic receptor expressed in CHO-K1 cells,CHEMBL2311283,KI,CN1CCC(c2ccccc2F)=C(C(=O)OCCc2ccc3c(c2)CCO3)C1
CHEMBL2312361,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2840.0,nM,CHEMBL2320130,B,Displacement of [3H]NMS from human M3 muscarinic receptor expressed in CHO-K1 cells,CHEMBL2311283,KI,CN1CCC(c2ccccc2)=C(C(=O)OCCc2ccc3c(c2)CCO3)C1
CHEMBL2312376,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,31100.0,nM,CHEMBL2320130,B,Displacement of [3H]NMS from human M3 muscarinic receptor expressed in CHO-K1 cells,CHEMBL2311283,KI,CCN1CCC(c2ccccc2)=C(C(=O)OCCc2ccc3c(c2)CCO3)C1
CHEMBL2312389,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4070.0,nM,CHEMBL2320130,B,Displacement of [3H]NMS from human M3 muscarinic receptor expressed in CHO-K1 cells,CHEMBL2311283,KI,CCN1CCC(c2ccccc2)=C(C(=O)OCCCc2ccc(OC)cc2)C1
CHEMBL1180343,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1370.0,nM,CHEMBL2320130,B,Displacement of [3H]NMS from human M3 muscarinic receptor expressed in CHO-K1 cells,CHEMBL2311283,KI,CCN1CCC(c2ccccc2)=C(C(=O)OCCc2ccc(OC)cc2)C1
CHEMBL569713,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.5,nM,CHEMBL2320130,B,Displacement of [3H]NMS from human M3 muscarinic receptor expressed in CHO-K1 cells,CHEMBL2311283,KI,CN1[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12
CHEMBL326450,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,151.0,nM,CHEMBL2317637,B,Binding affinity to human M3 muscarinic receptor,CHEMBL2311283,KI,CCCCc1[nH]c2ccc3c(c2c1C(=O)OCC)CN1CCc2cc(OC)ccc2C1O3
CHEMBL215180,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL2317637,B,Binding affinity to human M3 muscarinic receptor,CHEMBL2311283,KI,O=C(NCC1CCNCC1)[C@H]1CCCN1C(=O)[C@@H]1C[C@@H](O)CN1C(=O)CC(c1ccc(F)cc1)(c1ccc(F)cc1)c1ccc(F)cc1
CHEMBL12098,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,700.0,nM,CHEMBL2317637,B,Binding affinity to human M3 muscarinic receptor,CHEMBL2311283,KI,Cc1cccc(C(=O)N2CCC(N3CCC(Cc4ccc(S(=O)(=O)c5cccc(Cl)c5)cc4)CC3)CC2)c1N
CHEMBL17045,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2089.0,nM,CHEMBL2317637,B,Binding affinity to human M3 muscarinic receptor,CHEMBL2311283,KI,CCN(CC)CC1CCCCN1CC(=O)N1c2ccccc2C(=O)Nc2cccnc21
CHEMBL9967,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,158.0,nM,CHEMBL2317637,B,Binding affinity to human M3 muscarinic receptor,CHEMBL2311283,KI,CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1
CHEMBL2335158,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7943.28,nM,CHEMBL2344886,B,Displacement of [3H]-NMS from recombinant muscarinic M3 receptor (unknown origin) expressed in CHOK1 cells after 60 mins by liquid scintillation counting analysis,CHEMBL2331162,KI,Clc1cc(Cl)cc(N2CCNCC2)c1
CHEMBL26505,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7760.0,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CCN(CC)CCOC(=O)C(C)(c1ccccc1)c1ccccc1
CHEMBL1191560,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,243.0,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CCN(CC)CCOC(=O)C(CC)(c1ccccc1)c1ccccc1
CHEMBL2377383,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.543,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CC[N+](CC)(CC)CCOC(=O)C(c1ccccc1)c1ccccc1.[I-]
CHEMBL1101,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.95,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2
CHEMBL37372,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,52.2,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CCN(CC)CCOC(=O)C(C)(c1ccccc1)c1ccc(O)cc1
CHEMBL2377269,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8.37,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CCN(CC)CCOC(=O)C(c1ccccc1)C1(O)CCCCC1
CHEMBL2377268,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,11.2,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CN1CCC(OC(=O)C(CO)c2cccc(C(F)(F)F)c2)CC1
CHEMBL2377267,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.55,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CCN(CC)CCOC(=O)C(O)(c1cccs1)C1CCCCC1
CHEMBL2106570,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.25,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL2110892,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,186.0,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CCN(CC)CCOC(=O)C(c1ccccc1)N1CCCCC1
CHEMBL2377262,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,109.0,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CCN(CC)CCOC(=O)c1ccccc1Sc1ccc(Cl)cc1
CHEMBL2377261,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,59.0,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CC(C)N(CCOC(=O)C(O)(c1ccccc1)c1ccccc1)C(C)C
CHEMBL2377392,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.97,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CC[C@H](C)C(C(=O)OCCCN(CC)CC)c1ccccc1
CHEMBL517712,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.18,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2
CHEMBL2377388,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,254.0,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CCN(CC)CCOC(=O)C(O)(c1ccccc1)c1c(C)cccc1C
CHEMBL2377387,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.12,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CCN(CC)CCSC(=O)C(O)(c1ccccc1)c1ccccc1
CHEMBL2377385,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,270.0,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,CC[N+](C)(CC)CCOC(=O)C(c1ccccc1)c1ccccc1.[Br-]
CHEMBL2377384,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,384.0,nM,CHEMBL2380033,B,Displacement of [3H] N-methylscopolamine from human muscarinic M3 receptor expressed in CHOK1 cells after 30 mins by scintillation counting analysis,CHEMBL2375349,KI,C[N+](C)(C)CCOC(=O)C(c1ccccc1)c1ccccc1.[Br-]
CHEMBL76897,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.5,nM,CHEMBL2395093,B,Displacement of [3H]N-methylscopolamine from human recombinant muscarinic M3 receptor expressed in CHOK1 cells after 2 hrs,CHEMBL2390918,KI,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL76897,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.4,nM,CHEMBL2395684,B,Binding affinity to human muscarinic M3 receptor by radioligand displacement assay,CHEMBL2390830,KI,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL481153,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,66.0,nM,CHEMBL2404427,B,Antagonist activity at muscarinic M3 receptor (unknown origin) by PDSP assay,CHEMBL2401658,KI,O=C(OCCN1CCCC1)N1c2ccccc2Sc2ccccc21
CHEMBL519609,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,170.0,nM,CHEMBL2404427,B,Antagonist activity at muscarinic M3 receptor (unknown origin) by PDSP assay,CHEMBL2401658,KI,CCN(CC)CCCOC(=O)N1c2ccccc2Sc2ccccc21
CHEMBL2432039,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,466.0,nM,CHEMBL2432437,B,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,C1C2C3CC4C2C2C1C3[C@H](NCC13C5C6C7C5C1C7C63)C42
CHEMBL2432049,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2119.0,nM,CHEMBL2432437,B,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)nc1
CHEMBL1643900,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1395.0,nM,CHEMBL2432437,B,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1
CHEMBL2432048,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2155.0,nM,CHEMBL2432437,B,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)cc1
CHEMBL2205829,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1609.0,nM,CHEMBL2432437,B,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1ccc2c(c1)OCO2
CHEMBL2205816,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,209.0,nM,CHEMBL2432437,B,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1ccccn1
CHEMBL2205827,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1728.0,nM,CHEMBL2432437,B,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,COc1ccc(CN2C3C4C5CC6C7C5C3C7C2(O)C64)cc1OC
CHEMBL2432054,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1301.0,nM,CHEMBL2432437,B,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,CN(CCCc1cccc(F)c1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
CHEMBL2432041,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1782.0,nM,CHEMBL2432437,B,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,CN(Cc1cccc(F)c1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
CHEMBL2432040,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1058.0,nM,CHEMBL2432437,B,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,CN(Cc1ccccc1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
CHEMBL1189234,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,336.0,nM,CHEMBL2432437,B,Inhibition of muscarinic M3 receptor (unknown origin) by PDSP assay,CHEMBL2429832,KI,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1ccccc1
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.01,nM,CHEMBL3095624,B,Binding affinity to human M3 K523A mutant expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.01,nM,CHEMBL3095625,B,Binding affinity to human M3 D518A mutant expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.01995,nM,CHEMBL3095626,B,Binding affinity to human M3 E228A mutant expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.01585,nM,CHEMBL3095627,B,Binding affinity to human M3 F225A mutant expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.02512,nM,CHEMBL3095628,B,Binding affinity to human M3 Q224A mutant expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.01585,nM,CHEMBL3095629,B,Binding affinity to human M3 F222A mutant expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.01585,nM,CHEMBL3095630,B,Binding affinity to human M3 E220A mutant expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.01,nM,CHEMBL3095631,B,Binding affinity to human M3 K213A mutant expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.01,nM,CHEMBL3095632,B,Binding affinity to human M3 R133A mutant expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL3091666,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.585,nM,CHEMBL3095633,B,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,COC(C(=O)O[C@H]1C[C@@H]2[C@H]3O[C@H]3[C@H](C1)[N+]2(C)C)(c1cccs1)c1cccs1.[Br-]
CHEMBL3091665,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.05012,nM,CHEMBL3095633,B,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,CC(C(=O)O[C@H]1C[C@@H]2[C@H]3O[C@H]3[C@H](C1)[N+]2(C)C)(c1cccs1)c1cccs1.[Br-]
CHEMBL3091664,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.0631,nM,CHEMBL3095633,B,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@H](OC(=O)C(O)(c3ccccc3)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12.[Br-]
CHEMBL3091670,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL3095633,B,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@H](OC(=O)C(CO)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.[Br-]
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.01585,nM,CHEMBL3095633,B,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL3091669,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.012,nM,CHEMBL3095633,B,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@H](OC(=O)C(O)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.[Br-]
CHEMBL3091668,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.995,nM,CHEMBL3095633,B,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@H](OC(=O)C(O)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12.[Br-]
CHEMBL3091667,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1585,nM,CHEMBL3095633,B,Binding affinity to wild type human M3 receptor expressed in HEK293T cells up to 24 hrs by radioligand displacement assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12.[Br-]
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.01,nM,CHEMBL3095634,B,Antagonist activity at human M3 receptor expressed in CHO cells assessed as inhibition of carbachol-induced response after 30 mins by AP-1-driven luciferase reporter gene assay,CHEMBL3091362,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL2449003,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2692,nM,CHEMBL3106108,B,Displacement of [3H]QNB from muscarinic M3 receptor (unknown origin),CHEMBL3102773,KI,CN1[C@@H]2CC[C@H]1CC(OC(=O)[C@H](CO)c1ccccc1)C2
CHEMBL2449003,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.27,nM,CHEMBL3106108,B,Displacement of [3H]QNB from muscarinic M3 receptor (unknown origin),CHEMBL3102773,KI,CN1[C@@H]2CC[C@H]1CC(OC(=O)[C@H](CO)c1ccccc1)C2
CHEMBL3104091,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3761.0,nM,CHEMBL3106108,B,Displacement of [3H]QNB from muscarinic M3 receptor (unknown origin),CHEMBL3102773,KI,CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1
CHEMBL3104091,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3801.89,nM,CHEMBL3106108,B,Displacement of [3H]QNB from muscarinic M3 receptor (unknown origin),CHEMBL3102773,KI,CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1
CHEMBL1683934,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.82,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1
CHEMBL3219031,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.39,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1O
CHEMBL3219032,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.2,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)cc3)CC2)ccc1O
CHEMBL3219033,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.7,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3cccc(O)c3)CC2)ccc1O
CHEMBL3219034,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,18.0,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3O)CC2)ccc1O
CHEMBL3219035,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,26.0,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(F)cc3O)CC2)ccc1O
CHEMBL3219036,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.0,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3cccc(F)c3O)CC2)ccc1O
CHEMBL3219038,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,22.0,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3cc(F)cc(F)c3O)CC2)ccc1O
CHEMBL3219039,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,76.0,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3cc(O)cc(F)c3)CC2)ccc1O
CHEMBL3219040,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.0,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)c(F)c3)CC2)ccc1O
CHEMBL3219041,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8.3,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3cc(F)c(O)cc3F)CC2)ccc1O
CHEMBL3219042,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.73,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)CC2)ccc1O
CHEMBL3219043,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.8,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,Cc1ccc(NC(=O)OC2CCN(CCCCCCCCCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)c(-c2ccc(O)c(Cl)c2)c1
CHEMBL3219044,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.0,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,Cc1ccc(-c2ccc(O)c(Cl)c2)c(NC(=O)OC2CCN(CCCCCCCCCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)c1
CHEMBL3219045,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,38.0,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,Cc1cc(C)c(NC(=O)OC2CCN(CCCCCCCCCNC[C@H](O)c3ccc(O)c(NS(C)(=O)=O)c3)CC2)c(-c2ccc(O)c(Cl)c2)c1
CHEMBL3219046,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.1,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccc(F)cc3-c3ccc(O)c(Cl)c3)CC2)ccc1O
CHEMBL3219047,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.4,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3cc(F)ccc3-c3ccc(O)c(Cl)c3)CC2)ccc1O
CHEMBL3219048,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.1,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)CC2)ccc1O
CHEMBL3219049,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.0,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)CC2)ccc1O
CHEMBL3219050,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.4,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCCCN2CCC(OC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)CC2)ccc1O
CHEMBL3219051,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,9.2,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CC[C@@H](OC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)C2)ccc1O
CHEMBL3219052,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.3,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2C[C@H]3C[C@@]3(COC(=O)Nc3ccccc3-c3ccc(O)c(Cl)c3)C2)ccc1O
CHEMBL3219053,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.3,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2C[C@@H]3[C@@H](COC(=O)Nc4ccccc4-c4ccc(O)c(Cl)c4)[C@@H]3C2)ccc1O
CHEMBL3219054,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8.9,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2C3CCC2CC(OC(=O)Nc2ccccc2-c2ccc(O)c(Cl)c2)C3)ccc1O
CHEMBL3219055,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,36.0,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCc2ccc(OCCN3CCC(OC(=O)Nc4ccccc4-c4ccc(O)c(Cl)c4)CC3)cc2)ccc1O
CHEMBL3219056,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.1,nM,CHEMBL3227039,B,Displacement of [3H]-N-methyl scopolamine from human cloned muscarinic M3 receptor,CHEMBL3217601,KI,CS(=O)(=O)Nc1cc([C@@H](O)CNCCc2ccc(OCCCN3CCC(OC(=O)Nc4ccccc4-c4ccc(O)c(Cl)c4)CC3)cc2)ccc1O
CHEMBL715,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,100.0,nM,CHEMBL3225988,B,Binding affinity to M3 receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL42,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,100.0,nM,CHEMBL3225988,B,Binding affinity to M3 receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL3289390,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.11,nM,CHEMBL3293105,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cells after 2 hrs by scintillation counting analysis,CHEMBL3286356,KI,C[N+]1(C)CCC[C@@H](OC(=O)C(O)(c2ccccc2)c2ccccc2)C1.[Br-]
CHEMBL3289391,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,28.0,nM,CHEMBL3293105,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cells after 2 hrs by scintillation counting analysis,CHEMBL3286356,KI,C[N+]1(C)CCC[C@H](OC(=O)C(O)(c2ccccc2)c2ccccc2)C1.[Br-]
CHEMBL1724,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.6,nM,CHEMBL3293105,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cells after 2 hrs by scintillation counting analysis,CHEMBL3286356,KI,C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1.[Br-]
CHEMBL76897,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.44,nM,CHEMBL3295396,B,Displacement of [3H]4-DAMP from human recombinant M3 receptor expressed in CHO cells,CHEMBL3286108,KI,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,43651.58,nM,CHEMBL3367784,B,Displacement of [3H]NMS from human muscarinic M3 receptor transfected in CHO cells after 120 mins by scintillation counting analysis,CHEMBL3351776,KI,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL3309718,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,26915.35,nM,CHEMBL3367784,B,Displacement of [3H]NMS from human muscarinic M3 receptor transfected in CHO cells after 120 mins by scintillation counting analysis,CHEMBL3351776,KI,C[N+](C)(C)C[C@@H]1COCCO1.[I-]
CHEMBL387632,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,13489.63,nM,CHEMBL3367784,B,Displacement of [3H]NMS from human muscarinic M3 receptor transfected in CHO cells after 120 mins by scintillation counting analysis,CHEMBL3351776,KI,C[C@H]1OC[C@@H](C[N+](C)(C)C)O1.[I-]
CHEMBL390842,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7585.78,nM,CHEMBL3367784,B,Displacement of [3H]NMS from human muscarinic M3 receptor transfected in CHO cells after 120 mins by scintillation counting analysis,CHEMBL3351776,KI,C[C@H]1COC[C@@H](C[N+](C)(C)C)O1.[I-]
CHEMBL168815,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2570.4,nM,CHEMBL3367784,B,Displacement of [3H]NMS from human muscarinic M3 receptor transfected in CHO cells after 120 mins by scintillation counting analysis,CHEMBL3351776,KI,CC1OC2(CS1)CN1CCC2CC1
CHEMBL74300,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2398.83,nM,CHEMBL3367784,B,Displacement of [3H]NMS from human muscarinic M3 receptor transfected in CHO cells after 120 mins by scintillation counting analysis,CHEMBL3351776,KI,C[N+](C)(C)CC#CCOC(=O)Nc1cccc(Cl)c1.[Cl-]
CHEMBL21536,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.762,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,CCCCCCOc1nsnc1C1=CCCN(C)C1
CHEMBL3354065,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1202.26,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,CCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1
CHEMBL3354066,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,93.33,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,CN1CCC=C(c2nsnc2OCCCC2CCN(CCCN3C(=O)CCc4ccccc43)CC2)C1
CHEMBL3354067,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.677,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,CN1CCC=C(c2nsnc2OCCCCCC2CCN(CCCN3C(=O)CCc4ccccc43)CC2)C1
CHEMBL3354068,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.7943,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,CN1CCC=C(c2nsnc2OCCCCCCCC2CCN(CCCN3C(=O)CCc4ccccc43)CC2)C1
CHEMBL3354069,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.096,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,CN1CCC=C(c2nsnc2OCCCCCCCCCC2CCN(CCCN3C(=O)CCc4ccccc43)CC2)C1
CHEMBL3354070,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.0,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,CN1CCC=C(c2nsnc2OCCCCCCCCCCCC2CCN(CCCN3C(=O)CCc4ccccc43)CC2)C1
CHEMBL3354071,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,44.67,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,CN1CCC=C(c2nsnc2OCCCCCCCCCCCCCC2CCN(CCCN3C(=O)CCc4ccccc43)CC2)C1
CHEMBL3354072,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,11748.98,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,O=C1CCc2ccccc2N1CCCN1CCC(CCCO)CC1
CHEMBL3354073,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1905.46,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,O=C1CCc2ccccc2N1CCCN1CCC(CCCCCO)CC1
CHEMBL3354074,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,630.96,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,O=C1CCc2ccccc2N1CCCN1CCC(CCCCCCCO)CC1
CHEMBL3354075,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,199.53,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,O=C1CCc2ccccc2N1CCCN1CCC(CCCCCCCCCO)CC1
CHEMBL3354076,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,575.44,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,O=C1CCc2ccccc2N1CCCN1CCC(CCCCCCCCCCCO)CC1
CHEMBL3354077,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,338.84,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,O=C1CCc2ccccc2N1CCCN1CCC(CCCCCCCCCCCCCO)CC1
CHEMBL143469,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.884,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,CN1CCC=C(c2nsnc2OCCCCCCCCCOc2nsnc2C2=CCCN(C)C2)C1
CHEMBL3354078,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,57.54,nM,CHEMBL3383644,B,Displacement of [3H]NMS from human M3 receptor expressed in CHO cells by microplate scintillation counting based radioligand binding assay,CHEMBL3351363,KI,O=C1CCc2ccccc2N1CCCN1CCC(CCCCCCCCCC2CCN(CCCN3C(=O)CCc4ccccc43)CC2)CC1
CHEMBL3426708,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.995,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,COc1ccc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)cc1CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3426707,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.943,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,COc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1NC(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3426706,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.0,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)Nc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1
CHEMBL3426705,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1995,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3426704,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.631,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,COc1cc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3426703,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,COc1cc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3426702,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.7943,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,CN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1
CHEMBL3426701,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.162,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,Cc1cc(C(=O)NCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3426700,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.31,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,COc1cc(C(=O)NCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3426699,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.631,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCNC(=O)c2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)CC1
CHEMBL1900528,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.03162,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12
CHEMBL3426698,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)N[C@H]1CC[C@H](CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1
CHEMBL3426697,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)NCCCCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL1683934,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1259,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,O=C(Nc1ccccc1-c1ccccc1)OC1CCN(CCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1
CHEMBL3426696,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3426695,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.5012,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,COc1c(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1C
CHEMBL3426694,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.259,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,Cc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3426693,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.05012,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3039518,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.995,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3426692,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.631,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,COc1c(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1Cl
CHEMBL3426691,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1585,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3426690,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1995,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c(Cl)c1
CHEMBL3426689,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.585,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3426688,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1995,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1Cl
CHEMBL3426687,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.07943,nM,CHEMBL3428929,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressing CHO-K1 cells incubated for 60 mins or 6 hrs by liquid scintillation counting,CHEMBL3425497,KI,O=C(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1
CHEMBL1773267,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.31,nM,CHEMBL3630581,B,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,CHEMBL3627605,KI,CC(C)N(CC[C@H](c1ccccc1)c1cc(CCCCOc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)ccc1O)C(C)C
CHEMBL3629353,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.73,nM,CHEMBL3630581,B,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,CHEMBL3627605,KI,O=C(Nc1ccccc1-c1ccc(O)c(Cl)c1)OC1CCN(CCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)CC1
CHEMBL143228,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.1,nM,CHEMBL3630581,B,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,CHEMBL3627605,KI,CN1CCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)CC1
CHEMBL3629354,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.34,nM,CHEMBL3630581,B,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,CHEMBL3627605,KI,CN1CCC(Cn2cnc(C(O)(c3ccccc3)c3ccccc3)n2)CC1
CHEMBL3629355,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.1,nM,CHEMBL3630581,B,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,CHEMBL3627605,KI,CN1CCC(Cn2cnc(C(O)(c3ccccc3)C3CCCCC3)n2)CC1
CHEMBL3629356,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.7,nM,CHEMBL3630581,B,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,CHEMBL3627605,KI,O=c1ccc2c([C@@H](O)CNCCCCCCCCCN3CCC(Cn4cnc(C(O)(c5ccccc5)c5ccccc5)n4)CC3)ccc(O)c2[nH]1
CHEMBL3629357,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,18.0,nM,CHEMBL3630581,B,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,CHEMBL3627605,KI,O=c1ccc2c([C@@H](O)CNCCc3ccc(CCN4CCC(Cn5cnc(C(O)(c6ccccc6)c6ccccc6)n5)CC4)cc3)ccc(O)c2[nH]1
CHEMBL3629358,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.7,nM,CHEMBL3630581,B,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,CHEMBL3627605,KI,O=c1ccc2c([C@@H](O)CNCCCCCCCCCN3CCC(Cn4cnc(C(O)(c5ccccc5)C5CCCCC5)n4)CC3)ccc(O)c2[nH]1
CHEMBL3629359,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.7,nM,CHEMBL3630581,B,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,CHEMBL3627605,KI,O=c1ccc2c([C@@H](O)CNCCCCCCCCCN3CCC(Cn4cnc([C@](O)(c5ccccc5)C5CCCCC5)n4)CC3)ccc(O)c2[nH]1
CHEMBL3629360,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.29,nM,CHEMBL3630581,B,Displacement of [3H]N-methyl scopolamine from human cloned muscarinic M3 receptor by dilution method,CHEMBL3627605,KI,O=c1ccc2c([C@@H](O)CNCCc3ccc(CCN4CCC(Cn5cnc([C@](O)(c6ccccc6)C6CCCCC6)n5)CC4)cc3)ccc(O)c2[nH]1
CHEMBL3629529,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5260.0,nM,CHEMBL3630285,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,CHEMBL3627629,KI,COc1ccc(CCOC(=O)C2(c3ccccc3)CCN(C)CC2)cc1OC
CHEMBL3629530,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,640.0,nM,CHEMBL3630285,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,CHEMBL3627629,KI,COc1ccc(CCOC(=O)C2(c3ccccc3)CCN(C)CC2)cc1
CHEMBL3629532,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3290.0,nM,CHEMBL3630285,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,CHEMBL3627629,KI,COc1ccc(CCNC(=O)C2(c3ccccc3)CCN(C)CC2)cc1
CHEMBL3629533,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4600.0,nM,CHEMBL3630285,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,CHEMBL3627629,KI,COc1ccc(CCC(=O)OCC2(c3ccccc3)CCN(C)CC2)cc1OC
CHEMBL3629534,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,370.0,nM,CHEMBL3630285,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,CHEMBL3627629,KI,COc1ccc(CCC(=O)OCC2(c3ccccc3)CCN(C)CC2)cc1
CHEMBL3627739,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1540.0,nM,CHEMBL3630285,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,CHEMBL3627629,KI,COc1ccc(CCC(=O)NCC2(c3ccccc3)CCN(C)CC2)cc1
CHEMBL3629536,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4030.0,nM,CHEMBL3630285,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,CHEMBL3627629,KI,COc1ccc(CCNC(=O)OCC2(c3ccccc3)CCN(C)CC2)cc1OC
CHEMBL3629537,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2300.0,nM,CHEMBL3630285,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,CHEMBL3627629,KI,COc1ccc(CCOC(=O)NCC2(c3ccccc3)CCN(C)CC2)cc1
CHEMBL3629539,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3550.0,nM,CHEMBL3630285,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cells after 2 hrs by liquid scintillation spectrometry analysis,CHEMBL3627629,KI,COc1ccc(CCNC(=O)NCC2(c3ccccc3)CCN(C)CC2)cc1
CHEMBL3764557,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1000.0,nM,CHEMBL3768213,B,Binding affinity to muscarinic M3 receptor (unknown origin),CHEMBL3763143,KI,Cc1ncoc1-c1nnc(SCCCN2CCOC(c3ccc(C(F)(F)F)cc3)C2)n1C
CHEMBL3936289,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,661.0,nM,CHEMBL3869832,B,Binding affinity to human M3 receptor expressed in CHO cells measured after 90 mins by radioligand binding assay,CHEMBL3868615,KI,CN1CC[C@H]2CC(=O)[C@H](Cc3ccccc3)[C@H]3CCC[C@@H]1[C@H]23
CHEMBL3645362,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(CCCC(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3666066,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(CCCC(=O)Nc1cccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3666067,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12)c1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1
CHEMBL3645363,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(CCCCC(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3666068,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645364,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(C(=O)Nc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1
CHEMBL3645361,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1ccc(C(=O)Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645365,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@H](Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645362,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(CCCC(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645359,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(CCCC(=O)Nc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645360,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@@H](Cc1ccc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645363,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(CCCCC(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645364,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(C(=O)Nc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1
CHEMBL3645361,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1ccc(C(=O)Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645365,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@H](Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645274,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645275,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645276,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645277,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645278,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645359,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(CCCC(=O)Nc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645279,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1ccc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)cc1CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645280,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1cccc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645281,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645282,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@H](Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645283,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645284,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645285,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645286,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645287,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(CCCCC(=O)Nc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645288,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(CCCCC(=O)Nc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645289,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645290,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@H](Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645293,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1cccc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1
CHEMBL3645291,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@@H](Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645292,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1ccc(C(=O)Nc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645294,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1ccc(C)c(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1
CHEMBL3645295,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1cccc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1
CHEMBL3645296,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1cc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645297,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1cc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645298,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(C(=O)Nc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)c1
CHEMBL3645299,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1ccc(C(=O)Nc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645361,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1ccc(C(=O)Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645301,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1cccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645302,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1ccc(C(=O)Nc2cccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645303,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@H](Cc1cccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645304,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@@H](Cc1cccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645305,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1ccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645306,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1ccc(C(=O)Nc2ccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645307,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@H](Cc1ccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645308,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@@H](Cc1ccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645309,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1cccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645310,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1ccc(C(=O)NCc2cccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645311,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645312,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1ccc(C(=O)NCc2ccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645313,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@H](Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645314,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@@H](Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645315,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.4,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@H](Cc1cccc(CNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645316,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@@H](Cc1cccc(CNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645317,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1cccc(CC(=O)Nc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645318,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1ccc(CC(=O)Nc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645319,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1ccc(CC(=O)Nc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645320,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@H](Cc1cccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645321,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@@H](Cc1cccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645322,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@H](Cc1ccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645323,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@@H](Cc1ccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645324,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(CC(=O)Nc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1
CHEMBL3645325,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1cc(NC(=O)Cc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645326,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1cc(NC(=O)Cc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645327,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(CC(=O)Nc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)c1
CHEMBL3645328,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1
CHEMBL3645329,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CC(=O)NCc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1
CHEMBL3645330,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CC(=O)NCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1
CHEMBL3645331,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645331,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645332,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@H](Cc1cccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645333,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@@H](Cc1cccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645334,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645335,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,Cc1c(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cccc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645336,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.4,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645337,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1cc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645338,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)Cc2cccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1
CHEMBL3645339,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)Cc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1
CHEMBL3645340,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)Cc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1
CHEMBL3645341,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1cccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645342,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@H](Cc1cccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645343,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@@H](Cc1cccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645344,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645345,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645346,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1C[C@@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645347,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1C[C@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645348,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1cc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645349,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645350,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@@H](Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645351,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1ccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645352,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@@H](Cc1ccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3639442,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@H](Cc1ccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645353,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1cccc(CCC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645354,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@H](Cc1cccc(CCC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645355,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.8,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,C[C@@H](Cc1cccc(CCC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645356,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,COc1ccc(CC(C)NC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1CC(=O)NCc1ccc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)cc1
CHEMBL3645357,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CC(Cc1ccc(F)c(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645358,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705059,B,Radioligand Binding Assay: Radioligand binding assay using muscarinic receptors.,CHEMBL3638982,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)CCc2cccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1
CHEMBL3917058,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.16,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,KI,C[C@@](C(=O)O[C@@H]1CC2CCC1[N+]2(C)C)(c1ccccc1)C1CCCC1
CHEMBL3670826,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.18,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,KI,C[N+]1(C)C2CCC1[C@H](OC(=O)[C@@](O)(c1ccccc1)C1CCCC1)C2
CHEMBL3670827,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.18,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,KI,C[N+]1(C)C2CCC1[C@@H](OC(=O)[C@@](O)(c1ccccc1)C1CCCC1)C2
CHEMBL3670828,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.22,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,KI,C[N+]1(C)C2CCC1[C@@H](OC(=O)[C@](O)(c1ccccc1)C1CCCC1)C2
CHEMBL3670828,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.5,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,KI,C[N+]1(C)C2CCC1[C@@H](OC(=O)[C@](O)(c1ccccc1)C1CCCC1)C2
CHEMBL3670828,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.1,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,KI,C[N+]1(C)C2CCC1[C@@H](OC(=O)[C@](O)(c1ccccc1)C1CCCC1)C2
CHEMBL3670826,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,14.0,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,KI,C[N+]1(C)C2CCC1[C@H](OC(=O)[C@@](O)(c1ccccc1)C1CCCC1)C2
CHEMBL3670827,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,26.0,nM,CHEMBL3705168,B,"Radioligand Binding Assay: Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). Incubations of test ligands (or standard) with 0.2 nM [3H]4-DAMP were incubated for 120 minutes at 22 C. using human M3 receptor-expressing cell homogenates. Specific ligand binding to the receptors was defined as the difference between the total radioligand binding and the nonspecific binding determined in the presence of an excess of unlabelled ligand (10 atropine). The results were expressed as a percent of control specific binding ((measured specific binding/control specific binding)x100) obtained in the presence of various concentrations of the test compounds.",CHEMBL3639295,KI,C[N+]1(C)C2CCC1[C@@H](OC(=O)[C@@](O)(c1ccccc1)C1CCCC1)C2
CHEMBL3645275,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645277,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645279,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1ccc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)cc1CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645281,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645363,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(CCCCC(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645285,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645286,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645288,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(CCCCC(=O)Nc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645290,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@H](Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645293,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1cccc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1
CHEMBL3645295,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1cccc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1
CHEMBL3645297,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1cc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645299,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1ccc(C(=O)Nc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645302,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1ccc(C(=O)Nc2cccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645304,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@@H](Cc1cccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645306,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1ccc(C(=O)Nc2ccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645308,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@@H](Cc1ccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645310,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1ccc(C(=O)NCc2cccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645312,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1ccc(C(=O)NCc2ccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645314,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@@H](Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645316,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@@H](Cc1cccc(CNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645318,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1ccc(CC(=O)Nc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645320,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@H](Cc1cccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645322,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@H](Cc1ccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645324,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(CC(=O)Nc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1
CHEMBL3645326,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1cc(NC(=O)Cc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645328,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1
CHEMBL3645330,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CC(=O)NCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1
CHEMBL3645331,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645333,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@@H](Cc1cccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645335,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1c(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cccc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645337,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1cc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645339,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)Cc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1
CHEMBL3645341,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1cccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645343,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@@H](Cc1cccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645345,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645347,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1C[C@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645349,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645352,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@@H](Cc1ccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645353,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1cccc(CCC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645355,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.8,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@@H](Cc1cccc(CCC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645357,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1ccc(F)c(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645274,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645276,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645278,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645359,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(CCCC(=O)Nc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645280,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1cccc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645282,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@H](Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645284,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645287,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(CCCCC(=O)Nc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645289,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645291,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@@H](Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645292,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1ccc(C(=O)Nc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645294,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1ccc(C)c(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1
CHEMBL3645296,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1cc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645298,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(C(=O)Nc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)c1
CHEMBL3645300,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(C(=O)Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1
CHEMBL3645301,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1cccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645303,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@H](Cc1cccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645305,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1ccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645307,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@H](Cc1ccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645309,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1cccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645311,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645313,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@H](Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645315,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.4,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@H](Cc1cccc(CNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645317,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1cccc(CC(=O)Nc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645319,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1ccc(CC(=O)Nc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645321,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@@H](Cc1cccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645323,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@@H](Cc1ccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645325,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1cc(NC(=O)Cc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645327,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(CC(=O)Nc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)c1
CHEMBL3645329,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CC(=O)NCc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1
CHEMBL3645331,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645332,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@H](Cc1cccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645334,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,Cc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645336,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.4,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645338,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)Cc2cccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1
CHEMBL3645340,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)Cc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1
CHEMBL3645342,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@H](Cc1cccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645344,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645346,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1C[C@@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645348,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1cc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645350,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@@H](Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645351,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CC(Cc1ccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3639442,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@H](Cc1ccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645354,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,C[C@H](Cc1cccc(CCC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645356,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,COc1ccc(CC(C)NC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1CC(=O)NCc1ccc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)cc1
CHEMBL3645358,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3705468,B,"Radioligand Binding Assay: Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell membranes stably expressing either the hM1, hM2, hM3, hM4 or hM5 muscarinic subtype were diluted in assay buffer to the following specific target protein concentrations (ug/well): 10 ug for hM1, 10-15 ug for hM2, 10-20 ug for hM3, 10-20 ug for hM4, and 10-12 ug for hM5 to get similar signals (cpm). The membranes were briefly homogenized using a Polytron tissue disruptor (10 seconds) prior to assay plate addition.Saturation binding studies for determining KD values of the radioligand were performed using L-[N-methyl-3H]scopolamine methyl chloride ([3H]-NMS) (TRK666, 84.0 Ci/mmol, Amersham Pharmacia Biotech, Buckinghamshire, England) at concentrations ranging from 0.001 nM to 20 nM.Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM.",CHEMBL3638913,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)CCc2cccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1
CHEMBL3645362,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CN(CCCC(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645275,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645277,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645365,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@H](Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645279,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1ccc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)cc1CCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645281,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3896828,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@@H](Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645283,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645285,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645286,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645288,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CN(CCCCC(=O)Nc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645290,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@H](Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3426704,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1cc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645293,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1cccc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1
CHEMBL3645295,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1cccc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1
CHEMBL3981221,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1cc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645299,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1ccc(C(=O)Nc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645361,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1ccc(C(=O)Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645302,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1ccc(C(=O)Nc2cccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645304,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@@H](Cc1cccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3952427,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1ccc(C(=O)Nc2ccc(CC(C)NC[C@H](C)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645308,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@@H](Cc1ccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645310,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1ccc(C(=O)NCc2cccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645312,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1ccc(C(=O)NCc2ccc(CC(C)NC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645314,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@@H](Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645316,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@@H](Cc1cccc(CNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645311,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645320,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@H](Cc1cccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL4114219,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@@H](NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12)c1cccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1
CHEMBL3645324,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(CC(=O)Nc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1
CHEMBL3645326,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1cc(NC(=O)Cc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645328,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(CC(=O)Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1
CHEMBL3645330,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CC(=O)NCc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1
CHEMBL3965175,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NCCc1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645333,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@@H](Cc1cccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645335,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1c(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cccc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645337,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1cc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645339,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)Cc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1
CHEMBL3645341,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1cccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645343,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@@H](Cc1cccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645345,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645347,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1C[C@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645349,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645350,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@@H](Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645352,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@@H](Cc1ccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645353,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1cccc(CCC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645355,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.8,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@@H](Cc1cccc(CCC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645357,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1ccc(F)c(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645274,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645276,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)ccc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645278,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1cc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645359,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CN(CCCC(=O)Nc1ccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645280,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1cccc(NC(=O)CCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645282,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@H](Cc1cccc(CC(=O)NCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645363,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CN(CCCCC(=O)Nc1ccc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645284,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)CCCCN(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3666068,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1cc(NC(=O)CCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645287,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CN(CCCCC(=O)Nc1cccc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645289,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645291,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@@H](Cc1cccc(CC(=O)NCCCCN(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645292,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1ccc(C(=O)Nc2ccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645294,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1cc(CNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1NC(=O)c1ccc(C)c(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c1
CHEMBL3645296,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1cc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645298,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(C(=O)Nc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)c1
CHEMBL3645361,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1ccc(C(=O)Nc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1N(C)C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL3645301,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1cccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645303,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@H](Cc1cccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645305,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1ccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645307,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@H](Cc1ccc(NC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645309,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1cccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645311,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645313,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@H](Cc1ccc(CNC(=O)c2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645315,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.4,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@H](Cc1cccc(CNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645317,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1cccc(CC(=O)Nc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645319,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1ccc(CC(=O)Nc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645321,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@@H](Cc1cccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645323,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@@H](Cc1ccc(CCNC(=O)c2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645325,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1cc(NC(=O)Cc2cccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)c2)c(C)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645327,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1cccc(CC(=O)Nc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)c1
CHEMBL3645329,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CC(=O)NCc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)cc1
CHEMBL3645331,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645332,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@H](Cc1cccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645334,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,Cc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645336,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.4,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1ccc(CNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1CC(C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645338,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)Cc2cccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1
CHEMBL3645340,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)Cc2cccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1
CHEMBL3645342,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@H](Cc1cccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645344,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645346,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1ccc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1C[C@@H](C)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645348,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1cc(CC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)ccc1F)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645349,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1cccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645351,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CC(Cc1ccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3639442,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@H](Cc1ccc(CCNC(=O)Cc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645354,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,C[C@H](Cc1cccc(CCC(=O)NCc2ccc(N(C)C(=O)CCN3CCC(OC(=O)Nc4ccccc4-c4ccccc4)CC3)cc2)c1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL3645356,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,COc1ccc(CC(C)NC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1CC(=O)NCc1ccc(N(C)C(=O)CCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)cc1
CHEMBL3645358,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL3888781,B,"Radioligand Binding Assay: Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a concentration of 400 μM in dilution buffer and then serially diluted 5× with dilution buffer to final concentrations ranging from 10 pM to 100 μM. The order of addition and volumes added to the assay plates were as follows: 25 μL radioligand, 25 μL diluted test compound, and 50 μL membranes. Assay plates were incubated for 6 hours at 37° C. Binding reactions were terminated by rapid filtration over GF/B glass fiber filter plates (PerkinElmer, Inc.) pre-treated in 1% BSA. Filter plates were rinsed three times with wash buffer (10 mM HEPES) to remove unbound radioactivity. The plates were then air-dried and 50 μL Microscint-20 liquid scintillation fluid (PerkinElmer, Inc.) were added to each well. The plates were then counted in a PerkinElmer Topcount liquid scintillation counter (PerkinElmer, Inc.).",CHEMBL3886834,KI,CN(C(=O)CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)c1ccc(CNC(=O)CCc2cccc(CNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)cc1
CHEMBL76897,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.22,nM,CHEMBL4001175,B,Displacement of [3H]4-DAMP from human recombinant Muscarinic acetylcholine receptor M3 expressed in CHO cells after 60 mins by scintillation counting,CHEMBL4000185,KI,C[N+]1(C)CCC(OC(=O)C(c2ccccc2)c2ccccc2)CC1.[I-]
CHEMBL4071109,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4700.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,COc1ccccc1CC[N+](C)(C)C.O=C[O-]
CHEMBL4081662,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,620.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,COc1cccc(CCC[N+](C)(C)C)c1.[I-]
CHEMBL4099667,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,21000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,COc1cccc(/C=C/C[N+](C)(C)C)c1.O=C[O-]
CHEMBL4092769,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,20000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,COc1cccc(C#CC[N+](C)(C)C)c1.O=C[O-]
CHEMBL4061384,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8700.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,COc1cccc(C2CC2C[N+](C)(C)C)c1.O=C[O-]
CHEMBL4097248,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,24000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,COc1cccc2c1CC[N+](C)(C)C2.O=C[O-]
CHEMBL4070055,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5800.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,COc1cccc2c1C[N+](C)(C)CC2.O=C[O-]
CHEMBL4085150,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,COc1cccc2c1CC([N+](C)(C)C)CC2.[I-]
CHEMBL4103087,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,16000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,C[N+](C)(C)C1CCc2cccc(O)c2C1.[I-]
CHEMBL4103375,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3900.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,COc1cccc2c1CC(C[N+](C)(C)C)CC2.O=C[O-]
CHEMBL4085451,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,COc1cccc2c1CCC([N+](C)(C)C)C2.[I-]
CHEMBL4095626,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,COc1cccc2c1CCC(C[N+](C)(C)C)C2.O=C[O-]
CHEMBL4075227,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,830.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,COc1cccc2c1CC(N(C)C)CC2
CHEMBL146953,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,28000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,CN(C)C1CCc2cccc(O)c2C1
CHEMBL4100938,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,41.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,C[N+](C)(C)CCc1ccc2ccoc2c1.O=C[O-]
CHEMBL4065555,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,140.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,C[N+](C)(C)CCCc1ccc2ccoc2c1.O=C[O-]
CHEMBL4093215,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,690.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,C[N+](C)(C)C1CCc2ccc3ccoc3c2C1.O=C[O-]
CHEMBL4069313,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,550.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,C[N+](C)(C)CC#CCOC1=NOCC1.[I-]
CHEMBL667,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4700.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,CC(=O)OCC[N+](C)(C)C
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,51000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL4073256,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,780.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,CNCCc1cccc(OC)c1
CHEMBL4092348,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,13000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,C[N+](C)(C)CCc1cccc(O)c1.O=C[O-]
CHEMBL4064668,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,14000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,COc1ccc(F)c(CC[N+](C)(C)C)c1.O=C[O-]
CHEMBL4084607,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,12000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,COc1cccc(C(O)C[N+](C)(C)C)c1.O=C[O-]
CHEMBL4102555,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,210.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,COc1cccc(C(=O)C[N+](C)(C)C)c1.O=C[O-]
CHEMBL4074319,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,43000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,CCOc1cccc(CC[N+](C)(C)C)c1.O=C[O-]
CHEMBL4094819,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5800.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,C[N+](C)(C)CCc1cccc(Cl)c1.O=C[O-]
CHEMBL4089027,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,11000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,C[N+](C)(C)CCc1cccc(OC(F)(F)F)c1.O=C[O-]
CHEMBL4060823,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6300.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,C[N+](C)(C)CCc1ccc2c(c1)OCC2.O=C[O-]
CHEMBL4072787,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4100.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,c1csc(COC2CCNC2)n1
CHEMBL4099673,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,36000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,c1cncc(COCC2CCNC2)c1
CHEMBL4083241,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,c1cncc(COC2CCCNC2)c1
CHEMBL4061390,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,12000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,C[N+]1(C)CCC(OCc2nccs2)C1.O=C[O-]
CHEMBL4091032,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,75000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,CN1CCC(COCc2cccnc2)C1
CHEMBL4070061,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,42000.0,nM,CHEMBL4026880,B,Displacement of [3H]N-methyl-scopolamine bromide from human recombinant muscarinic M3 receptor expressed in HEK293T cell membranes after 1 hr by liquid scintillation counting method,CHEMBL4024758,KI,CN1CCCC(OCc2cccnc2)C1
CHEMBL4091934,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,81283.05,nM,CHEMBL4026885,B,Displacement of [3H]N-methyl-scopolamine from human recombinant muscarinic M3 receptor expressed in CHO-FlpIn cells after 6 hrs by liquid scintillation counting method,CHEMBL4024758,KI,COc1cccc(CC[N+](C)(C)C)c1.O=C[O-]
CHEMBL4091934,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,81000.0,nM,CHEMBL4026885,B,Displacement of [3H]N-methyl-scopolamine from human recombinant muscarinic M3 receptor expressed in CHO-FlpIn cells after 6 hrs by liquid scintillation counting method,CHEMBL4024758,KI,COc1cccc(CC[N+](C)(C)C)c1.O=C[O-]
CHEMBL667,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6760.83,nM,CHEMBL4026885,B,Displacement of [3H]N-methyl-scopolamine from human recombinant muscarinic M3 receptor expressed in CHO-FlpIn cells after 6 hrs by liquid scintillation counting method,CHEMBL4024758,KI,CC(=O)OCC[N+](C)(C)C
CHEMBL667,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6800.0,nM,CHEMBL4026885,B,Displacement of [3H]N-methyl-scopolamine from human recombinant muscarinic M3 receptor expressed in CHO-FlpIn cells after 6 hrs by liquid scintillation counting method,CHEMBL4024758,KI,CC(=O)OCC[N+](C)(C)C
CHEMBL4060823,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7762.47,nM,CHEMBL4026885,B,Displacement of [3H]N-methyl-scopolamine from human recombinant muscarinic M3 receptor expressed in CHO-FlpIn cells after 6 hrs by liquid scintillation counting method,CHEMBL4024758,KI,C[N+](C)(C)CCc1ccc2c(c1)OCC2.O=C[O-]
CHEMBL4060823,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7800.0,nM,CHEMBL4026885,B,Displacement of [3H]N-methyl-scopolamine from human recombinant muscarinic M3 receptor expressed in CHO-FlpIn cells after 6 hrs by liquid scintillation counting method,CHEMBL4024758,KI,C[N+](C)(C)CCc1ccc2c(c1)OCC2.O=C[O-]
CHEMBL4074104,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,14125.38,nM,CHEMBL4048890,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cell membranes after 2 hrs by liquid scintillation counting method,CHEMBL4043296,KI,CC1CCN(CCCN2C(=O)CCc3ccccc32)CC1
CHEMBL4098720,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2344.23,nM,CHEMBL4048890,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cell membranes after 2 hrs by liquid scintillation counting method,CHEMBL4043296,KI,CCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1
CHEMBL4080675,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1348.96,nM,CHEMBL4048890,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cell membranes after 2 hrs by liquid scintillation counting method,CHEMBL4043296,KI,CCCCCC1CCN(CCCN2C(=O)CCc3ccccc32)CC1
CHEMBL4091231,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4677.35,nM,CHEMBL4048890,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cell membranes after 2 hrs by liquid scintillation counting method,CHEMBL4043296,KI,O=C1CCc2ccccc2N1CCCN1CCC(c2ccccc2)CC1
CHEMBL4072818,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3019.95,nM,CHEMBL4048890,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cell membranes after 2 hrs by liquid scintillation counting method,CHEMBL4043296,KI,O=C1CCc2ccccc2N1CCCN1CCC(Cc2ccccc2)CC1
CHEMBL4093527,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,501.19,nM,CHEMBL4048890,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cell membranes after 2 hrs by liquid scintillation counting method,CHEMBL4043296,KI,O=C1CCc2ccccc2N1CCCN1CCC(CCc2ccccc2)CC1
CHEMBL4064222,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7079.46,nM,CHEMBL4048890,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cell membranes after 2 hrs by liquid scintillation counting method,CHEMBL4043296,KI,CCCCN1CCN(CCCN2C(=O)CCc3ccccc32)CC1
CHEMBL4085780,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,17782.79,nM,CHEMBL4048890,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cell membranes after 2 hrs by liquid scintillation counting method,CHEMBL4043296,KI,O=C1CCc2ccccc2N1CCCN1CCN(c2ccccc2)CC1
CHEMBL4091058,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6760.83,nM,CHEMBL4048890,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cell membranes after 2 hrs by liquid scintillation counting method,CHEMBL4043296,KI,O=C1CCc2ccccc2N1CCCN1CCN(Cc2ccccc2)CC1
CHEMBL4063176,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6606.93,nM,CHEMBL4048890,B,Displacement of [3H]NMS from human muscarinic M3 receptor expressed in CHO cell membranes after 2 hrs by liquid scintillation counting method,CHEMBL4043296,KI,O=C1CCc2ccccc2N1CCCN1CCN(CCc2ccccc2)CC1
CHEMBL4097258,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,15.49,nM,CHEMBL4051385,B,Displacement of [3H]NMS from human muscarinic acetylcholine receptor M3 expressed in CHOK9 cells after 3 hrs by liquid scintillation counting assay,CHEMBL4049434,KI,CCC(=O)NCc1cc(C(=O)NCCNC(=O)CCc2cn(CCCCC3CCN(CC(=O)N4c5ccccc5NC(=O)c5ccccc54)CC3)cn2)cc(C(=O)NCCNC(=O)CCc2cn(CCCCC3CCN(CC(=O)N4c5ccccc5NC(=O)c5ccccc54)CC3)cn2)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4079233,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,199.53,nM,CHEMBL4051385,B,Displacement of [3H]NMS from human muscarinic acetylcholine receptor M3 expressed in CHOK9 cells after 3 hrs by liquid scintillation counting assay,CHEMBL4049434,KI,CCC(=O)NC1CN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)C1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4129382,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,14454.4,nM,CHEMBL4119546,B,Displacement of [3H]NMS from recombinant human muscarinic M3 receptor expressed in CHOK1 cell membranes after 120 mins by scintillation counting method,CHEMBL4118068,KI,O=C(O[C@@H]1CN2CCC1CC2)[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1
CHEMBL4126071,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,269.15,nM,CHEMBL4119546,B,Displacement of [3H]NMS from recombinant human muscarinic M3 receptor expressed in CHOK1 cell membranes after 120 mins by scintillation counting method,CHEMBL4118068,KI,O=C(O[C@H]1CN2CCC1CC2)[C@H]1COCC(c2ccccc2)(c2ccccc2)O1
CHEMBL4128667,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2630.27,nM,CHEMBL4119546,B,Displacement of [3H]NMS from recombinant human muscarinic M3 receptor expressed in CHOK1 cell membranes after 120 mins by scintillation counting method,CHEMBL4118068,KI,O=C(O[C@H]1CN2CCC1CC2)[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1
CHEMBL4130037,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1698.24,nM,CHEMBL4119546,B,Displacement of [3H]NMS from recombinant human muscarinic M3 receptor expressed in CHOK1 cell membranes after 120 mins by scintillation counting method,CHEMBL4118068,KI,O=C(O[C@@H]1CN2CCC1CC2)[C@H]1COCC(c2ccccc2)(c2ccccc2)O1
CHEMBL4128764,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1621.81,nM,CHEMBL4119546,B,Displacement of [3H]NMS from recombinant human muscarinic M3 receptor expressed in CHOK1 cell membranes after 120 mins by scintillation counting method,CHEMBL4118068,KI,C[C@@]1(C(=O)O[C@@H]2CN3CCC2CC3)COCC(c2ccccc2)(c2ccccc2)O1
CHEMBL4127373,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,398.11,nM,CHEMBL4119546,B,Displacement of [3H]NMS from recombinant human muscarinic M3 receptor expressed in CHOK1 cell membranes after 120 mins by scintillation counting method,CHEMBL4118068,KI,C[C@]1(C(=O)O[C@H]2CN3CCC2CC3)COCC(c2ccccc2)(c2ccccc2)O1
CHEMBL4127428,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,416.87,nM,CHEMBL4119546,B,Displacement of [3H]NMS from recombinant human muscarinic M3 receptor expressed in CHOK1 cell membranes after 120 mins by scintillation counting method,CHEMBL4118068,KI,C[C@@]1(C(=O)O[C@H]2CN3CCC2CC3)COCC(c2ccccc2)(c2ccccc2)O1
CHEMBL4128497,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1548.82,nM,CHEMBL4119546,B,Displacement of [3H]NMS from recombinant human muscarinic M3 receptor expressed in CHOK1 cell membranes after 120 mins by scintillation counting method,CHEMBL4118068,KI,C[C@]1(C(=O)O[C@@H]2CN3CCC2CC3)COCC(c2ccccc2)(c2ccccc2)O1
CHEMBL4126290,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,104.71,nM,CHEMBL4119546,B,Displacement of [3H]NMS from recombinant human muscarinic M3 receptor expressed in CHOK1 cell membranes after 120 mins by scintillation counting method,CHEMBL4118068,KI,c1ccc(C2(c3ccccc3)COC[C@@H](CO[C@@H]3CN4CCC3CC4)O2)cc1
CHEMBL4129580,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,43.65,nM,CHEMBL4119546,B,Displacement of [3H]NMS from recombinant human muscarinic M3 receptor expressed in CHOK1 cell membranes after 120 mins by scintillation counting method,CHEMBL4118068,KI,c1ccc(C2(c3ccccc3)COC[C@H](CO[C@H]3CN4CCC3CC4)O2)cc1
CHEMBL4129723,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,616.6,nM,CHEMBL4119546,B,Displacement of [3H]NMS from recombinant human muscarinic M3 receptor expressed in CHOK1 cell membranes after 120 mins by scintillation counting method,CHEMBL4118068,KI,c1ccc(C2(c3ccccc3)COC[C@@H](CO[C@H]3CN4CCC3CC4)O2)cc1
CHEMBL4128341,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,19.95,nM,CHEMBL4119546,B,Displacement of [3H]NMS from recombinant human muscarinic M3 receptor expressed in CHOK1 cell membranes after 120 mins by scintillation counting method,CHEMBL4118068,KI,c1ccc(C2(c3ccccc3)COC[C@H](CO[C@@H]3CN4CCC3CC4)O2)cc1
CHEMBL2078987,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,72.44,nM,CHEMBL4119546,B,Displacement of [3H]NMS from recombinant human muscarinic M3 receptor expressed in CHOK1 cell membranes after 120 mins by scintillation counting method,CHEMBL4118068,KI,CN(C)C[C@@H]1COCC(c2ccccc2)(c2ccccc2)O1
CHEMBL2078942,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.514,nM,CHEMBL4119546,B,Displacement of [3H]NMS from recombinant human muscarinic M3 receptor expressed in CHOK1 cell membranes after 120 mins by scintillation counting method,CHEMBL4118068,KI,CN(C)C[C@H]1COCC(c2ccccc2)(c2ccccc2)O1
CHEMBL1734,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,13.18,nM,CHEMBL4119546,B,Displacement of [3H]NMS from recombinant human muscarinic M3 receptor expressed in CHOK1 cell membranes after 120 mins by scintillation counting method,CHEMBL4118068,KI,O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1
CHEMBL4160064,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2369.0,nM,CHEMBL4153432,B,Displacement of [3H]-QNB/[3H]-NMS from human muscarinic M3 receptor expressed in stable CHO cells after 90 mins by microbeta scintillation counting method,CHEMBL4152214,KI,COc1cccc(-c2ccc3c(c2)CCN(Cc2ccccc2)C3)c1
CHEMBL76,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3311.31,nM,CHEMBL4303775,B,Activity of compound against Muscarinic acetylcholine receptor M3 (CHRM3) by displacement of 3H-QNB,CHEMBL4303773,KI,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12
CHEMBL1626,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,56.23,nM,CHEMBL4303775,B,Activity of compound against Muscarinic acetylcholine receptor M3 (CHRM3) by displacement of 3H-QNB,CHEMBL4303773,KI,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1
CHEMBL1535,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4786.3,nM,CHEMBL4303775,B,Activity of compound against Muscarinic acetylcholine receptor M3 (CHRM3) by displacement of 3H-QNB,CHEMBL4303773,KI,CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12
CHEMBL53325,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,19498.45,nM,CHEMBL4303775,B,Activity of compound against Muscarinic acetylcholine receptor M3 (CHRM3) by displacement of 3H-QNB,CHEMBL4303773,KI,COc1cccc2c1CCCC2CCCN1CCN(C2CCCCC2)CC1
CHEMBL4088272,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,23988.33,nM,CHEMBL4303775,B,Activity of compound against Muscarinic acetylcholine receptor M3 (CHRM3) by displacement of 3H-QNB,CHEMBL4303773,KI,CCCN1CCC=C(c2cc(-c3ccc(C)cc3)no2)C1
CHEMBL4442460,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25000.0,nM,CHEMBL4323496,B,Displacement of [3H] NMS from muscarinic M3 receptor (unknown origin),CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1
CHEMBL4544086,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,37000.0,nM,CHEMBL4323496,B,Displacement of [3H] NMS from muscarinic M3 receptor (unknown origin),CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1
CHEMBL4470080,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3000.0,nM,CHEMBL4369939,B,Inhibition of muscarinic M3 receptor (unknown origin),CHEMBL4368904,KI,OC[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC(C4CCC4)C4CCC4)nc(Cl)nc31)[C@H](O)[C@@H]2O
CHEMBL4572905,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5900.0,nM,CHEMBL4369939,B,Inhibition of muscarinic M3 receptor (unknown origin),CHEMBL4368904,KI,CCOC(=O)[C@@]12C[C@@H]1[C@@H](n1cnc3c(NC(C4CCC4)C4CCC4)nc(Cl)nc31)[C@H](O)[C@@H]2O
CHEMBL517712,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.53,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2
CHEMBL4573269,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2760.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(CCOC(=O)N(c2ccccc2)C2CN3CCC2CC3)cc1OC
CHEMBL4570052,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1020.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(COC(=O)N(c2ccccc2)C2CN3CCC2CC3)cc1OC
CHEMBL4451822,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1560.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(CCCOC(=O)N(c2ccccc2)C2CN3CCC2CC3)cc1OC
CHEMBL4441786,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,90.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,O=C(OCc1ccccc1)N(c1ccccc1)C1CN2CCC1CC2
CHEMBL4571841,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,300.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,O=C(OCCc1ccccc1)N(c1ccccc1)C1CN2CCC1CC2
CHEMBL4443613,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,550.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,O=C(OCCCc1ccccc1)N(c1ccccc1)C1CN2CCC1CC2
CHEMBL4442996,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1150.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(COC(=O)N(c2ccccc2)C2CN3CCC2CC3)cc1
CHEMBL4461216,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,420.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(CCOC(=O)N(c2ccccc2)C2CN3CCC2CC3)cc1
CHEMBL4435123,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,390.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(CCCOC(=O)N(c2ccccc2)C2CN3CCC2CC3)cc1
CHEMBL4576768,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,19.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,O=C(OCc1ccc2c(c1)OCO2)N(c1ccccc1)C1CN2CCC1CC2
CHEMBL4456047,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,290.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,O=C(OCCc1ccc2c(c1)OCO2)N(c1ccccc1)C1CN2CCC1CC2
CHEMBL4446039,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,70.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,O=C(OCc1ccc(Cl)c(Cl)c1)N(c1ccccc1)C1CN2CCC1CC2
CHEMBL4451770,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,260.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,O=C(OCCc1ccc(Cl)c(Cl)c1)N(c1ccccc1)C1CN2CCC1CC2
CHEMBL4435641,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,60.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,O=C(OCCCc1ccc(Cl)c(Cl)c1)N(c1ccccc1)C1CN2CCC1CC2
CHEMBL4473985,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,50.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(COC(=O)N(c2ccccc2)C2CN3CCC2CC3)cc1F
CHEMBL4455481,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,250.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(CCCOC(=O)N(c2ccccc2)C2CN3CCC2CC3)cc1F
CHEMBL4462631,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,20.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,Cc1ccc(COC(=O)N(c2ccccc2)C2CN3CCC2CC3)cc1F
CHEMBL4541518,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,130.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,Cc1ccc(CCCOC(=O)N(c2ccccc2)C2CN3CCC2CC3)cc1F
CHEMBL4577453,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,220.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,O=C(OCCCc1ccc(F)c(F)c1)N(c1ccccc1)C1CN2CCC1CC2
CHEMBL4580590,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,60.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(CCN(C(=O)OC2CN3CCC2CC3)c2ccccc2)cc1OC
CHEMBL4559952,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4360.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(CCN(C(=O)OC2CCCN(C)C2)c2ccccc2)cc1OC
CHEMBL4516350,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1280.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(CCN(C(=O)OC2CCN(C)CC2)c2ccccc2)cc1OC
CHEMBL4541656,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2800.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(CCN(C(=O)OC2C[C@H]3CC[C@H](C2)N3C)c2ccccc2)cc1OC
CHEMBL4585326,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(CCN(C(=O)OC2CN3CCC2CC3)c2ccccc2)cc1
CHEMBL4540291,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1320.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(CCN(C(=O)OC2CCCN(C)C2)c2ccccc2)cc1
CHEMBL4456775,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,570.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(CCN(C(=O)OC2CCN(C)CC2)c2ccccc2)cc1
CHEMBL4545030,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,270.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,COc1ccc(CCN(C(=O)OC2C[C@H]3CC[C@H](C2)N3C)c2ccccc2)cc1
CHEMBL4519301,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.6,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,O=C(OC1CN2CCC1CC2)N(CCc1ccc(F)cc1)c1ccccc1
CHEMBL4448667,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,350.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,CN1CCCC(OC(=O)N(CCc2ccc(F)cc2)c2ccccc2)C1
CHEMBL4472832,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,140.0,nM,CHEMBL4373112,B,Displacement of [3H]NMS from human M3 AChR expressed in CHO cell membranes after 1 to 2 hrs by liquid scintillation spectrometry method,CHEMBL4371071,KI,CN1CCC(OC(=O)N(CCc2ccc(F)cc2)c2ccccc2)CC1
CHEMBL1724,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.3,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,C[N+]1(C)CCCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1.[Br-]
CHEMBL4440620,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.[Br-]
CHEMBL1201027,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.81,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1.[Br-]
CHEMBL551466,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.56,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1cccs1)c1cccs1.[Br-]
CHEMBL4461243,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.88,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCOc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4442329,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.8,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCOc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4457734,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.65,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCSc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4576060,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,41.0,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCCOc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4567385,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,42.0,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCOCc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4591883,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,81.0,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(Cc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4540604,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.86,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4448944,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.44,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4474694,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.7,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCCc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4436947,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,17.0,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCCCc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4436930,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.1,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCc3cccc(F)c3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4452706,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.5,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCc3cccc(Cl)c3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4470924,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,20.0,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCc3cccc(Br)c3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4541647,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.8,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCc3cccc(I)c3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4463636,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.9,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,Cc1cccc(CCC[N+]23CCC(CC2)C(OC(=O)C(O)(c2ccccc2)c2ccccc2)C3)c1.[Br-]
CHEMBL4441041,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,19.0,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCc3cccc(C(F)(F)F)c3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4450188,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.7,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCc3ccc(F)cc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4519930,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.51,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCc3ccc(Cl)cc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4539799,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.6,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCc3ccc(Br)cc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4590868,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.86,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,Cc1ccc(CCC[N+]23CCC(CC2)C(OC(=O)C(O)(c2ccccc2)c2ccccc2)C3)cc1.[Br-]
CHEMBL4516342,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.3,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCc3ccc(C(F)(F)F)cc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4545504,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.8,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,COc1ccc(CCC[N+]23CCC(CC2)C(OC(=O)C(O)(c2ccccc2)c2ccccc2)C3)cc1.[Br-]
CHEMBL4521993,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.5,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(OC1C[N+]2(CCCc3ccc(OC(F)(F)F)cc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4483083,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.4,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(O[C@H]1C[N+]2(CCCc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4514058,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,184.0,nM,CHEMBL4390203,B,Displacement of [3H]NMS from human M3R expressed in CHOK1 cell membranes incubated for 2 hrs by microbeta scintillation counting method,CHEMBL4387754,KI,O=C(O[C@@H]1C[N+]2(CCCc3ccccc3)CCC1CC2)C(O)(c1ccccc1)c1ccccc1.[Br-]
CHEMBL4572614,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,9200.0,nM,CHEMBL4392153,B,Displacement of [3H]-QNB/[3H]-NMS from human muscarinic M3 receptor expressed in stable CHO cells after 90 mins by microbeta scintillation counting method,CHEMBL4390674,KI,Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F
CHEMBL4466483,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2700.0,nM,CHEMBL4392153,B,Displacement of [3H]-QNB/[3H]-NMS from human muscarinic M3 receptor expressed in stable CHO cells after 90 mins by microbeta scintillation counting method,CHEMBL4390674,KI,FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12
CHEMBL4084262,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,514.0,nM,CHEMBL4397397,B,Displacement of [3H]-QNB/[3H]-NMS from human muscarinic M3 receptor expressed in stable CHO cells after 90 mins by microbeta scintillation counting method,CHEMBL4396871,KI,COc1ccccc1N1CCC2(CCN(CCCSc3nnc(-c4ccccc4)n3C)CC2)CC1
CHEMBL279453,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,66.07,nM,CHEMBL4397757,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in stable CHO-K1 cells by radioligand binding assay,CHEMBL4396879,KI,CCCN(CCC)CC1CCCCN1CCNC(=O)N1c2ccccc2C(=O)Nc2cccnc21
CHEMBL43383,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,63.1,nM,CHEMBL4397757,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in stable CHO-K1 cells by radioligand binding assay,CHEMBL4396879,KI,CCN(CC)CCCCC1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1
CHEMBL4468100,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,776.25,nM,CHEMBL4397778,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K1 cells by scintillation counting method,CHEMBL4396879,KI,CCCC(C)(C)C(=O)N(CC)CCCC1CCN(CC(=O)N2c3ccc(Cl)cc3C(=O)Nc3cccnc32)CC1
CHEMBL4448108,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,38.02,nM,CHEMBL4397783,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K1 cells after 3 hrs by beta counting method,CHEMBL4396879,KI,CN(CCCCCCCCN(C)CCCCCCN(CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CC(=O)N1c2ccccc2C(=O)Nc2cccnc21)CCCCCCNCC(=O)N1c2ncccc2NC(=O)c2cccnc21
CHEMBL295388,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.0,nM,CHEMBL4397788,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in mouse A9L cell membranes after 60 mins by scintillation counting method,CHEMBL4396879,KI,CCN(CC)CCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1
CHEMBL4455570,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,13.18,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CN1CC=C(c2nsnc2OCCCN2CCN(CCCCC3CCN(CC(=O)N4c5ccccc5NC(=O)c5ccccc54)CC3)CC2)CC1
CHEMBL4471882,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,28.18,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CCC(=O)NCc1cc(C(=O)NCCN2CCC(N3CCC(n4c(=O)[nH]c5ccccc54)CC3)CC2)cc(C(=O)NCCN2CCN(CCCCC3CCN(CC(=O)N4c5ccccc5NC(=O)c5ccccc54)CC3)CC2)c1
CHEMBL43383,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,100.0,nM,CHEMBL4397762,B,Binding affinity to muscarinic M3 receptor (unknown origin) expressed in CHO cells,CHEMBL4396879,KI,CCN(CC)CCCCC1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1
CHEMBL4440484,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,398.11,nM,CHEMBL4397762,B,Binding affinity to muscarinic M3 receptor (unknown origin) expressed in CHO cells,CHEMBL4396879,KI,CCCC(C)(C)C(=O)N(CC)CCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1
CHEMBL4548432,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,154.88,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4454300,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,13.49,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4589047,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,35.48,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4568151,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,61.66,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4567026,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,151.36,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4569639,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,27.54,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4554682,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,44.67,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4451383,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,16.22,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4515788,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,28.18,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4540949,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,48.98,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4582879,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,109.65,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4456524,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1380.38,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F
CHEMBL4582069,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1584.89,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F
CHEMBL4555411,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1148.15,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F
CHEMBL4562770,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1621.81,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4443219,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,660.69,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4544820,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10000.0,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4543584,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5011.87,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4451030,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6760.83,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4454134,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2691.53,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4461081,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5495.41,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4439675,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,954.99,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4565234,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,776.25,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4564922,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,645.65,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4537517,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1258.93,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,N=C(N)NCCC[C@H](N)C(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4450522,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1479.11,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4569929,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5370.32,nM,CHEMBL4397795,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO-K9 cells after 3 hrs by microbeta2 scintillation counting method,CHEMBL4396879,KI,CCC(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F
CHEMBL1346,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.74,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1
CHEMBL4644670,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.36,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccccc1-c1ccccc1)O[C@H]1CN2CCC1CC2
CHEMBL4636302,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.47,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccccc1-c1ccccc1)OCC1CCNCC1
CHEMBL4635566,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,11.0,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccccc1-c1ccc(Cl)cc1)OCC1CCNCC1
CHEMBL4640544,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.9,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccccc1-c1cc(F)c(F)c(F)c1)OCC1CCNCC1
CHEMBL4644192,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.17,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,C[N@+]12CC[C@H](CC1)[C@@H](OC(=O)Nc1ccccc1-c1ccccc1)C2.O=C([O-])C(F)(F)F
CHEMBL4644852,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.63,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccc(F)cc1-c1ccccc1)OCC1CCNCC1
CHEMBL4646717,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,30.0,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccc(F)cc1-c1ccccc1Cl)OCC1CCNCC1
CHEMBL4648196,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.0,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccc(F)cc1-c1ccc(F)cc1)OCC1CCNCC1
CHEMBL4632545,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,14.0,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccc(F)cc1-c1ccc(Cl)cc1)OCC1CCNCC1
CHEMBL4633165,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.0,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccc(F)cc1-c1ccc(Br)cc1)OCC1CCNCC1
CHEMBL4636009,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2000.0,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,N#Cc1ccc(-c2cc(F)ccc2NC(=O)OCC2CCNCC2)cc1
CHEMBL4641288,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,84.0,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,COc1ccc(-c2cc(F)ccc2NC(=O)OCC2CCNCC2)cc1
CHEMBL4649201,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.25,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccc(F)cc1-c1ccc(Cl)c(Cl)c1)OCC1CCNCC1
CHEMBL4637155,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.6,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccc(F)cc1-c1cc(F)c(F)c(F)c1)OCC1CCNCC1
CHEMBL4643867,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.53,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccc(F)cc1-c1ccc(Cl)c(Cl)c1)O[C@H]1CN2CCC1CC2
CHEMBL4648071,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.39,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccc(F)cc1-c1cccc(Cl)c1)O[C@H]1CN2CCC1CC2
CHEMBL4640324,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.35,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccc(F)cc1-c1ccc(F)c(Cl)c1)O[C@H]1CN2CCC1CC2
CHEMBL4640703,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.084,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccc(F)cc1-c1cccc(Cl)c1)OCC1CCNCC1
CHEMBL4636528,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.069,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccc(F)cc1-c1ccc(F)c(Cl)c1)OCC1CCNCC1
CHEMBL4644999,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.5,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccc(F)cc1-c1cc(Cl)cc(Cl)c1)OCC1CCNCC1
CHEMBL4647437,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.072,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,C[N+]12CCC(CC1)[C@@H](OC(=O)Nc1ccc(F)cc1-c1cccc(Cl)c1)C2.O=C[O-]
CHEMBL4633816,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.07,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,C[N+]12CCC(CC1)[C@@H](OC(=O)Nc1ccc(F)cc1-c1ccc(F)c(Cl)c1)C2.O=C[O-]
CHEMBL4636887,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.7,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,C[N+]1(C)CCC(COC(=O)Nc2ccc(F)cc2-c2cccc(Cl)c2)CC1.O=C[O-]
CHEMBL4645235,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.7,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,C[N+]1(C)CCC(COC(=O)Nc2ccc(F)cc2-c2ccc(F)c(Cl)c2)CC1.O=C[O-]
CHEMBL4645543,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.34,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccc(F)cc1-c1ccccc1)O[C@H]1CN2CCC1CC2
CHEMBL4643643,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.1,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,CN1[C@@H]2CC[C@H]1C[C@H](OC(=O)Nc1ccc(F)cc1-c1ccccc1)C2
CHEMBL4639938,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.65,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,CN1[C@@H]2C[C@H](OC(=O)Nc3ccc(F)cc3-c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12
CHEMBL4632615,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.3,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,O=C(Nc1ccc(F)cc1-c1ccccc1)N[C@H]1CN2CCC1CC2
CHEMBL4637749,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,19.0,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,C[N@+]12CC[C@H](CC1)[C@@H](NC(=O)Nc1ccc(F)cc1-c1ccccc1)C2.O=C([O-])C(F)(F)F
CHEMBL4639307,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.23,nM,CHEMBL4605227,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor transiently expressed in HEK293T cell membranes incubated for 1 hr by scintillation counting method,CHEMBL4602697,KI,C[N@+]12CC[C@H](CC1)[C@@H](OC(=O)Nc1ccc(F)cc1-c1ccccc1)C2.O=C([O-])C(F)(F)F
CHEMBL4642045,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,85.11,nM,CHEMBL4605353,B,Displacement of [3H]-NMS from human muscarinic M3 receptor stably expressed in CHO-K9 cells by radioligand competitive binding assay,CHEMBL4602702,KI,Cc1cc(/C=C/C=C/c2ccc(N(C)C)cc2)cc(C)[n+]1CCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1.O=C(O)C(F)(F)F.O=C([O-])C(F)(F)F
CHEMBL4634575,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,630.96,nM,CHEMBL4605353,B,Displacement of [3H]-NMS from human muscarinic M3 receptor stably expressed in CHO-K9 cells by radioligand competitive binding assay,CHEMBL4602702,KI,C[N+]1=C(/C=C/C=C/C=C2/N(CCCCCC(=O)NCCCCC3CCN(CC(=O)N4c5ccccc5NC(=O)c5ccccc54)CC3)c3ccccc3C2(C)C)C(C)(C)c2ccccc21.O=C(O)C(F)(F)F.O=C([O-])C(F)(F)F
CHEMBL4643290,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,870.96,nM,CHEMBL4605353,B,Displacement of [3H]-NMS from human muscarinic M3 receptor stably expressed in CHO-K9 cells by radioligand competitive binding assay,CHEMBL4602702,KI,CC1(C)C(/C=C/C=C/C=C2/N(CCCCCC(=O)NCCCCC3CCN(CC(=O)N4c5ccccc5NC(=O)c5ccccc54)CC3)c3ccccc3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccccc21.O=C(O)C(F)(F)F
CHEMBL4646116,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,147.91,nM,CHEMBL4605353,B,Displacement of [3H]-NMS from human muscarinic M3 receptor stably expressed in CHO-K9 cells by radioligand competitive binding assay,CHEMBL4602702,KI,Cc1cc(/C=C/C=C/c2ccc(N(C)C)cc2)cc(C)[n+]1CCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C([O-])C(F)(F)F
CHEMBL4649420,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,85.11,nM,CHEMBL4605353,B,Displacement of [3H]-NMS from human muscarinic M3 receptor stably expressed in CHO-K9 cells by radioligand competitive binding assay,CHEMBL4602702,KI,C[N+]1=C(/C=C/C=C/C=C2/N(CCCCCC(=O)NCCN3CCN(CCCCC4CCN(CC(=O)N5c6ccccc6NC(=O)c6ccccc65)CC4)CC3)c3ccccc3C2(C)C)C(C)(C)c2ccccc21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C([O-])C(F)(F)F
CHEMBL4641714,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,67.61,nM,CHEMBL4605353,B,Displacement of [3H]-NMS from human muscarinic M3 receptor stably expressed in CHO-K9 cells by radioligand competitive binding assay,CHEMBL4602702,KI,CC1(C)C(/C=C/C=C/C=C2/N(CCCCCC(=O)NCCN3CCN(CCCCC4CCN(CC(=O)N5c6ccccc6NC(=O)c6ccccc65)CC4)CC3)c3ccccc3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccccc21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4641726,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,81.28,nM,CHEMBL4605353,B,Displacement of [3H]-NMS from human muscarinic M3 receptor stably expressed in CHO-K9 cells by radioligand competitive binding assay,CHEMBL4602702,KI,CC1(C)C(/C=C/C=C/C=C2/N(CCCCCC(=O)NCCN3CCN(CCCCC4CCN(CC(=O)N5c6ccccc6NC(=O)c6ccccc65)CC4)CC3)c3ccc(S(=O)(=O)O)cc3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccccc21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4644612,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,154.88,nM,CHEMBL4605353,B,Displacement of [3H]-NMS from human muscarinic M3 receptor stably expressed in CHO-K9 cells by radioligand competitive binding assay,CHEMBL4602702,KI,CC1(C)C(/C=C/C=C/C=C2/N(CCCCCC(=O)NCCNC(=O)CCc3cn(CCCCC4CCN(CC(=O)N5c6ccccc6NC(=O)c6ccccc65)CC4)cn3)c3ccc(S(=O)(=O)O)cc3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccccc21.O=C(O)C(F)(F)F
CHEMBL4636899,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,75.86,nM,CHEMBL4605353,B,Displacement of [3H]-NMS from human muscarinic M3 receptor stably expressed in CHO-K9 cells by radioligand competitive binding assay,CHEMBL4602702,KI,CC1(C)C(/C=C/C=C/C=C2/N(CCCCCC(=O)NCc3cc(C(=O)NCCNC(=O)CCc4cn(CCCCC5CCN(CC(=O)N6c7ccccc7NC(=O)c7ccccc76)CC5)cn4)cc(C(=O)NCCNC(=O)CCc4cn(CCCCC5CCN(CC(=O)N6c7ccccc7NC(=O)c7ccccc76)CC5)cn4)c3)c3ccc(S(=O)(=O)O)cc3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccccc21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4641328,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,16.98,nM,CHEMBL4605353,B,Displacement of [3H]-NMS from human muscarinic M3 receptor stably expressed in CHO-K9 cells by radioligand competitive binding assay,CHEMBL4602702,KI,NCc1cc(C(=O)NCCN2CCC(N3CCC(n4c(=O)[nH]c5ccccc54)CC3)CC2)cc(C(=O)NCCN2CCN(CCCCC3CCN(CC(=O)N4c5ccccc5NC(=O)c5ccccc54)CC3)CC2)c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4643273,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,21.88,nM,CHEMBL4605353,B,Displacement of [3H]-NMS from human muscarinic M3 receptor stably expressed in CHO-K9 cells by radioligand competitive binding assay,CHEMBL4602702,KI,CC1(C)C(/C=C/C=C/C=C2/N(CCCCCC(=O)NCc3cc(C(=O)NCCN4CCC(N5CCC(n6c(=O)[nH]c7ccccc76)CC5)CC4)cc(C(=O)NCCN4CCN(CCCCC5CCN(CC(=O)N6c7ccccc7NC(=O)c7ccccc76)CC5)CC4)c3)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)=[N+](CCCCS(=O)(=O)O)c2ccccc21.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4636083,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,144.54,nM,CHEMBL4605353,B,Displacement of [3H]-NMS from human muscarinic M3 receptor stably expressed in CHO-K9 cells by radioligand competitive binding assay,CHEMBL4602702,KI,NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4648229,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,14.45,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1COC[C@@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL4634230,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.8511,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)CC1COCC(c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL4645019,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1698.24,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1COC[C@@H](c2ccc(Sc3ccccc3)cc2)O1.[I-]
CHEMBL4643329,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1318.26,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1COC[C@@H](c2ccc([S+]([O-])c3ccccc3)cc2)O1.[I-]
CHEMBL4633895,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2344.23,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1COC[C@@H](c2ccc(S(=O)(=O)c3ccccc3)cc2)O1.[I-]
CHEMBL4637485,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7244.36,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1CO[C@H](c2ccccc2)CO1.[I-]
CHEMBL4634066,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,134.9,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1COC(c2ccccc2)(c2ccccc2)CO1.[I-]
CHEMBL4635385,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,37.15,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1CO[C@@](c2ccccc2)(C2CCCCC2)CO1.[I-]
CHEMBL4648444,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,43.65,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1CO[C@](c2ccccc2)(C2CCCCC2)CO1.[I-]
CHEMBL4648657,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1698.24,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1CO[C@H](C(c2ccccc2)c2ccccc2)CO1.[I-]
CHEMBL4638935,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2398.83,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1CO[C@@H](C(c2ccccc2)c2ccccc2)CO1.[I-]
CHEMBL4638067,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2238.72,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1CO[C@H](c2ccc(Cc3ccccc3)cc2)CO1.[I-]
CHEMBL4633679,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,977.24,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1CO[C@H](c2ccc(Sc3ccccc3)cc2)CO1.[I-]
CHEMBL4640846,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4466.84,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1CO[C@@H](c2ccc(Sc3ccccc3)cc2)CO1.[I-]
CHEMBL4634475,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1318.26,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1CO[C@@H](c2ccc([S+]([O-])c3ccccc3)cc2)CO1.[I-]
CHEMBL4648218,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7244.36,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1CO[C@H](c2ccc(S(=O)(=O)c3ccccc3)cc2)CO1.[I-]
CHEMBL4647816,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4677.35,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1CO[C@@H](c2ccccc2)[C@H](c2ccccc2)O1.[I-]
CHEMBL4646457,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1548.82,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1CO[C@H](c2ccccc2)[C@@H](c2ccccc2)O1.[I-]
CHEMBL4639004,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,354.81,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1CO[C@@H](c2ccccc2)[C@@H](c2ccccc2)O1.[I-]
CHEMBL4637731,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1995.26,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1CO[C@H](c2ccccc2)C(c2ccccc2)(c2ccccc2)O1.[I-]
CHEMBL4639297,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1096.48,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1CO[C@@H](c2ccccc2)C(c2ccccc2)(c2ccccc2)O1.[I-]
CHEMBL3084748,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.023,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,O=C(O[C@H]1C[C@H]2CC[C@@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1.[Cl-]
CHEMBL4645580,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.8913,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@H]1COC[C@@](c2ccccc2)(C2CCCCC2)O1.[I-]
CHEMBL4649224,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.905,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,CN(C)CC1COCC(c2ccccc2)(C2CCCCC2)O1
CHEMBL4644285,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,186.21,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,CN(C)C[C@@H]1COC[C@](c2ccccc2)(C2CCCCC2)O1
CHEMBL4635500,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.955,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,CN(C)C[C@H]1COC[C@@](c2ccccc2)(C2CCCCC2)O1
CHEMBL4648939,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,30.9,nM,CHEMBL4615172,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes incubated for 2 hrs by scintillation counting method,CHEMBL4613267,KI,C[N+](C)(C)C[C@@H]1COC[C@](c2ccccc2)(C2CCCCC2)O1
CHEMBL4740422,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,12882.5,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)NCc1cccc(F)c1
CHEMBL4787944,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25703.96,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,Cn1ccc(NC(=O)CCN2CCCc3ccccc32)n1
CHEMBL4796491,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7244.36,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)NCc1cccs1
CHEMBL4778178,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,12022.64,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)NCc1ccco1
CHEMBL4756873,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,29512.09,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)Nc1cccnn1
CHEMBL4777127,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,26302.68,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)Nc1cccc2ccccc12
CHEMBL4752973,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10715.19,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)Nc1ccc(Cl)cc1
CHEMBL4756164,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2570.4,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)NC1CCCC1
CHEMBL4760823,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1737.8,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)NC1CCCCC1
CHEMBL4789054,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,776.25,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)Nc1ccccc1
CHEMBL4748774,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2884.03,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)N1CCCC1
CHEMBL4744856,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,977.24,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,CC1CCN(C(=O)CCN2CCCc3ccccc32)CC1
CHEMBL4791819,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2884.03,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,CC1CCCN(C(=O)CCN2CCCc3ccccc32)C1
CHEMBL4745885,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,32359.37,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,COC1CN(C(=O)CCN2CCCc3ccccc32)C1
CHEMBL4758449,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,11481.54,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)N1CCC1
CHEMBL4758633,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,43651.58,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)N1CCC[C@H]1CO
CHEMBL4760037,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,32359.37,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)N1CCCC1CO
CHEMBL4763304,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4570.88,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(O)C1CCCN1C(=O)CCN1CCCc2ccccc21
CHEMBL4758316,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5248.07,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)N1CCCC(CO)C1
CHEMBL4763422,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,31622.78,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)N1CCCCC1CO
CHEMBL4756442,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,33113.11,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)N1CCC(O)CC1
CHEMBL4792360,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,53703.18,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CCN1CCCc2ccccc21)N1CCCC(O)C1
CHEMBL4760150,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,54954.09,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,CC1CCCC(C)N1C(=O)CCN1CCCc2ccccc21
CHEMBL4758635,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3548.13,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,C[C@@H]1CCC[C@H](C)N1C(=O)CCN1CCCc2ccccc21
CHEMBL4747590,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8511.38,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,CC1CCCCN1C(=O)CCN1CCCc2ccccc21
CHEMBL4756237,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,85113.8,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CN1CCCc2cnccc21)N1CCCC1
CHEMBL4792675,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,95499.26,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CN1CCc2ccc(F)cc21)N1CCCC1
CHEMBL4777543,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7413.1,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CN1CCCc2ccccc21)N1CCCC1
CHEMBL4745429,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,79432.82,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,CC1Cc2ccccc2N1CC(=O)N1CCCC1
CHEMBL4787283,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,66069.34,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,Cc1ccc2c(c1)CCCN2CC(=O)N1CCCCC1
CHEMBL4786868,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,60255.96,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CN1CCCc2cnccc21)N1CCCCC1
CHEMBL4758742,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,44668.36,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,CCn1c2ccccc2c2ccc(NCC(=O)N3CCCCC3)cc21
CHEMBL4762056,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10964.78,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,O=C(CN1CCCc2ccccc21)N1CCCCC1
CHEMBL4760904,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,52480.75,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,CC1CCc2ccccc2N1CC(=O)N1CCCCC1
CHEMBL4759774,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,21877.62,nM,CHEMBL4677118,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in CHO-K1 cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4673268,KI,CC(C)(C)OC(=O)N1CCN(CC(=O)n2c3ccccc3c3ccccc32)CC1
CHEMBL4790083,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.84,nM,CHEMBL4679801,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K1 cell membranes assessed as inhibition constant incubated for 1 hr by Radioligand binding assay,CHEMBL4673395,KI,N#Cc1ccc(N2C3CCC2CN(C(=O)CCS(=O)(=O)c2cccc4ncsc24)C3)nc1
CHEMBL4756833,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,81.28,nM,CHEMBL4716043,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K9 cell membranes measured after 3 hrs by radioligand competition binding assay,CHEMBL4715686,KI,CN(C)c1ccc2c(-c3ccc(C(=O)NCCN4CCN(CCCCC5CCN(CC(=O)N6c7ccccc7NC(=O)c7ccccc76)CC5)CC4)cc3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4748004,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,63.1,nM,CHEMBL4716043,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K9 cell membranes measured after 3 hrs by radioligand competition binding assay,CHEMBL4715686,KI,Cc1cc(/C=C/c2cc3c4c(c2)CCCN4CCC3)cc(C)[n+]1CCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C([O-])C(F)(F)F
CHEMBL4754371,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,85.11,nM,CHEMBL4716043,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K9 cell membranes measured after 3 hrs by radioligand competition binding assay,CHEMBL4715686,KI,Cc1cc(/C=C/C=C/c2ccc(N(C)C)cc2)cc(C)[n+]1CCNC(=O)CCc1cn(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)cn1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C([O-])C(F)(F)F
CHEMBL4744233,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,69.18,nM,CHEMBL4716043,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K9 cell membranes measured after 3 hrs by radioligand competition binding assay,CHEMBL4715686,KI,Cc1cc(/C=C/c2cc3c4c(c2)CCCN4CCC3)cc(C)[n+]1CCNC(=O)CCc1cn(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)cn1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C([O-])C(F)(F)F
CHEMBL4742721,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,37.15,nM,CHEMBL4716043,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K9 cell membranes measured after 3 hrs by radioligand competition binding assay,CHEMBL4715686,KI,O=C(CCCCCNC(=O)COc1ccc(/C=C/C2=[N+]3C(=Cc4ccc(-c5cccs5)n4[B-]3(F)F)C=C2)cc1)NCCNC(=O)CCc1cn(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)cn1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4789147,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,128.82,nM,CHEMBL4716043,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K9 cell membranes measured after 3 hrs by radioligand competition binding assay,CHEMBL4715686,KI,CN(C)c1ccc2c(-c3ccc(C(=O)NCCNC(=O)CCc4cn(CCCCC5CCN(CC(=O)N6c7ccccc7NC(=O)c7ccccc76)CC5)cn4)cc3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4650998,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,147.91,nM,CHEMBL4716043,B,Displacement of [3H]NMS from human recombinant muscarinic receptor M3 expressed in CHO-K9 cell membranes measured after 3 hrs by radioligand competition binding assay,CHEMBL4715686,KI,Cc1cc(/C=C/C=C/c2ccc(N(C)C)cc2)cc(C)[n+]1CCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1
CHEMBL295388,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.0,nM,CHEMBL4716050,B,Displacement of [3H]-NMS from muscarinic M3 receptor (unknown origin) expressed in A9 cells by scintillation counting analysis,CHEMBL4715686,KI,CCN(CC)CCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1
CHEMBL295388,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.0,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,CCN(CC)CCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1
CHEMBL4596899,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1258.93,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1
CHEMBL4596065,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6309.57,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCCCC1CCN(CC(=O)N2c3ccccc3NC(=O)c3ccccc32)CC1
CHEMBL4597498,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,100.0,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCN1CCN(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1
CHEMBL4059733,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,63.1,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,CCC(=O)NCCNC(=O)CCc1cn(CCCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)cn1
CHEMBL4448933,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,676.08,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,Nc1ccccc1C(=O)N1CCC(N2CCC(Cc3ccc(S(=O)(=O)c4cccc(Cl)c4)cc3)CC2)CC1
CHEMBL4850130,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,251.19,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,N=C(N)NCCC[C@@H](N)C(=O)NCCN1CCN(CCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4862996,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1202.26,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,CC(=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NCCN1CCN(CCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4876453,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,173.78,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,CC(=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NCCN1CCN(CCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4854886,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1318.26,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,CC(=O)N[C@@H](CCCN)C(=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NCCN1CCN(CCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4856659,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1148.15,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,CC(=O)N[C@H](CCCN)C(=O)NC(=O)[C@H](C)NC(=O)[C@H](CCNC(=N)N)NCCN1CCN(CCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4852868,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,645.65,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,CC(=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(=N)N)N[C@H](CCCN)C(=O)NCCN1CCN(CCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4872608,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,758.58,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,CC(=O)N[C@@H](CCCN)C(=O)NC(=O)[C@H](C)NC(=O)[C@@H](CCCNC(=N)N)NCCN1CCN(CCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4862098,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10471.29,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,CC(=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NCCN1CCN(CCC(=O)NC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4869723,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,9549.93,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,CC(=O)N[C@@H](CCCN)C(=O)NC(=O)[C@H](C)NC(=O)[C@H](CCNC(=N)N)NCCN1CCN(CCC(=O)NC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4865939,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,8511.38,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,CC(=O)N[C@H](CCCN)C(=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NCCN1CCN(CCC(=O)NC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4850553,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,9332.54,nM,CHEMBL4815611,B,Displacement of [3H]-NMS from human muscarinic M3 receptor expressed in CHO cell membranes assessed as inhibition constant by radioligand competition analysis,CHEMBL4813954,KI,CC(=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NCCN1CCN(C(=O)CCCC2CCN(CC(=O)N3c4ccccc4NC(=O)c4ccccc43)CC2)CC1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL4871517,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL4817487,B,Displacement of [3H]-N-methylscopolamine from human muscarinic M3 receptor,CHEMBL4814011,KI,O=C(N[C@@H](c1ccccc1)c1ccc(-c2cccc(OCc3ccc(C(=O)NCCCNC[C@H](O)c4ccc(O)c5[nH]c(=O)ccc45)cc3)c2)cc1)O[C@H]1CN2CCC1CC2
CHEMBL4847910,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1259,nM,CHEMBL4817487,B,Displacement of [3H]-N-methylscopolamine from human muscarinic M3 receptor,CHEMBL4814011,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1)O[C@H]1CN2CCC1CC2
CHEMBL4857743,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.981,nM,CHEMBL4817487,B,Displacement of [3H]-N-methylscopolamine from human muscarinic M3 receptor,CHEMBL4814011,KI,O=C(N[C@H](c1ccccc1)c1cccc(OCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1)O[C@H]1CN2CCC1CC2
CHEMBL4874819,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3981,nM,CHEMBL4817487,B,Displacement of [3H]-N-methylscopolamine from human muscarinic M3 receptor,CHEMBL4814011,KI,O=C(NC(c1ccccc1)c1cccc(OCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1)O[C@H]1CN2CCC1CC2
CHEMBL4863525,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL4817487,B,Displacement of [3H]-N-methylscopolamine from human muscarinic M3 receptor,CHEMBL4814011,KI,O=C(NC(c1ccccc1)c1cccc(OCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1)O[C@H]1CN2CCC1CC2
CHEMBL4854418,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3981,nM,CHEMBL4817487,B,Displacement of [3H]-N-methylscopolamine from human muscarinic M3 receptor,CHEMBL4814011,KI,O=C(NC(c1ccccc1)c1cccc(OCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1)O[C@H]1CN2CCC1CC2
CHEMBL4852629,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1585,nM,CHEMBL4817487,B,Displacement of [3H]-N-methylscopolamine from human muscarinic M3 receptor,CHEMBL4814011,KI,O=C(NC(c1ccccc1)c1cccc(OCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1)O[C@H]1CN2CCC1CC2
CHEMBL4846536,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2512,nM,CHEMBL4817487,B,Displacement of [3H]-N-methylscopolamine from human muscarinic M3 receptor,CHEMBL4814011,KI,O=C(NC(c1ccccc1)c1cccc(OCCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)c1)O[C@H]1CN2CCC1CC2
CHEMBL4878395,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.0,nM,CHEMBL4817487,B,Displacement of [3H]-N-methylscopolamine from human muscarinic M3 receptor,CHEMBL4814011,KI,O=C(NC(c1ccccc1)c1ccc(OCCCCCCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1)O[C@H]1CN2CCC1CC2
CHEMBL4866806,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2512,nM,CHEMBL4817487,B,Displacement of [3H]-N-methylscopolamine from human muscarinic M3 receptor,CHEMBL4814011,KI,CCN(CCCNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12)C(=O)c1ccc(COc2cccc(-c3ccc([C@@H](NC(=O)O[C@H]4CN5CCC4CC5)c4ccccc4)cc3)c2)cc1
CHEMBL4871702,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1259,nM,CHEMBL4817487,B,Displacement of [3H]-N-methylscopolamine from human muscarinic M3 receptor,CHEMBL4814011,KI,O=C(N[C@@H](c1ccccc1)c1ccc(-c2cccc(OCc3ccc(C(=O)N(CCCNC[C@H](O)c4ccc(O)c5[nH]c(=O)ccc45)Cc4ccccc4)cc3)c2)cc1)O[C@H]1CN2CCC1CC2
CHEMBL4854091,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1259,nM,CHEMBL4817487,B,Displacement of [3H]-N-methylscopolamine from human muscarinic M3 receptor,CHEMBL4814011,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1)O[C@H]1CN2CCC1CC2
CHEMBL4878138,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.981,nM,CHEMBL4817487,B,Displacement of [3H]-N-methylscopolamine from human muscarinic M3 receptor,CHEMBL4814011,KI,COc1cc(C(=O)NCCN2CCC(OC(=O)Nc3ccccc3-c3ccccc3)CC2)c(Cl)cc1CNC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12
CHEMBL4869096,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.259,nM,CHEMBL4817487,B,Displacement of [3H]-N-methylscopolamine from human muscarinic M3 receptor,CHEMBL4814011,KI,O=C(NC(c1ccccc1)c1ccccc1)O[C@H]1CN2CCC1CC2
CHEMBL4535474,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,972.03,nM,CHEMBL4880059,B,GPCRScan assay: inhibition of M3,CHEMBL4507273,KI,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
CHEMBL4535474,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,954.99,nM,CHEMBL4880059,B,GPCRScan assay: inhibition of M3,CHEMBL4507273,KI,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
CHEMBL3480577,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10000.0,nM,CHEMBL4880059,B,GPCRScan assay: inhibition of M3,CHEMBL4507309,KI,Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1
CHEMBL3480577,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1000000000.0,nM,CHEMBL4880059,B,GPCRScan assay: inhibition of M3,CHEMBL4507309,KI,Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1
CHEMBL5078680,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.7943,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,O=C(O[C@@H](Cc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1)c1cccc(NC(C(=O)O[C@H]2CN3CCC2CC3)c2ccccc2)c1
CHEMBL5081214,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.259,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,O=C(O[C@@H](Cc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1)c1cccc(S(=O)(=O)NC(C(=O)O[C@H]2CN3CCC2CC3)c2ccccc2)c1
CHEMBL5086895,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.631,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,O=C(O[C@@H](Cc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1)c1cccc(CNC(C(=O)O[C@H]2CN3CCC2CC3)c2ccccc2)c1
CHEMBL5080391,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.259,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,O=C(O[C@@H](Cc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1)c1cccc(CN(C(=O)O[C@H]2CN3CCC2CC3)c2ccccc2)c1
CHEMBL5087564,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3981,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2cccc(NC(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)c2)cc1OC
CHEMBL5094110,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.631,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2cccc(S(=O)(=O)NC(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)c2)cc1OC
CHEMBL5076558,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3981,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2cccc(CNC(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)c2)cc1OC
CHEMBL5088742,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2cccc(CN(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)c2)cc1OC
CHEMBL5077161,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1585,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)cc2)cc1OC
CHEMBL5076680,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)Cc2ccc(CN(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)cc2)cc1OC
CHEMBL5075132,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1585,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)cc2F)cc1OC
CHEMBL5076266,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1995,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(F)c(CN(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)c2)cc1OC
CHEMBL5070876,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)cc1OC
CHEMBL5091461,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1259,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3F)s2)cc1OC
CHEMBL5084383,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1995,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN(C(=O)O[C@H]3CN4CCC3CC4)c3cccc(F)c3)s2)cc1OC
CHEMBL5069430,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.943,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN(C(=O)O[C@H]3CN4CCC3CC4)c3cccnc3)s2)cc1OC
CHEMBL5085166,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.5012,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN(C(=O)O[C@H]3CN4CCC3CC4)c3ccccn3)s2)cc1OC
CHEMBL5086272,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.7943,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN(C(=O)O[C@H]3CN4CCC3CC4)c3nccs3)s2)cc1OC
CHEMBL5077250,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.162,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN(C(=O)O[C@H]3CN4CCC3CC4)c3cccc(C(F)F)c3)s2)cc1OC
CHEMBL5086769,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN(C(=O)O[C@H]3CN4CCC3CC4)c3cccc(O)c3)s2)cc1OC
CHEMBL5090179,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2512,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1cc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3F)s2)ccc1OC(F)F
CHEMBL5084829,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,CCOc1cc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3F)s2)ccc1OC(F)F
CHEMBL5085717,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,CC(C)Oc1cc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3F)s2)ccc1OC(F)F
CHEMBL5090464,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1995,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,O=C(O[C@@H](Cc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1)c1ccc(CN(C(=O)O[C@H]2CN3CCC2CC3)c2ccccc2F)s1
CHEMBL5076558,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1585,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2cccc(CNC(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)c2)cc1OC
CHEMBL5076558,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1995,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2cccc(CNC(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)c2)cc1OC
CHEMBL5074599,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1259,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)cc1OC
CHEMBL5074599,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.0631,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)cc1OC
CHEMBL5076637,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3F)s2)cc1OC
CHEMBL5076637,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1585,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3F)s2)cc1OC
CHEMBL5077424,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.631,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN(C)C(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)cc1OC
CHEMBL5077424,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.631,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN(C)C(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)cc1OC
CHEMBL5076886,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.5012,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)OC3C[C@H]4CC[C@H](C3)N4C)c3ccccc3)s2)cc1OC
CHEMBL5076886,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.0,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)OC3C[C@H]4CC[C@H](C3)N4C)c3ccccc3)s2)cc1OC
CHEMBL5086393,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.0,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)OC3CCN(C)CC3)c3ccccc3)s2)cc1OC
CHEMBL5086393,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2512,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)OC3CCN(C)CC3)c3ccccc3)s2)cc1OC
CHEMBL5074216,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.943,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)O[C@@H]3CCN(C)C3)c3ccccc3)s2)cc1OC
CHEMBL5074216,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1259,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)O[C@@H]3CCN(C)C3)c3ccccc3)s2)cc1OC
CHEMBL5078006,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.31,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)OC[C@H]3CN4CCC3CC4)c3ccccc3)s2)cc1OC
CHEMBL5078006,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.5012,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)OC[C@H]3CN4CCC3CC4)c3ccccc3)s2)cc1OC
CHEMBL5081816,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.0,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)OCC3CCN(C)CC3)c3ccccc3)s2)cc1OC
CHEMBL5081816,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)OCC3CCN(C)CC3)c3ccccc3)s2)cc1OC
CHEMBL5076445,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.512,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)OC[C@H]3CCN3C)c3ccccc3)s2)cc1OC
CHEMBL5076445,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1995,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)OC[C@H]3CCN3C)c3ccccc3)s2)cc1OC
CHEMBL5076535,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,12.59,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)OCCN(C)C)c3ccccc3)s2)cc1OC
CHEMBL5076535,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3981,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)OCCN(C)C)c3ccccc3)s2)cc1OC
CHEMBL4650755,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1259,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,C[N+]1(C)[C@@H]2C[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12
CHEMBL1621597,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.7943,nM,CHEMBL5034532,B,Displacement of [3H]-N-methyl Scopolamine Chloride from human M3 receptor membranes incubated for 2 hrs by scintillation counting analysis,CHEMBL5034004,KI,CC(C)[N+]1(C)[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2
CHEMBL4854091,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1259,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2ccc(CCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5208201,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(NC(c1ccccc1)c1cccc(OCc2ccc(C(=O)OCCCCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5184455,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1259,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2ccc(C(=O)OCCCCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5184598,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.7943,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@H](c1ccccc1)c1cccc(OCc2ccc(C(=O)OCCCCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)cc2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5200448,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.7943,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,COC(=O)c1ccc(COc2cccc([C@@H](NC(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)c2)cc1
CHEMBL5193865,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25.12,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,COC(=O)c1ccc(COc2cccc([C@H](NC(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)c2)cc1
CHEMBL5195203,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.585,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,COC(=O)c1ccc(COc2cccc(C(NC(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)c2)cc1
CHEMBL5202567,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.943,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2ccc(C(=O)O)cc2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5202787,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.943,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2cccc(C(=O)O)c2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5170720,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25.12,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2ccc(C(=O)O)o2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5181855,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.943,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2nc(C(=O)O)co2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5195224,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.943,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2csc(C(=O)O)c2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5187593,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.981,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2nc(C(=O)O)cs2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5202045,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.31,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2cc(C(=O)O)co2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5178217,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.162,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,Cn1nc(COc2cccc([C@@H](NC(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)c2)cc1C(=O)O
CHEMBL5207792,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,10.0,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2cnc(C(=O)O)cn2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5179380,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.162,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2ccc(C(=O)O)nc2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5194569,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.981,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2ccc(C(=O)O)c(F)c2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5193776,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.012,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2ccc(C(=O)O)cc2F)c1)O[C@H]1CN2CCC1CC2
CHEMBL5180420,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,199.53,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,COc1cc(C(=O)O)ccc1COc1cccc([C@@H](NC(=O)O[C@H]2CN3CCC2CC3)c2ccccc2)c1
CHEMBL5177499,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.0,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OC[C@H]2CC[C@H](C(=O)O)CC2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5190387,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.0631,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2ccc(C(=O)OCCCCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)o2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5172865,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.0631,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,Cn1nc(C(=O)OCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)cc1COc1cccc([C@@H](NC(=O)O[C@H]2CN3CCC2CC3)c2ccccc2)c1
CHEMBL5208957,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1585,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2nc(C(=O)OCCCCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)co2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5193853,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.07943,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,O=C(N[C@@H](c1ccccc1)c1cccc(OCc2cccc(C(=O)OCCCCNC[C@H](O)c3ccc(O)c4[nH]c(=O)ccc34)c2)c1)O[C@H]1CN2CCC1CC2
CHEMBL5200887,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1995,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,COc1cc(C(=O)OCCCCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1COc1cccc([C@@H](NC(=O)O[C@H]2CN3CCC2CC3)c2ccccc2)c1
CHEMBL5203937,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,39.81,nM,CHEMBL5129799,B,Displacement of [3H]-methylscopolamine from human muscarinic M3 receptor expressed in CHO-K1 cell membrane measured after 2 hr by Cheng-prusoff equation analysis,CHEMBL5126603,KI,Cn1nc(C(=O)O)cc1COc1cccc([C@@H](NC(=O)O[C@H]2CN3CCC2CC3)c2ccccc2)c1
CHEMBL2426364,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,890.0,nM,CHEMBL5214482,B,Selectivity interaction (NIMH Psychoactive Drug Screening Program Selectivity Panel (radioligand binding assay)) EUB0000214b CHRM3,CHEMBL5212743,KI,O=C(c1ccc(C(=O)N2CCC(N3CCCC3)CC2)c(Nc2ccccc2)c1)N1CCC(N2CCCC2)CC1
CHEMBL5219452,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1515.0,nM,CHEMBL5216400,B,Binding affinity to Muscarinic acetylcholine receptor M3 (unknown origin) assessed as inhibition constant,CHEMBL5214927,KI,CNC(=O)Oc1cccc2c1CCC1C2CCN1CCC1CCCCC1
CHEMBL5274390,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4.3,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,O=C(Nc1ccc(F)cc1-c1ccc(F)c(Cl)c1)OC1CCNCC1
CHEMBL4636528,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.064,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,O=C(Nc1ccc(F)cc1-c1ccc(F)c(Cl)c1)OCC1CCNCC1
CHEMBL5282659,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.6,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,NCCCCCCN1CCC(OC(=O)Nc2ccc(F)cc2-c2ccc(F)c(Cl)c2)CC1
CHEMBL5284000,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.28,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,NCCCCCCCCN1CCC(OC(=O)Nc2ccc(F)cc2-c2ccc(F)c(Cl)c2)CC1
CHEMBL5281043,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.081,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,NCCCCCCN1CCC(COC(=O)Nc2ccc(F)cc2-c2ccc(F)c(Cl)c2)CC1
CHEMBL5270870,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.15,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,NCCCCCCCCN1CCC(COC(=O)Nc2ccc(F)cc2-c2ccc(F)c(Cl)c2)CC1
CHEMBL5287315,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.8,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,C#CCCCCCN1CCC(OC(=O)Nc2ccc(F)cc2-c2ccc(F)c(Cl)c2)CC1
CHEMBL5270925,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.0,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,C#CCCCCCCN1CCC(OC(=O)Nc2ccc(F)cc2-c2ccc(F)c(Cl)c2)CC1
CHEMBL5279174,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.77,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,C#CCCCCCN1CCC(COC(=O)Nc2ccc(F)cc2-c2ccc(F)c(Cl)c2)CC1
CHEMBL5265833,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.32,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,C#CCCCCCCN1CCC(COC(=O)Nc2ccc(F)cc2-c2ccc(F)c(Cl)c2)CC1
CHEMBL5277670,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,27.0,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,CN1/C(=C/C=C/C=C/C2=[N+](CCCCCC(=O)NCCCCCCN3CCC(OC(=O)Nc4ccc(F)cc4-c4ccc(F)c(Cl)c4)CC3)c3ccccc3C2(C)C)C(C)(C)c2ccccc21
CHEMBL5289667,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.6,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,CN1/C(=C/C=C/C=C/C2=[N+](CCCCCC(=O)NCCCCCCCCN3CCC(OC(=O)Nc4ccc(F)cc4-c4ccc(F)c(Cl)c4)CC3)c3ccccc3C2(C)C)C(C)(C)c2ccccc21
CHEMBL5273907,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.3,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,CN1/C(=C/C=C/C=C/C2=[N+](CCCCCC(=O)NCCCCCCN3CCC(COC(=O)Nc4ccc(F)cc4-c4ccc(F)c(Cl)c4)CC3)c3ccccc3C2(C)C)C(C)(C)c2ccccc21
CHEMBL5289601,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.2,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,CN1/C(=C/C=C/C=C/C2=[N+](CCCCCC(=O)NCCCCCCCCN3CCC(COC(=O)Nc4ccc(F)cc4-c4ccc(F)c(Cl)c4)CC3)c3ccccc3C2(C)C)C(C)(C)c2ccccc21
CHEMBL5271406,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,14.0,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,CC1(C)C(/C=C/C=C/C=C2/N(CCCCS(=O)(=O)O)c3ccccc3C2(C)C)=[N+](CCCCCC(=O)NCCCCCCCCN2CCC(OC(=O)Nc3ccc(F)cc3-c3ccc(F)c(Cl)c3)CC2)c2ccc(S(=O)(=O)[O-])cc21
CHEMBL5283759,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,6.8,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,CN(C)c1ccc2c(-c3ccc(-c4cn(CCCCCn5cc(CCCCCN6CCC(OC(=O)Nc7ccc(F)cc7-c7ccc(F)c(Cl)c7)CC6)nn5)nn4)cc3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1
CHEMBL5267836,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,12.0,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,CN(C)c1ccc2c(-c3ccc(-c4cn(CCCCCn5cc(CCCCCCN6CCC(OC(=O)Nc7ccc(F)cc7-c7ccc(F)c(Cl)c7)CC6)nn5)nn4)cc3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1
CHEMBL5268503,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.1,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,CN(C)c1ccc2c(-c3ccc(-c4cn(CCCCCn5cc(CCCCCN6CCC(COC(=O)Nc7ccc(F)cc7-c7ccc(F)c(Cl)c7)CC6)nn5)nn4)cc3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1
CHEMBL5285607,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.2,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,CN(C)c1ccc2c(-c3ccc(-c4cn(CCCCCn5cc(CCCCCCN6CCC(COC(=O)Nc7ccc(F)cc7-c7ccc(F)c(Cl)c7)CC6)nn5)nn4)cc3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1
CHEMBL5289083,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,7.7,nM,CHEMBL5239840,B,Displacement of [3H]N-methylscopolamine from human muscarinic M3 receptor expressed in human HEK293T cell membranes by radioligand competition binding based analysis,CHEMBL5236624,KI,CN1/C(=C/C=C/C=C/C2=[N+](CCCCCC(=O)NCCCNCCCCCCN3CCC(COC(=O)Nc4ccc(F)cc4-c4ccc(F)c(Cl)c4)CC3)c3ccccc3C2(C)C)C(C)(C)c2ccccc21
CHEMBL5271406,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.4,nM,CHEMBL5239860,B,Displacement of atropine from human muscarinic M3 receptor expressed in CHO cells incubated for 2 hrs by flow cytometric competition binding assay,CHEMBL5236624,KI,CC1(C)C(/C=C/C=C/C=C2/N(CCCCS(=O)(=O)O)c3ccccc3C2(C)C)=[N+](CCCCCC(=O)NCCCCCCCCN2CCC(OC(=O)Nc3ccc(F)cc3-c3ccc(F)c(Cl)c3)CC2)c2ccc(S(=O)(=O)[O-])cc21
CHEMBL5285607,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.3,nM,CHEMBL5239860,B,Displacement of atropine from human muscarinic M3 receptor expressed in CHO cells incubated for 2 hrs by flow cytometric competition binding assay,CHEMBL5236624,KI,CN(C)c1ccc2c(-c3ccc(-c4cn(CCCCCn5cc(CCCCCCN6CCC(COC(=O)Nc7ccc(F)cc7-c7ccc(F)c(Cl)c7)CC6)nn5)nn4)cc3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1
CHEMBL5271406,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.138,nM,CHEMBL5239860,B,Displacement of atropine from human muscarinic M3 receptor expressed in CHO cells incubated for 2 hrs by flow cytometric competition binding assay,CHEMBL5236624,KI,CC1(C)C(/C=C/C=C/C=C2/N(CCCCS(=O)(=O)O)c3ccccc3C2(C)C)=[N+](CCCCCC(=O)NCCCCCCCCN2CCC(OC(=O)Nc3ccc(F)cc3-c3ccc(F)c(Cl)c3)CC2)c2ccc(S(=O)(=O)[O-])cc21
CHEMBL5285607,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.188,nM,CHEMBL5239860,B,Displacement of atropine from human muscarinic M3 receptor expressed in CHO cells incubated for 2 hrs by flow cytometric competition binding assay,CHEMBL5236624,KI,CN(C)c1ccc2c(-c3ccc(-c4cn(CCCCCn5cc(CCCCCCN6CCC(COC(=O)Nc7ccc(F)cc7-c7ccc(F)c(Cl)c7)CC6)nn5)nn4)cc3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1
CHEMBL5271406,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.14,nM,CHEMBL5239861,B,Displacement of tiotropium bromide from human muscarinic M3 receptor expressed in CHO cells incubated for 4 hrs by flow cytometric competition binding assay,CHEMBL5236624,KI,CC1(C)C(/C=C/C=C/C=C2/N(CCCCS(=O)(=O)O)c3ccccc3C2(C)C)=[N+](CCCCCC(=O)NCCCCCCCCN2CCC(OC(=O)Nc3ccc(F)cc3-c3ccc(F)c(Cl)c3)CC2)c2ccc(S(=O)(=O)[O-])cc21
CHEMBL5285607,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.15,nM,CHEMBL5239861,B,Displacement of tiotropium bromide from human muscarinic M3 receptor expressed in CHO cells incubated for 4 hrs by flow cytometric competition binding assay,CHEMBL5236624,KI,CN(C)c1ccc2c(-c3ccc(-c4cn(CCCCCn5cc(CCCCCCN6CCC(COC(=O)Nc7ccc(F)cc7-c7ccc(F)c(Cl)c7)CC6)nn5)nn4)cc3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1
CHEMBL5271406,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1445,nM,CHEMBL5239861,B,Displacement of tiotropium bromide from human muscarinic M3 receptor expressed in CHO cells incubated for 4 hrs by flow cytometric competition binding assay,CHEMBL5236624,KI,CC1(C)C(/C=C/C=C/C=C2/N(CCCCS(=O)(=O)O)c3ccccc3C2(C)C)=[N+](CCCCCC(=O)NCCCCCCCCN2CCC(OC(=O)Nc3ccc(F)cc3-c3ccc(F)c(Cl)c3)CC2)c2ccc(S(=O)(=O)[O-])cc21
CHEMBL5285607,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1318,nM,CHEMBL5239861,B,Displacement of tiotropium bromide from human muscarinic M3 receptor expressed in CHO cells incubated for 4 hrs by flow cytometric competition binding assay,CHEMBL5236624,KI,CN(C)c1ccc2c(-c3ccc(-c4cn(CCCCCn5cc(CCCCCCN6CCC(COC(=O)Nc7ccc(F)cc7-c7ccc(F)c(Cl)c7)CC6)nn5)nn4)cc3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1
CHEMBL5395401,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,219.0,nM,CHEMBL5319329,B,Binding affinity to M3 receptor (unknown origin) assessed as inhibition constant,CHEMBL5316327,KI,CCN(CC)CCCC(C)Nc1cnc(C(=O)Nc2ccc(Cl)c3cccnc23)cn1
CHEMBL5431371,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1349.0,nM,CHEMBL5319329,B,Binding affinity to M3 receptor (unknown origin) assessed as inhibition constant,CHEMBL5316327,KI,CCN(CC)CCCC(C)Nc1cnc(C(=O)Nc2cc(F)cc3cccnc23)cn1
CHEMBL5426968,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.0631,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN[C@@H](C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)cc1OC
CHEMBL5395712,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1995,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C)(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)cc1OC
CHEMBL5395712,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1585,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C)(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)cc1OC
CHEMBL5410533,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3162,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,CCC(NCc1ccc(C(=O)O[C@@H](Cc2c(Cl)c[n+]([O-])cc2Cl)c2ccc(OC)c(OC)c2)s1)(C(=O)O[C@H]1CN2CCC1CC2)c1ccccc1
CHEMBL5410533,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.981,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,CCC(NCc1ccc(C(=O)O[C@@H](Cc2c(Cl)c[n+]([O-])cc2Cl)c2ccc(OC)c(OC)c2)s1)(C(=O)O[C@H]1CN2CCC1CC2)c1ccccc1
CHEMBL5408238,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.631,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(CO)(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)cc1OC
CHEMBL5408238,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.1995,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(CO)(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)cc1OC
CHEMBL5430170,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.162,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,COCC(NCc1ccc(C(=O)O[C@@H](Cc2c(Cl)c[n+]([O-])cc2Cl)c2ccc(OC)c(OC)c2)s1)(C(=O)O[C@H]1CN2CCC1CC2)c1ccccc1
CHEMBL5430170,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.012,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,COCC(NCc1ccc(C(=O)O[C@@H](Cc2c(Cl)c[n+]([O-])cc2Cl)c2ccc(OC)c(OC)c2)s1)(C(=O)O[C@H]1CN2CCC1CC2)c1ccccc1
CHEMBL5402697,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2512,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)cc2)cc1OC
CHEMBL5397387,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.631,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,COc1cc(C(=O)O[C@@H](Cc2c(Cl)c[n+]([O-])cc2Cl)c2ccc(OC)c(OC)c2)ccc1CNC(C(=O)O[C@H]1CN2CCC1CC2)c1ccccc1
CHEMBL5433640,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1.0,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,CCOc1cc(C(=O)O[C@@H](Cc2c(Cl)c[n+]([O-])cc2Cl)c2ccc(OC)c(OC)c2)ccc1CNC(C(=O)O[C@H]1CN2CCC1CC2)c1ccccc1
CHEMBL5439180,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2.512,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)c(OCC3CC3)c2)cc1OC
CHEMBL5404020,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,31.62,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(CO)(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)c(OCC3CC3)c2)cc1OC
CHEMBL5417689,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.631,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,CCOc1cc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN[C@@](CO)(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)ccc1OC
CHEMBL5409010,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2512,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,CCOc1cc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN[C@](CO)(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)ccc1OC
CHEMBL5399363,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3981,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(CO)(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)cc1OCC1CC1
CHEMBL5399363,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.2512,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,COc1ccc([C@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CNC(CO)(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)cc1OCC1CC1
CHEMBL5420551,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,25.12,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,CCOc1cc([C@@H](Cc2c(Cl)c[n+]([O-])cc2Cl)OC(=O)c2ccc(CN[C@@](CO)(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)ccc1OC
CHEMBL5419862,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,3.162,nM,CHEMBL5364539,B,Displacement of [3H]N-methylscopolamine chloride from human muscarinic M3 receptor incubated for 2 hrs by radioligand binding assay,CHEMBL5360646,KI,CCOc1cc([C@H](Cc2c(Cl)cncc2Cl)OC(=O)c2ccc(CN[C@@](CO)(C(=O)O[C@H]3CN4CCC3CC4)c3ccccc3)s2)ccc1OC
CHEMBL43383,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,152.23,nM,CHEMBL5442210,B,"PDSP Secondary Binding target: CHRM3 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CCN(CC)CCCCC1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1
CHEMBL405355,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,2148.08,nM,CHEMBL5442210,B,"PDSP Secondary Binding target: CHRM3 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1
CHEMBL281350,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,926.08,nM,CHEMBL5442210,B,"PDSP Secondary Binding target: CHRM3 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1nc(-c2ccc(-c3ccc(C(=O)N4CCc5cc6c(cc54)C4(CCN(C)CC4)CO6)cc3)c(C)c2)no1
CHEMBL59898,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,172.9,nM,CHEMBL5442210,B,"PDSP Secondary Binding target: CHRM3 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CCOC(=O)c1c(C)[nH]c2ccc3c(c12)CN1CCc2cc(OC)ccc2C1O3
CHEMBL543113,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,5.82,nM,CHEMBL5442210,B,"PDSP Secondary Binding target: CHRM3 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN1C2CCC1CC(OC(c1ccc(F)cc1)c1ccc(F)cc1)C2.Cl
CHEMBL360648,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,706.8,nM,CHEMBL5442210,B,"PDSP Secondary Binding target: CHRM3 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1cc(C(=O)N2Cc3cnn(C)c3Nc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=S)N1CCCN(C)CC1
CHEMBL214957,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,4131.43,nM,CHEMBL5442210,B,"PDSP Secondary Binding target: CHRM3 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,COc1cc(-n2cnc3cc(-c4ccc(Cl)cc4)sc3c2=O)ccc1OCCN1CCCC1
CHEMBL4743049,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,850.84,nM,CHEMBL5442210,B,"PDSP Secondary Binding target: CHRM3 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cl.Clc1cccc(COc2cncc(N3CCNCC3)n2)c1
CHEMBL1633,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,995.75,nM,CHEMBL5442210,B,"PDSP Secondary Binding target: CHRM3 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1.O=C(O)/C=C/C(=O)O
CHEMBL2048820,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1527.21,nM,CHEMBL5442210,B,"PDSP Secondary Binding target: CHRM3 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1cn2cc(CC(=O)N3CCC4(CC3)CN(Cc3ccc(-n5nccn5)cc3Cl)C4)nc2s1
CHEMBL1474387,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,1138.54,nM,CHEMBL5442210,B,"PDSP Secondary Binding target: CHRM3 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1c(P(=S)(c2ccccc2)c2ccccc2)n2ccccc2[n+]1C/C=C/c1ccccc1.[Br-]
CHEMBL3545181,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,0.3298,nM,CHEMBL5442210,B,"PDSP Secondary Binding target: CHRM3 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,C[N+]1(C)[C@@H]2C[C@@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.O.[Br-]
CHEMBL1200871,CHEMBL245,Muscarinic acetylcholine receptor M3,Ki,=,13.75,nM,CHEMBL5442210,B,"PDSP Secondary Binding target: CHRM3 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1.O=C(O)[C@H](O)[C@@H](O)C(=O)O
CHEMBL538793,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,25118864315095.82,nM,CHEMBL752407,B,Effective concentration was evaluated against Muscarinic acetylcholine receptor M3 expressed in A9 L cells,CHEMBL1145111,EC50,CC(=O)OCCCCCCCCCCCCOc1nsnc1C1=CCCN(C)C1.Cl
CHEMBL21536,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,39810717055349.7,nM,CHEMBL752407,B,Effective concentration was evaluated against Muscarinic acetylcholine receptor M3 expressed in A9 L cells,CHEMBL1145111,EC50,CCCCCCOc1nsnc1C1=CCCN(C)C1
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,50118723362727.15,nM,CHEMBL752407,B,Effective concentration was evaluated against Muscarinic acetylcholine receptor M3 expressed in A9 L cells,CHEMBL1145111,EC50,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL136027,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,2511886431509.58,nM,CHEMBL752407,B,Effective concentration was evaluated against Muscarinic acetylcholine receptor M3 expressed in A9 L cells,CHEMBL1145111,EC50,COc1nsnc1OCCCCCCCCCCCCOc1nsnc1C1=CCCN(C)C1
CHEMBL545077,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,100000000000000.0,nM,CHEMBL752407,B,Effective concentration was evaluated against Muscarinic acetylcholine receptor M3 expressed in A9 L cells,CHEMBL1145111,EC50,CN1CCC=C(c2nsnc2OCCCCCCCCCCCCO)C1.Cl
CHEMBL69306,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,130.0,nM,CHEMBL746366,B,In Vitro activity at the cloned Human Muscarinic acetylcholine receptor M3 determined by receptor selection and amplification technology (R-SAT),CHEMBL1128399,EC50,C#CCOc1noc2c1CNCCC2
CHEMBL7634,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,210.0,nM,CHEMBL746366,B,In Vitro activity at the cloned Human Muscarinic acetylcholine receptor M3 determined by receptor selection and amplification technology (R-SAT),CHEMBL1128399,EC50,O=C1CCCN1CC#CCN1CCCC1
CHEMBL305264,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,140.0,nM,CHEMBL746366,B,In Vitro activity at the cloned Human Muscarinic acetylcholine receptor M3 determined by receptor selection and amplification technology (R-SAT),CHEMBL1128399,EC50,CC(C)Oc1noc2c1CNCCC2
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,1800.0,nM,CHEMBL746366,B,In Vitro activity at the cloned Human Muscarinic acetylcholine receptor M3 determined by receptor selection and amplification technology (R-SAT),CHEMBL1128399,EC50,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL69305,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,500.0,nM,CHEMBL746366,B,In Vitro activity at the cloned Human Muscarinic acetylcholine receptor M3 determined by receptor selection and amplification technology (R-SAT),CHEMBL1128399,EC50,CCOc1noc2c1CNCCC2
CHEMBL304142,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,620.0,nM,CHEMBL746366,B,In Vitro activity at the cloned Human Muscarinic acetylcholine receptor M3 determined by receptor selection and amplification technology (R-SAT),CHEMBL1128399,EC50,COc1noc2c1CNCCC2
CHEMBL7303,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,340.0,nM,CHEMBL746366,B,In Vitro activity at the cloned Human Muscarinic acetylcholine receptor M3 determined by receptor selection and amplification technology (R-SAT),CHEMBL1128399,EC50,COC(=O)C1=CCCN(C)C1
CHEMBL440085,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,800.0,nM,CHEMBL749054,B,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",CHEMBL1123456,EC50,COc1noc2c1CN(C)CC2.Cl
CHEMBL6568,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,20000.0,nM,CHEMBL749054,B,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",CHEMBL1123456,EC50,CCN1CCc2onc(OC)c2C1.Cl
CHEMBL6680,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,3400.0,nM,CHEMBL749054,B,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",CHEMBL1123456,EC50,CCOc1noc2c1CNCC2.Cl
CHEMBL268175,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,13000.0,nM,CHEMBL749054,B,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",CHEMBL1123456,EC50,C=CCOc1noc2c1CNCC2.Cl
CHEMBL6767,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,1200.0,nM,CHEMBL749054,B,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",CHEMBL1123456,EC50,C#CCOc1noc2c1CNCC2.Cl
CHEMBL7303,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,100.0,nM,CHEMBL749054,B,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",CHEMBL1123456,EC50,COC(=O)C1=CCCN(C)C1
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,70.0,nM,CHEMBL749054,B,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",CHEMBL1123456,EC50,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL269706,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,1600.0,nM,CHEMBL749054,B,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",CHEMBL1123456,EC50,CCOc1noc2c1CN(C)CC2.Cl
CHEMBL7018,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,4500.0,nM,CHEMBL749054,B,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",CHEMBL1123456,EC50,CC#CCOc1noc2c1CNCC2.Cl
CHEMBL268808,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,300.0,nM,CHEMBL749054,B,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",CHEMBL1123456,EC50,COC(=O)C1=CCCNC1
CHEMBL6451,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,1800.0,nM,CHEMBL749054,B,"Contraction of guinea pig ileum by muscarinic AChR activation, which could be inhibited by application of atropine",CHEMBL1123456,EC50,COc1noc2c1CNCC2.Cl
CHEMBL1184,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,220.0,nM,CHEMBL1673550,B,Activation of M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as FRET signal,CHEMBL1671751,EC50,CC(=O)OCC[N+](C)(C)C.[Cl-]
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,1900.0,nM,CHEMBL1673550,B,Activation of M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as FRET signal,CHEMBL1671751,EC50,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL23957,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,1800.0,nM,CHEMBL1673550,B,Activation of M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as FRET signal,CHEMBL1671751,EC50,C[N+](C)(C)CC#CCN1CCCC1=O.[I-]
CHEMBL1255785,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,1000.0,nM,CHEMBL1673550,B,Activation of M3-ACh receptor-FLASH/CFP expressed in HEK293 cells assessed as FRET signal,CHEMBL1671751,EC50,C[C@@H]1O[C@H](C[N+](C)(C)C)C[C@H]1O.[Cl-]
CHEMBL523685,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,6400.0,nM,CHEMBL2067889,B,Positive allosteric modulation activity at muscarinic M3 receptor,CHEMBL2062464,EC50,O=C1C(=O)N(Cc2ccc(Br)cc2)c2ccccc21
CHEMBL4091934,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,10471.29,nM,CHEMBL4026888,B,Agonist activity at Gq/11 coupled recombinant human muscarinic M3 AChR expressed in CHO-FlpIn cells assessed as IP-one accumulation after 40 mins by HTRF assay,CHEMBL4024758,EC50,COc1cccc(CC[N+](C)(C)C)c1.O=C[O-]
CHEMBL4091934,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,10000.0,nM,CHEMBL4026888,B,Agonist activity at Gq/11 coupled recombinant human muscarinic M3 AChR expressed in CHO-FlpIn cells assessed as IP-one accumulation after 40 mins by HTRF assay,CHEMBL4024758,EC50,COc1cccc(CC[N+](C)(C)C)c1.O=C[O-]
CHEMBL667,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,239.88,nM,CHEMBL4026888,B,Agonist activity at Gq/11 coupled recombinant human muscarinic M3 AChR expressed in CHO-FlpIn cells assessed as IP-one accumulation after 40 mins by HTRF assay,CHEMBL4024758,EC50,CC(=O)OCC[N+](C)(C)C
CHEMBL667,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,240.0,nM,CHEMBL4026888,B,Agonist activity at Gq/11 coupled recombinant human muscarinic M3 AChR expressed in CHO-FlpIn cells assessed as IP-one accumulation after 40 mins by HTRF assay,CHEMBL4024758,EC50,CC(=O)OCC[N+](C)(C)C
CHEMBL4060823,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,3700.0,nM,CHEMBL4026888,B,Agonist activity at Gq/11 coupled recombinant human muscarinic M3 AChR expressed in CHO-FlpIn cells assessed as IP-one accumulation after 40 mins by HTRF assay,CHEMBL4024758,EC50,C[N+](C)(C)CCc1ccc2c(c1)OCC2.O=C[O-]
CHEMBL667,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,22.91,nM,CHEMBL4026901,B,Agonist activity at recombinant human muscarinic M3 receptor expressed in CHO cells assessed as upregulation in ERK1/2 phosphorylation after 5 mins by alphascreen assay,CHEMBL4024758,EC50,CC(=O)OCC[N+](C)(C)C
CHEMBL667,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,23.0,nM,CHEMBL4026901,B,Agonist activity at recombinant human muscarinic M3 receptor expressed in CHO cells assessed as upregulation in ERK1/2 phosphorylation after 5 mins by alphascreen assay,CHEMBL4024758,EC50,CC(=O)OCC[N+](C)(C)C
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,22.0,nM,CHEMBL4605234,B,Agonist activity at muscarinic M3 receptor (unknown origin) expressed in HEK293 cells coexpressing EA tagged beta-arrestin2 assessed as beta-arrestin2 recruitment incubated for 90 mins by PathHunter assay,CHEMBL4602697,EC50,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL4648071,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,27.0,nM,CHEMBL4605235,B,Antagonist activity at muscarinic M3 receptor (unknown origin) expressed in HEK293 cells coexpressing EA tagged beta-arrestin2 assessed as inhibition of carbachol-induced beta-arrestin2 recruitment preincubated for 30 mins followed by carbachol addition and measured after 90 mins by PathHunter assay,CHEMBL4602697,EC50,O=C(Nc1ccc(F)cc1-c1cccc(Cl)c1)O[C@H]1CN2CCC1CC2
CHEMBL4640324,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,25.0,nM,CHEMBL4605235,B,Antagonist activity at muscarinic M3 receptor (unknown origin) expressed in HEK293 cells coexpressing EA tagged beta-arrestin2 assessed as inhibition of carbachol-induced beta-arrestin2 recruitment preincubated for 30 mins followed by carbachol addition and measured after 90 mins by PathHunter assay,CHEMBL4602697,EC50,O=C(Nc1ccc(F)cc1-c1ccc(F)c(Cl)c1)O[C@H]1CN2CCC1CC2
CHEMBL4640703,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,26.0,nM,CHEMBL4605235,B,Antagonist activity at muscarinic M3 receptor (unknown origin) expressed in HEK293 cells coexpressing EA tagged beta-arrestin2 assessed as inhibition of carbachol-induced beta-arrestin2 recruitment preincubated for 30 mins followed by carbachol addition and measured after 90 mins by PathHunter assay,CHEMBL4602697,EC50,O=C(Nc1ccc(F)cc1-c1cccc(Cl)c1)OCC1CCNCC1
CHEMBL4636528,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,4.1,nM,CHEMBL4605235,B,Antagonist activity at muscarinic M3 receptor (unknown origin) expressed in HEK293 cells coexpressing EA tagged beta-arrestin2 assessed as inhibition of carbachol-induced beta-arrestin2 recruitment preincubated for 30 mins followed by carbachol addition and measured after 90 mins by PathHunter assay,CHEMBL4602697,EC50,O=C(Nc1ccc(F)cc1-c1ccc(F)c(Cl)c1)OCC1CCNCC1
CHEMBL4647437,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,2.2,nM,CHEMBL4605235,B,Antagonist activity at muscarinic M3 receptor (unknown origin) expressed in HEK293 cells coexpressing EA tagged beta-arrestin2 assessed as inhibition of carbachol-induced beta-arrestin2 recruitment preincubated for 30 mins followed by carbachol addition and measured after 90 mins by PathHunter assay,CHEMBL4602697,EC50,C[N+]12CCC(CC1)[C@@H](OC(=O)Nc1ccc(F)cc1-c1cccc(Cl)c1)C2.O=C[O-]
CHEMBL4633816,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,2.2,nM,CHEMBL4605235,B,Antagonist activity at muscarinic M3 receptor (unknown origin) expressed in HEK293 cells coexpressing EA tagged beta-arrestin2 assessed as inhibition of carbachol-induced beta-arrestin2 recruitment preincubated for 30 mins followed by carbachol addition and measured after 90 mins by PathHunter assay,CHEMBL4602697,EC50,C[N+]12CCC(CC1)[C@@H](OC(=O)Nc1ccc(F)cc1-c1ccc(F)c(Cl)c1)C2.O=C[O-]
CHEMBL4638964,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,0.4,nM,CHEMBL4605235,B,Antagonist activity at muscarinic M3 receptor (unknown origin) expressed in HEK293 cells coexpressing EA tagged beta-arrestin2 assessed as inhibition of carbachol-induced beta-arrestin2 recruitment preincubated for 30 mins followed by carbachol addition and measured after 90 mins by PathHunter assay,CHEMBL4602697,EC50,C[N+]1(C)[C@@H]2C[C@H](OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12.[Br-]
CHEMBL1346,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,11.0,nM,CHEMBL4605235,B,Antagonist activity at muscarinic M3 receptor (unknown origin) expressed in HEK293 cells coexpressing EA tagged beta-arrestin2 assessed as inhibition of carbachol-induced beta-arrestin2 recruitment preincubated for 30 mins followed by carbachol addition and measured after 90 mins by PathHunter assay,CHEMBL4602697,EC50,NC(=O)C(c1ccccc1)(c1ccccc1)[C@@H]1CCN(CCc2ccc3c(c2)CCO3)C1
CHEMBL1734,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,24.0,nM,CHEMBL5238148,B,Antagonist activity at M3 receptor (unknown origin),CHEMBL5236587,EC50,O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1
CHEMBL5284728,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,17000.0,nM,CHEMBL5238148,B,Antagonist activity at M3 receptor (unknown origin),CHEMBL5236587,EC50,O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccc(F)cc1
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,24.0,nM,CHEMBL5239849,B,Agonist activity at human muscarinic M3 receptor expressed in human HEK293T cells assessed as activation of G-protein signaling by measuring inositol accumulation incubated for 90 mins by HTRF assay,CHEMBL5236624,EC50,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL14,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,21.0,nM,CHEMBL5239850,B,Agonist activity at human muscarinic M3 receptor expressed in human HEK293T cells cells co-expressing beta-arrestin2 assessed as stimulation of beta-arrestin recruitment incubated 90 mins by PathHunter assay,CHEMBL5236624,EC50,C[N+](C)(C)CCOC(N)=O.[Cl-]
CHEMBL550,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,1445.44,nM,CHEMBL5259069,B,Partial agonist activity at C-terminal NanoLuc tagged human muscarinic M3 receptor expressed in HEK293T cells using furimazine as substrate assessed as receptor activation preincubated with substrate for 1 min followed by compound addition and measured for 6 mins 27 sec by NanoBRET assay,CHEMBL5257088,EC50,CC[C@@H]1C(=O)OC[C@@H]1Cc1cncn1C
CHEMBL91776,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,10232.93,nM,CHEMBL5259069,B,Partial agonist activity at C-terminal NanoLuc tagged human muscarinic M3 receptor expressed in HEK293T cells using furimazine as substrate assessed as receptor activation preincubated with substrate for 1 min followed by compound addition and measured for 6 mins 27 sec by NanoBRET assay,CHEMBL5257088,EC50,CC[C@H]1C(=O)OC[C@@H]1Cc1cncn1C
CHEMBL5272950,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,20892.96,nM,CHEMBL5259069,B,Partial agonist activity at C-terminal NanoLuc tagged human muscarinic M3 receptor expressed in HEK293T cells using furimazine as substrate assessed as receptor activation preincubated with substrate for 1 min followed by compound addition and measured for 6 mins 27 sec by NanoBRET assay,CHEMBL5257088,EC50,O=C1C[C@@H](Cc2cnc[nH]2)CO1
CHEMBL5287096,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,16218.1,nM,CHEMBL5259069,B,Partial agonist activity at C-terminal NanoLuc tagged human muscarinic M3 receptor expressed in HEK293T cells using furimazine as substrate assessed as receptor activation preincubated with substrate for 1 min followed by compound addition and measured for 6 mins 27 sec by NanoBRET assay,CHEMBL5257088,EC50,CC[C@@H]1C(=O)OC[C@@H]1Cc1c[n+](CCCCCC[N+](C)(C)CC(C)(C)CN2C(=O)c3cccc4cccc(c34)C2=O)cn1C.[Br-].[Br-]
CHEMBL5285668,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,2818.38,nM,CHEMBL5259069,B,Partial agonist activity at C-terminal NanoLuc tagged human muscarinic M3 receptor expressed in HEK293T cells using furimazine as substrate assessed as receptor activation preincubated with substrate for 1 min followed by compound addition and measured for 6 mins 27 sec by NanoBRET assay,CHEMBL5257088,EC50,CC[C@H]1C(=O)OC[C@@H]1Cc1c[n+](CCCCCC[N+](C)(C)CC(C)(C)CN2C(=O)c3cccc4cccc(c34)C2=O)cn1C.O=C[O-].O=C[O-]
CHEMBL5277944,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,31622.78,nM,CHEMBL5259069,B,Partial agonist activity at C-terminal NanoLuc tagged human muscarinic M3 receptor expressed in HEK293T cells using furimazine as substrate assessed as receptor activation preincubated with substrate for 1 min followed by compound addition and measured for 6 mins 27 sec by NanoBRET assay,CHEMBL5257088,EC50,CC[C@H]1C(=O)OC[C@@H]1Cc1c[n+](CCCCCCCC[N+](C)(C)CC(C)(C)CN2C(=O)c3cccc4cccc(c34)C2=O)cn1C.O=C[O-].O=C[O-]
CHEMBL667,CHEMBL245,Muscarinic acetylcholine receptor M3,EC50,=,501.19,nM,CHEMBL5259081,B,Agonist activity at C-terminal NanoLuc tagged human muscarinic M3 receptor expressed in HEK293T cells using furimazine as substrate assessed as receptor activation preincubated with substrate for 1 min followed by compound addition and measured for 6 mins 27 sec by NanoBRET assay,CHEMBL5257088,EC50,CC(=O)OCC[N+](C)(C)C
CHEMBL216927,CHEMBL245,Muscarinic acetylcholine receptor M3,Kd,=,158.49,nM,CHEMBL855414,B,Antagonist activity at human M3 receptor assessed as inhibition of carbachol binding,CHEMBL1138216,KD,COc1nsnc1OCCOCCOCCOCCOc1nsnc1C1=CCCN(C)C1
CHEMBL216928,CHEMBL245,Muscarinic acetylcholine receptor M3,Kd,=,158.49,nM,CHEMBL855414,B,Antagonist activity at human M3 receptor assessed as inhibition of carbachol binding,CHEMBL1138216,KD,COc1nsc(OCCOCCOCCOCCOc2nsnc2C2C=CCCN2C)n1
CHEMBL386983,CHEMBL245,Muscarinic acetylcholine receptor M3,Kd,=,63.1,nM,CHEMBL855414,B,Antagonist activity at human M3 receptor assessed as inhibition of carbachol binding,CHEMBL1138216,KD,COc1nsnc1OCCOCCOCCOCCOCCOc1nsnc1C1=CCCN(C)C1
CHEMBL4860528,CHEMBL245,Muscarinic acetylcholine receptor M3,Kd,=,0.12,nM,CHEMBL5151488,B,Displacement of [3H]N-methylscopolamine from human muscarinic acetylcholine M3 receptor stably expressed in CHO cells by radioligand competition binding based analysis,CHEMBL5149991,KD,CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C
CHEMBL5207281,CHEMBL245,Muscarinic acetylcholine receptor M3,Kd,=,0.12,nM,CHEMBL5151488,B,Displacement of [3H]N-methylscopolamine from human muscarinic acetylcholine M3 receptor stably expressed in CHO cells by radioligand competition binding based analysis,CHEMBL5149991,KD,CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5206565,CHEMBL245,Muscarinic acetylcholine receptor M3,Kd,=,0.12,nM,CHEMBL5151488,B,Displacement of [3H]N-methylscopolamine from human muscarinic acetylcholine M3 receptor stably expressed in CHO cells by radioligand competition binding based analysis,CHEMBL5149991,KD,N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5201074,CHEMBL245,Muscarinic acetylcholine receptor M3,Kd,=,0.12,nM,CHEMBL5151488,B,Displacement of [3H]N-methylscopolamine from human muscarinic acetylcholine M3 receptor stably expressed in CHO cells by radioligand competition binding based analysis,CHEMBL5149991,KD,C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1.Cl.Cl
CHEMBL5271406,CHEMBL245,Muscarinic acetylcholine receptor M3,Kd,=,54.0,nM,CHEMBL5239851,B,Binding affinity to saturated human muscarinic M3 expressed in CHO cells assessed as dissociation constant incubated for 2 hrs by flow cytometry,CHEMBL5236624,KD,CC1(C)C(/C=C/C=C/C=C2/N(CCCCS(=O)(=O)O)c3ccccc3C2(C)C)=[N+](CCCCCC(=O)NCCCCCCCCN2CCC(OC(=O)Nc3ccc(F)cc3-c3ccc(F)c(Cl)c3)CC2)c2ccc(S(=O)(=O)[O-])cc21
CHEMBL5285607,CHEMBL245,Muscarinic acetylcholine receptor M3,Kd,=,23.0,nM,CHEMBL5239851,B,Binding affinity to saturated human muscarinic M3 expressed in CHO cells assessed as dissociation constant incubated for 2 hrs by flow cytometry,CHEMBL5236624,KD,CN(C)c1ccc2c(-c3ccc(-c4cn(CCCCCn5cc(CCCCCCN6CCC(COC(=O)Nc7ccc(F)cc7-c7ccc(F)c(Cl)c7)CC6)nn5)nn4)cc3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1
CHEMBL5271406,CHEMBL245,Muscarinic acetylcholine receptor M3,Kd,=,49.7,nM,CHEMBL5239852,B,Binding affinity to saturated human muscarinic M3 expressed in CHO cells assessed as dissociation constant incubated for 2 hrs in presence of atropine by flow cytometry,CHEMBL5236624,KD,CC1(C)C(/C=C/C=C/C=C2/N(CCCCS(=O)(=O)O)c3ccccc3C2(C)C)=[N+](CCCCCC(=O)NCCCCCCCCN2CCC(OC(=O)Nc3ccc(F)cc3-c3ccc(F)c(Cl)c3)CC2)c2ccc(S(=O)(=O)[O-])cc21
CHEMBL5285607,CHEMBL245,Muscarinic acetylcholine receptor M3,Kd,=,24.0,nM,CHEMBL5239852,B,Binding affinity to saturated human muscarinic M3 expressed in CHO cells assessed as dissociation constant incubated for 2 hrs in presence of atropine by flow cytometry,CHEMBL5236624,KD,CN(C)c1ccc2c(-c3ccc(-c4cn(CCCCCn5cc(CCCCCCN6CCC(COC(=O)Nc7ccc(F)cc7-c7ccc(F)c(Cl)c7)CC6)nn5)nn4)cc3C(=O)[O-])c3ccc(=[N+](C)C)cc-3oc2c1
